Sentence,class,file
New Phytol 2002; 153:185-94; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Remote Sens Environ 2002; 81:337-54; http://dx.doi.org/10.1016/S0034-4257(02)00010-X 65.,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Planta 1999; 207:604-11; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Plant Sci 2000; 151:59-66; http://dx.doi.org/10.1016/ S0168-9452(99)00197-149.,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Plant  J 2007; 52:949-60; PMID:17892445; http://dx.doi.org/10.1111/j.1365-313X.2007.03283.x 50.,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Plant Physiol  1991; 96:275-9; PMID:16668164; http://dx.doi.org/10.1104/pp.96.1.275 53.,Non-OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Plant Physiol 2002; 130:2129-41; PMID:12481097; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Plant J 2000; 23:489-96;  PMID:10972875; http://dx.doi.org/10.1046/j.1365- 313x.2000.00813.x 55.,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Biochim Biophys Acta  2000; 1465:219-35; PMID:10748256; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Plant Cell Environ 1998; 21:253-68; http://dx.doi.org/10.1046/j.1365-3040.1998.00277.x 57.,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Plant J 2004; 39:612-28;  PMID:15272878; http://dx.doi.org/10.1111/j.1365-313X.2004.02160.x 58.,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
Int  J Mol Sci 2012; 13:15193-208; PMID:23203119; http://dx.doi.org/10.3390/ijms131115193,OADS,/arxiv_data1/oa_pdf/57/62/psb-8-e25479.PMC4011814.pdf
"Our studies revealed Interplay of PKA and Rac  Fine-tuning of Rac localization and signaling Verena A Bachmann, Klaus Bister, and Eduard Stefan* Institute of Biochemistry; University of Innsbruck; Innsbruck, Austria Keywords:  kinase, cross talk,  proliferation, scaffold, Rac, PKA, p21- activated kinase, cAMP, translocation *Correspondence to: Eduard Stefan;   Email: eduard.stefan@uibk.ac.at Submitted: 10/07/2013;  Revised: 11/18/2013;  Accepted: 11/20/2013;  Published Online: 12/10/2013 http://dx.doi.org/10.4161/sgtp.27281 Commentary to: Bachmann VA, Riml A, Huber RG,  Baillie GS, Liedl KR, Valovka T, Stefan E. Reciprocal  regulation of PKA and Rac signaling.",Non-OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Nat Rev Mol Cell Biol 2012; 13:646- 58; PMID:22992589 ; http://dx.doi.org/10.1038/ nrm3432 4.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Annu Rev Cell Dev Biol 2005; 21:247- 69; PMID:16212495 ; http://dx.doi.org/10.1146/ annurev.cellbio.21.020604.150721 5.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Nat Rev Mol Cell Biol  2004; 5:959-70;  PMID :15573134 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Nature  2009; 461:542-5;  PMID:19727074 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Nature 2002; 420:629-35;  PMID:12478284 ;  http://dx.doi.org/10.1038/nature01148 9.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
FEBS Lett 2008; 582:2093-101;   PMID:18460342 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Proc Natl Acad Sci U S A  2013; 110:8531-6;  PMID:23657011 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Nat Chem Biol 2013; 9:428- 36; PMID:23685672 ; http://dx.doi.org/10.1038/ nchembio.1257 14.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Nat Rev Drug Discov 2007; 6:569- 82; PMID:17599086 ; http://dx.doi.org/10.1038/ nrd2311 15.,Non-OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Nat Methods 2009; 6:83- 90; PMID:19060904 ; http://dx.doi.org/10.1038/ nmeth.1280 16.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Curr Opin Biotechnol 2011; 22:50- 8; PMID:20884196 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Proc Natl Acad Sci U S A 2007;  104:16916-21;  PMID:17942691 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
J Biol Chem 1999; 274:13198- 204; PMID:10224076 ; http://dx.doi.org/10.1074/ jbc.274.19.13198 19.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Science  2000; 290:333-7;  PMID:11030651 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Oncogene 2013;  32:2475-82;  PMID:22710715 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Nat Rev Cancer 2006; 6:459- 71; PMID:16723992 ; http://dx.doi.org/10.1038/ nrc1892 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Cell Logist  2012; 2:78-83;  PMID:23125950 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Cell 1989;  59:675-80;  PMID:2573431 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Proc Natl Acad Sci U S A 2010;  107:15467-72;  PMID:20716686 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Nat Rev  Mol Cell Biol 2001; 2:599-609;  PMID:11483993 ;  http://dx.doi.org/10.1038/35085068 27.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Cell 1995;  82:463-73;  PMID:7634336 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
J Cell Biol 2008; 181:485- 96; PMID:18443222 ; http://dx.doi.org/10.1083/ jcb.20080104729.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
J Biol Chem 2004; 279:44197- 210; PMID:15304504 ; http://dx.doi.org/10.1074/ jbc.M404977200 30.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
J Biol Chem 2003; 278:12495- 506; PMID:12551911 ; http://dx.doi.org/10.1074/ jbc.M211286200 31.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Proc Natl Acad Sci U S  A 2000; 97:185-9;  PMID:10618392 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Science  2000; 290:144-7;  PMID:11021801 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
FEBS J 2005;  272:3491-504;  PMID:16008550 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
Trends Cell Biol 2002; 12:258- 66; PMID:12074885 ; http://dx.doi.org/10.1016/ S0962-8924(02)02294-8,OADS,/arxiv_data1/oa_pdf/06/a2/sgtp-4-247.PMC4011821.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/1a/cia-9-741.PMC4011892.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 741–742Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  741letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S6205 424 weeks of Pilates-aerobic and educative   training to improve body fat mass in elderly  Serbian women Anne WS rutjes1 Marcello Di Nisio2,3 1Institute of Social and Preventive  Medicine, University of Bern, Bern,   Switzerland; 2Department of Medical,   Oral, and Biotechnological Sciences,   University G D’Annunzio of Chieti- Pescara, Chieti, Italy; 3Department of  Vascular Medicine, Academic Medical  Center, Amsterdam, the Netherlands Correspondence: Anne WS rutjes   Institute of Social and Preventive  Medicine, University of Bern,  Finkenhubelweg 11, 3012 Bern,  Switzerland   email a rutjes@ispm.unibe.c hDear editor We read with interest the article by Ruiz-Montero et al, in which the authors used a  before-and-after study design to examine changes in body composition (fat mass and  lean body mass) related to an aerobic-Pilates program in elderly Serbian women.1  The authors concluded that “a combined program of aerobic and Pilates, carried out  under the supervision of an instructor, at least twice a week, produces health benefits  in functionally independent women over the age of 60”.",Non-OADS,/arxiv_data1/oa_pdf/cc/1a/cia-9-741.PMC4011892.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/cc/1a/cia-9-741.PMC4011892.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/1a/cia-9-741.PMC4011892.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/e2/ppa-8-585.PMC4011893.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 585–592Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  585OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5955 4how patients experience the surroundings   in relation to patient participation: a qualitative  study of inpatients with intestinal failure gunvor Dichmann Thyssen Anne Beck Department of hepatology and  gastroenterology, Aarhus University  hospital, Aarhus, Denmark correspondence: gunvor Dichmann  Thyssen   Department of hepatology and  gastroenterology, Aarhus University  hospital, noerrebrogade 44, DK-8000  Aarhus c, Aarhus, Denmark   email g unvor.",Non-OADS,/arxiv_data1/oa_pdf/f9/e2/ppa-8-585.PMC4011893.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f9/e2/ppa-8-585.PMC4011893.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/e2/ppa-8-585.PMC4011893.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/30/cia-9-743.PMC4011894.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 743–751Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  743OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6122 4Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: To et al Running head recto: Cataract surgery and falls in Vietnam DOI: http://dx.doi.org/10.2147/CIA.S61224 Kien gia T o1,2 lynn Meuleners1 Max Bulsara3 Michelle l Fraser1 Dat Van Duong4 Dung Van Do2 Van-Anh ngoc huynh2 Tien Duy Phi5 hoang huy Tran5 nguyen Do nguyen5 1Curtin Monash Accident research  Centre (C-MArC), Faculty of health  sciences, Curtin University, Perth, WA,   Australia; 2University of Medicine   and Pharmacy, ho Chi Minh City,   Vietnam; 3Institute for health  research, University of notre Dame,   Fremantle, WA, Australia;    4United nations Population Fund,   hanoi, Vietnam; 5eye hospital,    ho Chi Minh City, Vietnam Correspondence: l ynn Meuleners Curtin Monash Accident research Centre  (C-MArC), Faculty of health sciences,  Curtin University, gPO Box U1987,   Perth, WA 6102, Australia T el +61 8 9266 4636 email l.meuleners@curtin.edu.a uA longitudinal cohort study of the impact   of first- and both-eye cataract surgery   on falls and other injuries in Vietnam Aim:  Little information exists on the impact of cataract surgery on falls and other injuries  in Vietnam.",Non-OADS,/arxiv_data1/oa_pdf/fb/30/cia-9-743.PMC4011894.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs344/en .,Non-OADS,/arxiv_data1/oa_pdf/fb/30/cia-9-743.PMC4011894.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs282/en .,Non-OADS,/arxiv_data1/oa_pdf/fb/30/cia-9-743.PMC4011894.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/fb/30/cia-9-743.PMC4011894.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fb/30/cia-9-743.PMC4011894.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/25/rru-6-021.PMC4011895.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpResearch and Reports in Urology 2014:6 21–25Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  21Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S4096 5Long-term effects of pediatric extracorporeal  shockwave lithotripsy on renal function Yigit Akin1 Selcuk Yucel2 1Department of Urology, Harran  University School of Medicine,   Sanliurfa, T urkey; 2Department of  Urology, Acibadem University School  of Medicine, istanbul, T urkey Correspondence: Yigit Akin   Department of Urology, Harran  University School of Medicine, Yenisehir,  Kampus, 63100 Sanliurfa, Turkey   Tel +90 414 318 3000   Fax +90 414 318 3005   email yigitakin@yahoo.co mIntroduction:  Extracorporeal shock wave lithotripsy (ESWL) is a well-known and successful  treatment modality.",Non-OADS,/arxiv_data1/oa_pdf/92/25/rru-6-021.PMC4011895.pdf
"Available from: http://www.uroweb.org/gls/pdf/22%20Paediatric%20 Urology_LR.pd f. Accessed February 4, 2014.",Non-OADS,/arxiv_data1/oa_pdf/92/25/rru-6-021.PMC4011895.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/92/25/rru-6-021.PMC4011895.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/25/rru-6-021.PMC4011895.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/1a/tcrm-10-313.PMC4011896.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 313–320Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  313Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6074 0Comparative clinical utility of once-weekly  subcutaneous abatacept in the management   of rheumatoid arthritis Chadi Rakieh Philip G Conaghan Leeds institute of Rheumatic and  Musculoskeletal Medicine, University  of Leeds, N iHR Leeds Musculoskeletal  Biomedical Research Unit, Leeds, UK Correspondence: Philip G Conaghan   Leeds institute of Rheumatic and  Musculoskeletal Medicine, Chapel  Allerton Hospital, Leeds LS7 4RX, UK   T el +44 113 3924883   Fax +44 113 3924991   email P .Conaghan@leeds.ac.u kAbstract:  Biologic therapies in rheumatoid arthritis are now part of standard practice for  disease that proves difficult to control with conventional disease-modifying anti-rheumatic  drugs.",Non-OADS,/arxiv_data1/oa_pdf/b2/1a/tcrm-10-313.PMC4011896.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b2/1a/tcrm-10-313.PMC4011896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/1a/tcrm-10-313.PMC4011896.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/77/prbm-7-137.PMC4011897.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2014:7 137–145Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  137Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S3506 1Discharged from a mental health admission ward:  is it safe to go home?,Non-OADS,/arxiv_data1/oa_pdf/b5/77/prbm-7-137.PMC4011897.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/b5/77/prbm-7-137.PMC4011897.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b5/77/prbm-7-137.PMC4011897.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/97/ppa-8-593.PMC4011898.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 593–601Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  593OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S5878 1Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Walz et al Running head recto: Impact of symptomatic hypoglycemia on medication adherence DOI: http://dx.doi.org/10.2147/PPA.S58781 impact of symptomatic hypoglycemia   on medication adherence, patient satisfaction   with treatment, and glycemic control in patients  with type 2 diabetes lotta Walz1,3 Billie Pettersson2,3 Ulf rosenqvist4 Anna Deleskog3,5 gunilla Journath6 Per Wändell7 1Department of Oncology-Pathology,   Karolinska institutet, stockholm,   2center for Medical Technology  Assessment, linköping University,   linköping, 3Merck sharp and  Dohme (sweden) AB, sollentuna,   4Department of internal Medicine,   Motala hospital, Motala, 5Department  of Molecular Medicine and surgery,   6Department of Medicine , Karolinska  institutet, stockholm, 7Department  of neurobiology, care sciences and  society, centre for Family Medicine,   Karolinska institutet, huddinge,   swedenBackground:  The purpose of this study was to evaluate the impact of symptomatic  hypoglycemia  on medication adherence, satisfaction with treatment, and glycemic control in patients with  type 2 diabetes based on the treatment goals stated in the  Swedish national guidelines.",Non-OADS,/arxiv_data1/oa_pdf/89/97/ppa-8-593.PMC4011898.pdf
Available from: http://www.socialstyrelsen.,Non-OADS,/arxiv_data1/oa_pdf/89/97/ppa-8-593.PMC4011898.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/89/97/ppa-8-593.PMC4011898.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/1c/ppa-8-565.PMC4011899.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 565–574Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  565OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S6150 5Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Rosdahl et al Running head recto: Ophthalmic patient preferences DOI: http://dx.doi.org/10.2147/PPA.S61505 Patient education preferences   in ophthalmic care Jullia A rosdahl lakshmi swamy sandra stinnett Kelly W Muir Department of Ophthalmology,    Duke eye center, Duke University,   Durham, nc, UsABackground:  The learning preferences of ophthalmology patients were examined.",Non-OADS,/arxiv_data1/oa_pdf/09/1c/ppa-8-565.PMC4011899.pdf
Available  from: http://www.nap.edu/books/0309072808/html.,Non-OADS,/arxiv_data1/oa_pdf/09/1c/ppa-8-565.PMC4011899.pdf
Available from: http://www.usvisionproblems.org.,Non-OADS,/arxiv_data1/oa_pdf/09/1c/ppa-8-565.PMC4011899.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/09/1c/ppa-8-565.PMC4011899.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/59/c2/ppa-8-519.PMC4011900.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 519–563Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  519Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S4729 0Psychosocial predictors of non-adherence   to chronic medication: systematic review   of longitudinal studies Hanneke e Zwikker1 Bart J van den Bemt1,2 Johanna e vriezekolk1 Cornelia H van den ende1 Sandra van Dulmen3–5 1Departments of Rheumatology  and Pharmacy, 2Department of  Pharmacy, Radboud University  Medical Centre, 3Department of  Primary and Community Care,   Radboud University Medical Centre,   Nijmegen, 4Netherlands institute  for Health Services Research, the  Netherlands; 5Department of Health  Science, Buskerud University College,   Drammen, Norway Correspondence: Bart van den Bemt   Departments of Rheumatology   and Pharmacy, Sint Maartenskliniek,   PO Box 9011, 6500 GM Nijmegen,   the Netherlands   Tel +31 24 365 8213   email b.vandenbemt@maartenskliniek.n lObjectives:  Several cross-sectional studies suggest that psychosocial factors are associated  with non-adherence to chronic preventive maintenance medication (CPMM); however, results  from longitudinal associations have not yet been systematically summarized.",Non-OADS,/arxiv_data1/oa_pdf/59/c2/ppa-8-519.PMC4011900.pdf
Available  from: http://abcproject.eu/index.php?pag e=publications.,Non-OADS,/arxiv_data1/oa_pdf/59/c2/ppa-8-519.PMC4011900.pdf
Avail - able from: http://www.cbs.nl/en-GB/menu/methoden/begrippen/default.,Non-OADS,/arxiv_data1/oa_pdf/59/c2/ppa-8-519.PMC4011900.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/59/c2/ppa-8-519.PMC4011900.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/c2/ppa-8-519.PMC4011900.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/e8/ppa-8-575.PMC4011901.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 575–583Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  575Short rePortopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/ 10.2147/PPA.S6227 8Journal name: Patient Preference and Adherence Journal Designation: Short Report Y ear: 2014 Volume: 8 Running head verso: Zendjidjian et al Running head recto: Satisfaction of hospitalized psychiatry patients DOI: http://dx.doi.org/10.2147/PPA.S62278 Satisfaction of hospitalized psychiatry patients:  why should clinicians care?,Non-OADS,/arxiv_data1/oa_pdf/f5/e8/ppa-8-575.PMC4011901.pdf
http://www.has-sante.fr/portail/jcms/ r_1439924/fr/manuel-de-certification-des-etablissements-de-sante- v2010-revise-avril-2011.,Non-OADS,/arxiv_data1/oa_pdf/f5/e8/ppa-8-575.PMC4011901.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f5/e8/ppa-8-575.PMC4011901.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/aa/vhrm-10-247.PMC4011902.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 247–251Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  247ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S6197 8The 24-hour pulse wave velocity,   aortic augmentation index, and central   blood pressure in normotensive volunteers Tatyana Y Kuznetsova1 Viktoria a Korneva1 evgeniya n Bryantseva2 Vitaliy s Barkan2 artemy V Orlov3 igor n Posokhov4 anatoly n  Rogoza5 On behalf of BP lab- Vasotens registry  collaborators 1Faculty of Medicine, Petrozavodsk  state University, Petrozavodsk, Russia;   2Diagnostics Department, The hospital  within the Russian Railroad network,    chita, Russia;  3Department  65  competitive system analysis, national  Research nuclear University M ePhi,   Moscow, Russia;  4Hemodynamic  laboratory ltd, nizhniy novgorod,   Russia;  5cardiology Research center,   Moscow, Russia correspondence: igor n Posokhov   Hemodynamic laboratory ltd,   PO Box  69, nizhniy novgorod  603009,  Russia   Tel +7 91 5939 6222  Fax +7 91 3825 9111  email posokhov@24h-monitoring.co mAbstract:  The purpose of this study was to examine the pulse wave velocity, aortic  augmentation  index corrected for heart rate  75 (AIx@75), and central systolic and diastolic blood pressure  during  24-hour monitoring in normotensive volunteers.",Non-OADS,/arxiv_data1/oa_pdf/5e/aa/vhrm-10-247.PMC4011902.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/5e/aa/vhrm-10-247.PMC4011902.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/aa/vhrm-10-247.PMC4011902.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0f/e8/oajsm-5-081.PMC4011903.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 81–87Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  81CASe SerieSopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S5822 5Diagnostic accuracy in detecting tears in  the proximal biceps tendon using standard  nonenhancing shoulder Mri Samuel A Dubrow1 Jonathan J Streit2 Y ousef Shishani2 Mark r robbin3 reuben Gobezie2 1Department of Orthopedics,  Alegent Creighton Clinic, Creighton  University School of Medicine,  Omaha, N e, USA;  2Department of  Orthopedics, Cleveland Shoulder  institute,  3Department of radiology,  University Hospitals of Cleveland,  Cleveland, OH, USA Correspondence: Samuel A Dubrow   Department of Orthopedics, Alegent  Creighton Clinic, Creighton University  School of Medicine, Lakeside ONe  Professional Center,  16909 Lakeside   Hills Court, Suite  300, Omaha,   Ne 68130, USA   Tel +1 402 717 0820  Fax +1 402 717 0830  email samueldubrow@gmail.co mBackground:  There is a paucity of data in the literature evaluating the performance of non - contrast MRI in the diagnosis of partial and complete tears of the proximal portion of the long  head of the biceps (LHB) tendon.",Non-OADS,/arxiv_data1/oa_pdf/0f/e8/oajsm-5-081.PMC4011903.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/0f/e8/oajsm-5-081.PMC4011903.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/e8/oajsm-5-081.PMC4011903.pdf
"*Correspondence to: Janice M Reichert;   Email: Reichert.biotechconsulting@gmail.comSubmitted: 02/20/14; Accepted: 02/20/14; Published Online: 03/03/2014http://dx.doi.org/10.4161/mabs.28421Antibody Engineering & Therapeutics,   The Annual Meeting of The Antibody Society December 8-12, 2013, Huntington Beach, CA Juan Carlos a lmagro,1 gary L g illiland,2 Felix Breden,3 Jamie K Scott,3 Devin Sok,4 Matthias Pauthner,4 Janice M r eichert5,*,  gustavo Helguera,6 raiees andrabi,4 robert Mabry,7 Mathieu Bléry,8 James e  Voss,4 Juha Laurén,9 Lubna a buqayyas10,†,   Stefan Barghorn11,†, eshel Ben-Jacob12,†, James e Crowe Jr13,†, James S Huston14,†, Stephen a lbert Johnston15,†, eric Krauland7,†,  Fridtjof Lund-Johansen 16,†, Wayne a Marasco17,†, Paul WH i Parren18,† and Kai y Xu19,† 1CTi-Boston, Pfizer; Boston, M a US a; 2Janssen r esearch & Development, LLC; Spring House, P a US a; 3Simon Fraser University; Burnaby, BC C a; 4The Scripps r esearch i nstitute;  La Jolla, C a US a; 5reichert Biotechnology Consulting, LLC; Framingham, M a US a; 6Coni CeT; Laboratorio Biotecnología Farmacéutica; i nstituto de Biología y Medicina  experimental, i ByMe; Ciudad autónoma de Buenos a ires, a rgentina; 7adimab, LLC; Lebanon, n H US a; 8innate Pharma; Marseille, France; 9regeneron Pharmaceuticals,  inc.; Tarrytown, ny US a; 10amgen, Thousand o aks, C a, USa; 11abbVie; Ludwigshafen, g ermany; 12Tel a viv University, Tel a viv, i srael; 13Vanderbilt University Medical Center,  nashville, T n, USa; 14Huston BioConsulting, LLC; n ewton, M a, USa; 15arizona State University; Phoenix, a Z US a; 16oslo University Hospital; o slo, n orway; 17Dana-Farber Cancer  Center; Boston, M a US a; 18genmab; Utrecht, The n etherlands; 19University of Maryland; Baltimore, MD US a †author who wrote only the summary for their own presentation.",Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
"Accelrys Software, Inc. Marc Fasnacht  described the methodology and results  obtained at Accelrys (http://accelrys.com/).",OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Gray’s lab at Johns Hopkins University Brian D. Weitzner presented the results from Jeffrey Gray’s  laboratory at Johns Hopkins University (http://graylab.jhu.edu/).,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
"The application developed for antibody modeling, RosettaAntibody, can be found through the web server ROSIE (http://rosie.rosettacommons.org/ ).",OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Dr. Shirai also acknowledged that AMA II helped to develop the server Kotai Antibody Builder (http://kotaiab.org/) for auto - mated antibody modeling.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
"Availability of Models and Supplementary Material The coordinates of benchmark structures and models, as well  as Supplementary Material of AMA-II and the first assessment, can be downloaded from: http://www.3DAbMod.com .",OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proteins 2011;  79:3050-66;  PMID:21935986 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Bioinformatics  2008; 24:1953-4;  PMID:18641403 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
FEBS Lett 1996; 399:1-8;  PMID:8980108 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Mol Biol 2006; 357:1566-74; PMID:16497332 ;  http://dx.doi.org/10.1016/j.jmb.2006.01.023 7.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proc Natl Acad Sci U S A 2013; 110:5145-50;  PMID:23479652 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Annu Rev Biochem 2008; 77:363-82;  PMID:18410248 ; http://dx.doi.org/10.1146/ annurev.biochem.77.062906.171838 10.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nature 2012; 491:222- 7; PMID:23135467 ; http://dx.doi.org/10.1038/ nature11600 11.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science 2012; 336:1171-4;  PMID:22654060 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nature 2010; 466:756- 60; PMID:20686574 ; http://dx.doi.org/10.1038/ nature09304 14.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Rev Immunol 2002; 2:706-13; PMID:12209139 ;  http://dx.doi.org/10.1038/nri891 15.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science 2013; 342:1477- 83; PMID :24179159 ; http://dx.doi.org/10.1126/ science.1245625 18.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science 2011;  333:1593-602;  PMID:21835983 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Immunity 2013; 39:245-58; PMID:23911655 ;  http://dx.doi.org/10.1016/j.immuni.2013.04.012 21.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Vaccine  2002; 20:3104-12;  PMID:12163261 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nature 2014; •••: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Available from:  http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science 2011; 333:1633- 7; PMID:21764753 ; http://dx.doi.org/10.1126/ science.1207227 26.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Available from: http://eutils.ncbi.nlm.nih.gov/ entrez/eutils/elink.fcgi?dbfrom=pubmed&id=   23300456&retmode=ref&cmd=prlinks 27.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
PLoS Pathog 2011; 7:e1002200; PMID:21909262 ;  http://dx.doi.org/10.1371/journal.ppat.100220028.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Cell 2013; 153:126- 38; PMID:23540694 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Cell Host Microbe  2012; 12:396-407;  PMID:23084910 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Virol 2011;  85:9998-10009;  PMID:21795340 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
PLoS Pathog  2013; 9:e1003754;  PMID:24278016 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science  2013; 340:711-6;  PMID:23539181 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proc Natl Acad Sci U  S A 2013; 110:6470-5; http://dx.doi.org/10.1073/ pnas.1219320110 ; PMID:23536288 34.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proc Natl Acad Sci U S A  2013; 110:E4088-97; http://dx.doi.org/10.1073/ pnas.1306262110 ; PMID:24106303 35.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Mol Metab 2013; 2:256-69;  http://dx.doi.org/10.1016/j.molmet.2013.06.001 ;  PMID:24049738 38.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Biochem Biophys Res Commun 2005; 338:1669- 77; PMID:16263081 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Biochem Biophys Res Commun  2006; 349:582-7;  PMID:16949050 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
FASEB J 2005; 19:53- 61; PMID :15629895 ; http://dx.doi.org/10.1096/ fj.04-2329com,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Biochem Biophys Res Commun  2008; 377:469-73;  PMID:18848919 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Biochem Biophys Res Commun 2011;  415:479-84 ;  PMID:22056556 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Mol Pharmacol 2009; 75:774-81;  PMID:19122004 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Biochem Biophys  Res Commun 2011; 406:200-3; PMID:21303662 ;  http://dx.doi.org/10.1016/j.bbrc.2011.02.013 45.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
N Engl J  Med 2012; 366:2455-65; http://dx.doi.org/10.1056/ NEJMoa1200694 ; PMID:22658128 46.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
N Engl J Med 2012; 366:2443-54; http://dx.doi.org/10.1056/NEJMoa1200690 ; PMID:22658127 47.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Cancer Discov 2013;  3:1355-63; http://dx.doi.org/10.1158/2159-8290.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
N Engl J Med  2006; 354:567-78;  PMID:16467544 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Blood 2010;  116:926-34; http://dx.doi.org/10.1182/blood-2009- 10-248609 ; PMID:20439625 50.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Clin Cancer Res 2013; 19:1476-86; http://dx.doi.org/10.1158/1078-0432.CCR-12-2522 ;  PMID:23363817 51.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Genes Immun  2012; 13:363-73;  PMID:22551722 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Am J Hum Genet  2013; 92:530-46;  PMID:23541343 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Annu Rev Immunol 2012; 30:337-56; PMID:22224771 ; http://dx.doi.org/10.1146/ annurev-immunol-020711-07500355.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Cell 1985;  40:271-81;  PMID:2578321 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Curr Top Microbiol Immunol 2012;  356:65-89;  PMID:21695632 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Immunity 2011; 34:175- 87; PMID:21349430 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Biol Chem  2010; 285:9327-38;  PMID:20100833 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Cell 2009; 137:1194-211; PMID:19563753 ;  http://dx.doi.org/10.1016/j.cell.2009.06.001 61.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Exp Med 2008; 205:747- 50; PMID:18347103 ; http://dx.doi.org/10.1084/ jem.20080066 62.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Immunity 2012; 37:412-25; PMID:22999947 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science 2010; 329:811-7;  PMID:20616231 ; http://dx.doi.org/10.1126/ science.1192819 64.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Cell 2013; 153:126- 38; PMID:23540694 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nature  2011; 477:466-70;  PMID:21849977 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science 2011; 334:1097- 103; PMID:21998254 ; http://dx.doi.org/10.1126/ science.1213256 67.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Mol Immunol 2009; 46:917-26; PMID:18952295 ;  http://dx.doi.org/10.1016/j.molimm.2008.09.00568.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Virology 2012; 427:198- 207; PMID:22402248 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Blood 2010; 116:5571-9; PMID:20837780 ;  http://dx.doi.org/10.1182/blood-2010-05-285528 70.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Rev Immunol 2009; 9:235-45; PMID:19319142 ;  http://dx.doi.org/10.1038/nri2524 71.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Biotechnol 2009; 27:1186- 90; PMID:19915550 ; http://dx.doi.org/10.1038/ nbt.1588 72.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Biotechnol 2002; 20:1135-9;  PMID:12368811 ; http://dx.doi.org/10.1038/nbt744 73.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Protein Eng Des Sel  2010; 23:871-80;  PMID:20847102 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Protein Sci  2013; 22:231-8;  PMID:23225662 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proc Natl Acad Sci U S A 2008;  105:14808-13;  PMID:18812512 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proc Natl Acad Sci U S A 2012; 109:9810- 5; PMID:22665811 ; http://dx.doi.org/10.1073/ pnas.1202107109 80.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Mol Biol  2012; 422:414-28;  PMID:22683350 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Mol Biol  2013; 425:662-77;  PMID:23164568 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proc Natl Acad Sci U S A 2014; 111:E655-62; http://dx.doi.org/10.1073/ pnas.1317903111 ; PMID :24453215 83.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science 1997; 276:614-7; PMID:9110984 ; http://dx.doi.org/10.1126/ science.276.5312.614 84.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Chem Biol 2014; In  press; http://dx.doi.org/10.1038/nchembio.1453 .,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Cancer Immunol Immunother 2008; 57:367- 78; PMID:17676323 ; http://dx.doi.org/10.1007/ s00262-007-0376-2 88.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Mol  Biol 2011; 406:228-56; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proteins 2009; 74:497-514; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
PLoS Comput Biol 2010; 6:e1000644;  http://dx.doi.org/10.1371/journal.pcbi.1000644 ;  PMID:20098500 91.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Chem Biol 2012; 19:449-55; http://dx.doi.org/10.1016/j.chembiol.2012.01.018 ;  PMID:22520751 92.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Immunol  2012; 189:5457-66;  PMID:23105143 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Breast Cancer  Res 2012; 14:R116; PMID:22873525 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Biol Chem 2013; 288:30843-54; PMID:23986451 ;  http://dx.doi.org/10.1074/jbc.M113.486142 96.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Rev Immunol 2008; 8:34-47;  PMID:18064051 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
EMBO Mol Med 2013; 5:1213- 26; PMID:23918228 ; http://dx.doi.org/10.1002/ emmm.201201929 98.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
ACS Chem Biol 2013; 8:368-75; PMID:23030766 ; http://dx.doi.org/10.1021/ cb300455f 99.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Immunol 2012; 188:3532- 41; PMID:22368276 ; http://dx.doi.org/10.4049/ jimmunol.1103693 103.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Biotechnol 2007; 25:1290- 7; PMID:17934452 ; http://dx.doi.org/10.1038/ nbt1345 104.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Cell Sci 2013; 126:1176- 88; PMID:23345403 ; http://dx.doi.org/10.1242/ jcs.116327 105.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
MAbs 2013; 5:655-9; PMID:23846320 ; http://dx.doi.org/10.4161/ mabs.25439 106.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
J Exp Med 2013; 210:1695-710; PMID:23897981 ;  http://dx.doi.org/10.1084/jem.20130579107.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Blood 2011; 117:2423- 32; PMID:21193697 ; http://dx.doi.org/10.1182/ blood-2010-08-301945 108.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Clin Cancer Res 2012; 18:3834-45; PMID:22615450 ;  http://dx.doi.org/10.1158/1078-0432.CCR-12-0715 109.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
N Engl J Med  2013 ; 368:1509-18 ;  PMID:23527958 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Clin Vaccine Immunol 2013;  20:377-90; http://dx.doi.org/10.1128/CVI.00625- 12; PMID:23324518 111.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
MAbs  2010; 2:84-100;  PMID:20065640 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
MAbs 2011; 3:76-99; PMID:21051951 ;  http://dx.doi.org/10.4161/mabs.3.1.13895 113.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
MAbs 2013; 5:513-7; PMID:23727858 ;  http://dx.doi.org/10.4161/mabs.24990 116.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science  2013; 340:711-6;  PMID:23539181 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Science 2013;  340:1232910; http://dx.doi.org/10.1126/sci - ence.1232910 ; PMID:23723240 118.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Biotechnol 2012; 30:423-33;  PMID:22565972 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proc Natl Acad Sci U S A 2013; 110:7-8;  PMID:23284164 ; http://dx.doi.org/10.1073/ pnas.1219396110 120.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proc Natl Acad Sci U S A 2013; 110:264-9;  PMID:23175789 ; http://dx.doi.org/10.1073/ pnas.1218256109,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Protein Eng Des Sel 2013; 26:599-609; PMID:23754530 ; http://dx.doi.org/10.1093/ protein/gzt027 122.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Front Immunol 2013; 4:302;  PMID :24115948 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Adv Protein Chem 1959; 14:1- 63; PMID:14404936 ; http://dx.doi.org/10.1016/ S0065-3233(08)60608-7 124.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Adv Immunol 1962; 2:1-40; http://dx.doi.org/10.1016/S0065-2776(08)60110-8 125.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Biochemistry 1972; 11:1327- 37; PMID:4623250 ; http://dx.doi.org/10.1021/ bi00758a001 126.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Biochemistry 1972; 11:1338-45;  PMID:5063174 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
"Huston JS, Björk I, Tanford C. Properties of the  Fd fragment from rabbit immunoglobulin G.  Biochemistry 1972; 11:4256-62; PMID:4628028 ;  http://dx.doi.org/10.1021/bi00773a010 128.",OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Preferential removal of immune complexes from serum by immobilized truncated FB analogues of the B domain from staphylococcal protein A. Biophys  J 1992; 62:87-91; PMID:1600106 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
AIDS 2011; 25:1247- 57; PMID :21508803 ; http://dx.doi.org/10.1097/ QAD.0b013e32834785cf 132.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
PLoS Comput Biol  2013; 9:e1003045;  PMID:23637590 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Rev Cancer 2006; 6:24-37;  PMID:16397525 ; http://dx.doi.org/10.1038/ nrc1782 137.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Pharmaceuticals (Basel) 2013; 6:659-80; PMID:23894228 ; http://dx.doi.org/10.3390/ ph6050659 138.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Cancer Res 2010; 70:1281-5; PMID:20145139 ;  http://dx.doi.org/10.1158/0008-5472.CAN-09-3276 140.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Med 2012; 18:883-91; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Mol Cell Proteomics 2010; 9:1085-99;  PMID:20124223 ; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proteomics 2011; 11:1550- 4; PMID:21413147 ; http://dx.doi.org/10.1002/ pmic.200900808 143.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
N Biotechnol 2012; 29:578-85; PMID:21840428 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Proteomics 2011;  11:4578-82;  PMID:21956872 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Mol  Cell Proteomics 2009; 8:245-57; PMID:18796702 ;  http://dx.doi.org/10.1074/mcp.M800171-MCP200 146.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Methods 2013; 10:703-7; http://dx.doi.org/10.1038/ nmeth.2570 147.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nature  1994; 368:856-9;  PMID :8159246 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Crit Care Med  2012; 40:2320-6;  PMID:22622405 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
http://mct.aacrjournals.org/content/12/11_ Supplement/C164.short 153.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
http://mct.aacrjournals.org/content/12/11_Supplement/C160.short 154.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
MAbs 2014; 6:34-45; PMID:24423619 ;  http://dx.doi.org/10.4161/mabs.27022 158.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Biotechnol 2008; 26:925-32; PMID:18641636 ;  http://dx.doi.org/10.1038/nbt.1480 159.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
http://cancerres.aacrjournals.org/cgi/content/ meeting_abstract/73/8_MeetingAbstracts/LB-290 160.,Non-OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
Nat Biotechnol 2012; 30:184-9; PMID:22267010 ;  http://dx.doi.org/10.1038/nbt.2108 161.,OADS,/arxiv_data1/oa_pdf/ac/65/mabs-6-577.PMC4011904.pdf
"Correspondence to: Janice M Reichert;   Email: reichert.biotechconsulting@gmail.comSubmitted: 03/18/14; Accepted: 03/18/14; Published Online: 03/21/2014http://dx.doi.org/10.4161/mabs.28617Antibody Fc: Linking Adaptive and Innate Immunity Editors Margaret E. Ackerman, Falk Nimmerjahn Janice M. r eichert reichert Biotechnology Consulting LLC; Framingham, M a US a Keywords:  Fc domain, Fc receptors, effector cells, complement, immunoglobulin glycoforms, antibody therapeutics Antibody Fc: Linking Adaptive and Innate Immunity , edited  by Margaret e. ackerman and Falk Nimmerjahn and published  by a cademic Press, provides a highly detailed examination of  the involvement of the antibody Fc in mechanisms critical to  both innate and adaptive immune responses.",Non-OADS,/arxiv_data1/oa_pdf/33/67/mabs-6-619.PMC4011905.pdf
"8 It has been shown  that decreasing the medium concentrations of B vitamins and iron reduced BDS “total color,” defined as the linear distance  *Correspondence to: Galye E Derfus; Email: gderfus@gilead.com Submitted: 11/27/2013; Revised: 02/13/2014; Accepted: 02/17/2014; Published Online: 02/19/2014 http://dx.doi.org/10.4161/mabs.28257Red colored IgG4 caused by vitamin B12   from cell culture media combined with disulfide  reduction at harvest Gayle e Derfus,* Jemelle Dizon-Maspat, Jared T Broddrick, a rleene C Velayo, Josh D Toschi, r odell T Santuray, Stephen K Hsu,  Charles M Winter, r ajesh Krishnan and a shraf a manullah Biologics Development; Gilead Sciences; o ceanside, C a USa Keywords:  monoclonal antibody, bioprocess, high concentration, color, Chinese hamster ovary Abbreviations: BDS, bulk drug substance (in this case derived from a manufacturing scale process); CCF, cell culture fluid;  C-HCCF, control harvested cell culture fluid; DO, dissolved oxygen; DTT, dithiothreitol; EP, European Pharmacopoeia;  HCCF, harvested cell culture fluid; HPLC, high performance liquid chromatography; ICP/MS, inductively coupled plasma/mass  spectrometry; IgG4, immunoglobulin subclass 4; LC/MS, liquid chromatography/mass spectroscopy; mAb, monoclonal antibody;  NADPH, nicotinamide adenine dinucleotide phosphate; RP-HCCF, reduction-promoting harvested cell culture fluid; UFDF,  ultrafiltration/diafiltration; UV, ultraviolet; WFI, water for injection While many antibody therapeutics are formulated at low concentration (~10–20 mg/mL) for intravenous administra - tion, high concentration (> 100 mg/mL) formulations may be required for subcutaneous delivery in certain clinical indi - cations.",Non-OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
J Pharm Sci 2004; 93:1390-402; PMID :15124199 ;  http://dx.doi.org/10.1002/jps.20079 2.,Non-OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
Eur J Pharm Sci 2013; 49:400-10;  PMID:23624326 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
Biotechnol Prog 2013; In press; http://dx.doi.org/10.1002/btpr.1772 .,Non-OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
"United States Food and Drug  Administration, 2009. http://www.fda.gov/forin - dustry/coloradditives/coloradditiveinventories/ ucm115641.htm 7.",Non-OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
Clin Chim Acta 2009; 401:63-7; PMID:19041637 ;  http://dx.doi.org/10.1016/j.cca.2008.11.007 8.,OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
Biotechnol Bioeng 2010; 107:622-32; PMID:20589844 ; http://dx.doi.org/10.1002/ bit.22848 11.,OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2012; 905:10-6;  PMID:22939270 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
J Photochem Photobiol B 2013; 122:7-14; PMID:23558034 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
MAbs  2013; 5:972-9;  PMID:23924851 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
J Am Chem Soc 1966;  88:5018-20; http://dx.doi.org/10.1021/ja00973a044 15.,OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
Anal Chem 2011; 83:5912- 9; PMID :21692515 ; http://dx.doi.org/10.1021/ ac200750u,Non-OADS,/arxiv_data1/oa_pdf/d2/f3/mabs-6-679.PMC4011912.pdf
"7,8 Consequently, FcRn plays an important role in  IgG catabolism5,9 and accounts for the persistence of IgG in  the circulation of rodents and higher species.10,11 Also known as  the major histocompatibility complex class I-related receptor,  *Correspondence to: C Andrew Boswell; Email: boswell.andy@gene.com Submitted: 01/24/2014; Revised: 02/26/2014; Accepted: 02/27/2014; Published Online: 03/05/2014http://dx.doi.org/10.4161/mabs.28254Quantitative cumulative biodistribution   of antibodies in mice Effect of modulating binding affinity   to the neonatal Fc receptor Victor y ip1, enzo Palma1, Devin B Tesar2, eduardo e Mundo1, Daniela Bumbaca1, elizabeth K Torres3, Noe a r eyes1,   Ben Q Shen1, Paul J Fielder1, Saileta Prabhu1, Leslie a Khawli1† and C a ndrew Boswell1,* 1Preclinical and Translational Pharmacokinetics; Genentech r esearch & e arly Development; South San Francisco, C a US a; 2Drug Delivery Department; Pharma Technical  Development, Genentech; South San Francisco, C a US a; 3Non-Clinical o perations; Genentech r esearch & e arly Development; South San Francisco, C a US a  †Current address: University of Southern California; Keck School of Medicine; Department of Pathology; Los a ngeles, C a US a Keywords:  FcRn, biodistribution, pharmacokinetics, radiolabeled, metabolism, indium The neonatal Fc receptor (Fc rn) plays an important and well-known role in antibody recycling in endothelial and  hematopoietic cells and thus it influences the systemic pharmacokinetics (PK) of immunoglobulin G (IgG).",Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Nat Rev Drug Discov 2003 ; 2:52-62;  PMID:12509759 ; http://dx.doi.org/10.1038/nrd984 3.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Nat Rev Immunol 2007 ; 7:715- 25; PMID:17703228 ; http://dx.doi.org/10.1038/ nri2155 6.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Immunol Res  1997 ; 16:29- 57; PMID:9048207 ; http://dx.doi.org/10.1007/ BF027863228.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Biochemistry  1995 ;  34:14649 -57; PMID:7578107 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Immunol Res  2002 ; 25:97-113;  PMID:11999172 ; http://dx.doi.org/10.1385/ IR:25:2:097 10.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
J Immunol  2009 ;  182:7663 -71; PMID:19494290 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Trends Immunol  2006 ; 27:343-8; PMID:16731041 ;  http://dx.doi.org/10.1016/j.it.2006.05.004 13.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Annu Rev Immunol 2000 ; 18:739-66;  PMID:10837074 ; http://dx.doi.org/10.1146/ annurev.immunol.18.1.73914.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Proc Natl Acad Sci U  S A 2009 ; 106:2788 -93; http://dx.doi.org/10.1073/ pnas.0810796106 ; PMID:19188594 15.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Int Immunol   1998 ; 10:1289 -98; PMID:9786428 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Immunology  2000 ; 100:245-51; PMID:10886402 ;  http://dx.doi.org/10.1046/j.1365-2567.2000.00034.x 17.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Drug Metab Dispos 2007 ; 35:86- 94; PMID:17050651 ; http://dx.doi.org/10.1124/ dmd.106.011734 18.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Nat Biotechnol  1997 ; 15:637-40;  PMID:9219265 ; http://dx.doi.org/10.1038/ nbt0797-637,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
J Immunol  2010 ;  184:1968 -76; PMID:20083659 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Mol  Immunol  2006 ; 43:1462 -73; PMID:16139891 ;  http://dx.doi.org/10.1016/j.molimm.2005.07.032 21.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Biochemistry  2000 ; 39:9698 -708;  PMID:10933786 ; http://dx.doi.org/10.1021/ bi000749m 22.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Traffic   2009 ; 10:600-14; http://dx.doi.org/10.1111/j.1600- 0854.2009.00887.x ; PMID:19192244 24.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
AAPS J 2012 ; 14:612-8;  http://dx.doi.org/10.1208/s12248-012-9374-1 ;  PMID:22648903 28.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Drug Metab Dispos 2010 ; 38:600-5; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Mol Cancer Ther 2012 ; 11:752-62;  http://dx.doi.org/10.1158/1535-7163.MCT-11-0742-T ; PMID:22222630 35.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Br J Pharmacol  2013 ; 168:445-57; http://dx.doi.org/10.1111/j.1476- 5381.2012.02138.x ; PMID:22889168 36.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Glycobiology  2000 ; 10:1347 - 55; PMID:11159927 ; http://dx.doi.org/10.1093/ glycob/10.12.1347 37.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Mol  Cancer Ther  2006 ; 5:1550 -8; PMID:16818514 ;  http://dx.doi.org/10.1158/1535-7163.MCT-06-0072 38.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
J Clin Invest  2007 ; 117:2422 -30; PMID:17717602 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
J Pharmacokinet Pharmacodyn  2007 ; 34:687- 709; PMID:17636457 ; http://dx.doi.org/10.1007/ s10928-007-9065-1 40.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Mol Pharm  2013 ; 10:1505 -13; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
AAPS  J 2009 ; 11:553-7; http://dx.doi.org/10.1208/s12248- 009-9129-9 ; PMID:19636712 42.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
J Neuroimmunol  2001 ; 114:168- 72; PMID:11240028 ; http://dx.doi.org/10.1016/ S0165-5728(01)00242-9 43.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
J Neurosci  2005 ; 25:11495 - 503; PMID:16354907 ; http://dx.doi.org/10.1523/ JNEUROSCI.3697-05.2005 44.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
J Neurochem 2002 ;  81:203-6; PMID:12067234 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Eur J Immunol 1999 ; 29:2819 -25;  PMID:10508256 ; http://dx.doi.org/10.1002/ (SICI)1521-4141(199909)29:09<2819::AID- IMMU2819>3.0.CO;2-6 46.,Non-OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Structure  1998 ; 6:63-73; PMID:9493268 ;  http://dx.doi.org/10.1016/S0969-2126(98)00008-2 47.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
Bioconjug Chem  2011 ; 22:1994 -2004 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
J Pharmacokinet Biopharm  1988 ;  16:303-9; PMID:3221328 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/2f/mabs-6-689.PMC4011913.pdf
"Indeed, elucidation of specific protein functions largely depends on the  *Correspondence to: Francesco Salvatore; Email: salvator@unina.it; Francisco E Baralle; Email: baralle@icgeb.org Submitted: 12/05/2013; Revised: 02/11/2014; Accepted: 02/11/2014; Published Online: 02/13/2014 http://dx.doi.org/10.4161/mabs.28191A novel anti-aldolase C antibody specifically  interacts with residues 85–102 of the protein Simona Langellotti1,2,†, Maurizio r omano3,†, Corrado Guarnaccia2, Vincenzo Granata1, Stefania o rrù4,5, Adriana Zagari1,  Francisco e  Baralle2,* and Francesco Salvatore1,5,* 1CeING e-Biotecnologie Avanzate; Naples, Italy; 2International Centre for Genetic e ngineering and Biotechnology; Trieste, Italy; 3Department of Life Sciences; University of  Trieste; Trieste, Italy; 4Department of Sports Science and Wellness; University of Naples “Parthenope”; Naples, Italy; 5IrCCS SDN-Foundation; Naples, Italy †These authors contributed equally to this work Keywords:  aldolase C, monoclonal antibodies, epitope mapping, ELISA, western blot, SPR.",Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
"To define the possible antigenic determinant located within the first 100 residues, we used the ElliPro software (http://tools.immuneepitope.org/tools/ElliPro) 31 that predicts and visual - izes putative antibody epitopes on a given protein 3D struc - ture, according to surface exposure and solvent accessibility of residues.",OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Protein  Sci 1994; 3:1383-91;  PMID:7833800 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Blood 2005; 105:905- 6; PMID :15632214 ; http://dx.doi.org/10.1182/ blood-2004-09-3558 3.,Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
"Kreuder J, Borkhardt A, Repp R, Pekrun A, Göttsche B, Gottschalk U, Reichmann H, Schachenmayr  W, Schlegel K, Lampert F. Brief report: inherited  metabolic myopathy and hemolysis due to a muta - tion in aldolase A. N Engl J Med 1996; 334:1100- 4; PMID:8598869 ; http://dx.doi.org/10.1056/ NEJM199604253341705 5.",Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
FEBS Lett 2002; 531:152- 6; PMID:12417303 ; http://dx.doi.org/10.1016/ S0014-5793(02)03451-8 8.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Am J Med 1978; 65:416-23;  PMID:213970 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Biochem J  2000; 350:823-8;  PMID:10970798 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Hum Genet 1989; 82:279-82; PMID:2731939 ; http://dx.doi.org/10.1007/ BF00291170 13.,Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Ann Clin Biochem  1980; 17:114-21;  PMID:7406436 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
J Neurocytol  2001; 30:957-65;  PMID:12626877 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
J Mol Neurosci  1995; 6:147-58;  PMID:8672398 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Molecular and catalytic properties of aldolase C. Biochemistry  1969; 8:4396-402;  PMID:4982047 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Eur J Biochem  1988; 171:471-8;  PMID:2831050 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Neurosci Lett 1997; 237:53- 5; PMID:9406878 ; http://dx.doi.org/10.1016/ S0304-3940(97)00802-1 22.,Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Brain-specific aldolase C amino acid sequence is closely related to aldolase A. Eur J Biochem 1986;  156 :229-35;  PMID:3009179 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Cell Res 2002; 12:85- 96; PMID:12118943 ; http://dx.doi.org/10.1038/ sj.cr.7290114 24.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Eur J Biochem 1987; 163:513-8;  PMID:3830170 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
J Neurosci 2005; 25:4353-64;  PMID:15858061 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Eur  J Neurosci 2007; 26:649-56; PMID:17686042 ;  http://dx.doi.org/10.1111/j.1460-9568.2007.05708.x 27.,Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Brain Res 2007; 1139:15-28; PMID:17276415 ;  http://dx.doi.org/10.1016/j.brainres.2006.12.092 29.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Biochimie  1987; 69:137-45;  PMID:3105602 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
BMC  Bioinformatics 2008; 9:514; PMID:19055730 ;  http://dx.doi.org/10.1186/1471-2105-9-514 32.,Non-OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Proc Natl Acad Sci U S A 1986; 83:226- 30; PMID:2417241 ; http://dx.doi.org/10.1073/ pnas.83.2.22633.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Protein Sci  2004; 13:3077-84;  PMID:15537755 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
J  Biol Chem 2003; 278:17307-13; PMID:12611890 ;  http://dx.doi.org/10.1074/jbc.M209185200 38.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
Nat Protoc  2008; 3:1101-8;  PMID:18546601 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/86/mabs-6-707.PMC4011915.pdf
"Two  *Correspondence to: Michael Hust; Email: m.hust@tu-bs.de Submitted: 12/11/2013; Revised: 02/07/2014; Accepted: 02/10/2014; Published Online: 02/11/2014http://dx.doi.org/10.4161/mabs.28170Human-like antibodies neutralizing   Western equine encephalitis virus Birgit Hülseweh1, Torsten r ülker2, Thibaut Pelat3, Claudia Langermann1, Andrè Frenzel2, Thomas Schirrmann2, Stefan Dübel2,  Philippe Thullier3 and Michael Hust2,* 1Wehrwissenschaftliches Institut für Schutztechnologien (WIS); ABC-Schutz; Munster, Germany; 2 Technische Universität Braunschweig; Institut für Biochemie, Biotechnologie  und Bioinformatik; Braunschweig, Germany; 3Institut de r echerche Biomédicale des Armées (I rBA-C rSSA); Département de Microbiologie; Unité de biotechnologie des  anticorps et des toxines; La Tronche, France Keywords:  Western equine encephalitis virus (WEEV), Alphavirus, scFv, scFv-Fc, phage display, immune antibody library,   NHP antibodies, passive vaccine This study describes the development of the first neutralizing antibodies against Western equine encephalitis virus  (WeeV), a member of the genus Alphavirus .",Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Proc Natl Acad Sci U S A 1988; 85:5997- 6001;  PMID:3413072 ; http://dx.doi.org/10.1073/ pnas.85.16.5997 2.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Virol  2010 ; 84:9775 -82; PMID:20631130 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Science  1933 ; 78:587- 8; PMID:17801697 ; http://dx.doi.org/10.1126/ science.78.2034.587-a6.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Exp Med 1939 ; 69:691-704; PMID:19870871 ;  http://dx.doi.org/10.1084/jem.69.5.691 7.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Science   1939 ; 90:20-1; PMID:17818578 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Vet Microbiol  2010 ; 140:281-6; PMID:19775836 ;  http://dx.doi.org/10.1016/j.vetmic.2009.08.023 10.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
N Engl J Med 1997 ;  336:1867 -74; PMID :9197215 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Am J Public Health Nations Health 1938 ; 28:1403 - 10; PMID:18014957 ; http://dx.doi.org/10.2105/ AJPH.28.12.1403 14.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Crit Rev Microbiol  2001 ; 27:267-320; PMID:11791799 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
PLoS One   2013 ; 8:e60427 ; PMID:23544138 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Vaccine   2011 ; 29:813-20; PMID:21084062 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Emerg Infect Dis 2011 ; 17:952-4; PMID:21529429 ;  http://dx.doi.org/10.3201/eid1705.101068 23.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Gen Virol 2009 ; 90:1848 - 58; PMID:19403754 ; http://dx.doi.org/10.1099/ vir.0.008656-0 25.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Gen Virol 2006 ; 87:2353 - 61; PMID:16847131 ; http://dx.doi.org/10.1099/ vir.0.81815-0 26.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Virus Res 2006 ; 120:107-12; PMID:16621103 ;  http://dx.doi.org/10.1016/j.virusres.2006.02.003 27.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J  Infect Dis 2005 ; 192:1173 -82; PMID:16136459 ;  http://dx.doi.org/10.1086/444397 28.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Annu Rev Microbiol  2001 ; 55:235-53; PMID :11544355 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Antiviral Res  2003 ; 57:101- 11; PMID :12615306 ; http://dx.doi.org/10.1016/ S0166-3542(02)00203-6 30.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Future  Virol  2013 ; 8:661-74; http://dx.doi.org/10.2217/ fvl.13.42 31.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Vaccine  2009 ; 27:4309 -19; PMID:19446595 ;  http://dx.doi.org/10.1016/j.vaccine.2009.05.011 32.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Vaccine  2007 ; 25:6271 - 6; PMID:17630056 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Vaccine  2007 ; 25:4368 - 75; PMID:17467858 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Vaccine  2005 ; 23:2280 - 3; PMID:15755611 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Vaccine  2009 ; 27:4152 -60;  PMID:19406186 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Antiviral Res  2010 ; 87:195- 203; PMID:20452378 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Virol Methods  2004 ; 117:169-77; PMID:15041214 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Hybridoma  1999 ; 18:315- 23; PMID:10571261 ; http://dx.doi.org/10.1089/ hyb.1999.18.315 40.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Hybridoma   2000 ; 19:1-13; PMID:10768836 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Curr Drug Discov Technol 2014 ; 11:20- 7; PMID:23410051 ; http://dx.doi.org/10.2174/1570 1638113109990030 42.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Mini Rev Med Chem  2009 ; 9:1633 -8; PMID:20105119 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Viral Immunol   2001 ; 14:263-73; PMID:11572636 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
PLoS Negl Trop Dis 2010 ; 4:e739 ; PMID:20644615 ;  http://dx.doi.org/10.1371/journal.pntd.0000739 45.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
BMC Biotechnol  2008 ; 8:66; PMID:18764933 ;  http://dx.doi.org/10.1186/1472-6750-8-66 46.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
PLoS One   2012 ; 7:e37242 ; PMID:22666347 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Biotechnol  2011 ;  152:159-70; PMID:20883731 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Nat Biotechnol  2001 ; 19:75-8;  PMID:11135557 ; http://dx.doi.org/10.1038/83567 49.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Biotechnol  2007 ; 127:626-37; PMID:16996161 ;  http://dx.doi.org/10.1016/j.jbiotec.2006.08.015,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
BMC Biotechnol   2013 ; 13:52; PMID:23802841 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Virology  2007 ; 369:206-13; PMID:17761207 ;  http://dx.doi.org/10.1016/j.virol.2007.07.024 53.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Proc Soc Exp Biol Med 1951 ;  78:655-8; PMID:14911984 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Biosecur Bioterror   2009 ; 7:413-27; PMID:20028250 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Immunol  2011 ;  186:3258 -64; PMID:21278338 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
PLoS Pathog  2013 ; 9:e1003312 ;  PMID:23637602 ; http://dx.doi.org/10.1371/ journal.ppat.1003312 57.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Virology  1982 ;  118:269-78; PMID:6178209 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Antiviral Res  2011 ; 90:1-8;  PMID:21310183 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Gen Virol 2006 ; 87:2467 - 76; PMID:16894184 ; http://dx.doi.org/10.1099/ vir.0.81925-0 60.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Vaccine  2010 ; 28:5558 -64; PMID:20600509 ;  http://dx.doi.org/10.1016/j.vaccine.2010.06.038 61.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Virol  J 2009 ; 6:206; PMID:19925641 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Antimicrob Agents Chemother  2007 ; 51:2758 - 64; PMID:17517846 ; http://dx.doi.org/10.1128/ A AC.01528-06 63.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
BMC Biotechnol   2011 ; 11:113; PMID:22111995 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Antimicrob Agents Chemother  2005 ;  49:3414 -20; PMID:16048955 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
J Mol Biol   2008 ; 384:1400 -7; PMID:18976662 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Proteomics  2006 ;  6:2972 -81; PMID:16622830 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Appl Environ Microbiol  2011 ; 77:7289 -95; PMID:21856830 ;  http://dx.doi.org/10.1128/AEM.05553-11 71.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
PLoS One  2009 ; 4:e6625 ;  PMID:19675673 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
Methods  Mol Biol  2014 ; 1060 :215-43; PMID:24037844 ;  http://dx.doi.org/10.1007/978-1-62703-586-6_12 74.,OADS,/arxiv_data1/oa_pdf/8c/35/mabs-6-717.PMC4011916.pdf
"6,7 Previously, there have been no reports of CD16A-specific anti - bodies lacking CD16B binding, and the majority of anti-CD16 antibodies bind both CD16 isoforms, CD16A and CD16B, except  *Correspondence to: Eugene A. Zhukovsky; Email: e.zhukovsky@affimed.com Submitted: 02/12/2014; Revised: 03/14/2014; Accepted: 03/18/2014; Published Online: 03/26/2014http://dx.doi.org/10.4161/mabs.28591A novel tetravalent bispecific TandAb   (CD30/CD16A) efficiently recruits NK cells   for the lysis of CD30+ tumor cells Uwe r eusch, Carmen Burkhardt, Ivica Fucek, Fabrice Le Gall†, Mikaelle Le Gall‡, Karin Hoffmann§, Stefan HJ Knackmuss,   Sergej Kiprijanov||, Melvyn Little and e ugene A Zhukovsky* Affimed Therapeutics AG; Heidelberg, Germany †Current affiliation: Ganymed Pharmaceuticals AG; Mainz, Germany ‡Current affiliation: ribological GmbH; Mainz, Germany §Current affiliation: Syntacoll GmbH; Saal/Donau, Germany ||Current affiliation: BerGenBio AS; Bergen, Norway Keywords:  FcγRIIIA, CD16A, NK cells, bispecific antibodies, Hodgkin’s lymphoma To improve recruitment and activation of natural killer (NK) cells to lyse tumor cells, we isolated a human anti-CD16A  antibody with similar affinity for the CD16A 158F/V allotypes, but no binding to the CD16B isoform.",Non-OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Proc Natl Acad Sci U S A 1999; 96:5640-4; PMID:10318937 ; http://dx.doi.org/10.1073/ pnas.96.10.5640 2.,OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
"Trends  Immunol 2001; 22:633-40;  PMID:11698225 ;  http://dx.doi.org/10.1016/S1471-4906(01)02060-9 4. van de Winkel JG, Capel PJ.",OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Immunol Today 1993; 14:215-21;  PMID:8517920 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Immunol Today 2000; 21:391-7; PMID:10916142 ; http://dx.doi.org/10.1016/ S0167-5699(00)01659-5 6.,Non-OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
J Clin Invest  1989; 83:1676-81;  PMID :2523415 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Blood 2002; 99:754-8; PMID:11806974 ;  http://dx.doi.org/10.1182/blood.V99.3.75414.,Non-OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
J Clin Oncol 2003; 21:3940-7; PMID:12975461 ; http://dx.doi.org/10.1200/ JCO.2003.05.013 15.,Non-OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Proc Natl Acad Sci U S A 2006;  103:4005-10;  PMID:16537476 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Int J Cancer  1993; 55:830-6;  PMID:8244580 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Blood  2006; 108:2280-9;  PMID:16757686 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Cancer Res 2004; 64:2148-52;  PMID :15026356 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Mol Ther 2013; 21:895- 903; PMID :23459515 ; http://dx.doi.org/10.1038/ mt.2013.14 28.,OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
Nature 2001; 409:1055-60;  PMID:11234016 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
J Immunol  Methods 2004; 285:111-27;  PMID:14871540 ;  http://dx.doi.org/10.1016/j.jim.2003.11.007,Non-OADS,/arxiv_data1/oa_pdf/e7/59/mabs-6-727.PMC4011917.pdf
"Rilonacept (Arcalyst®), is a dimeric fusion protein  *Correspondence to: Cheng-I Wang; Email: Wang_ChengI@immunol.a-star.edu.sg Submitted: 11/25/2013; Revised: 03/19/2014; Accepted: 03/20/2014; Published Online: 03/26/2014http://dx.doi.org/10.4161/mabs.28614A novel human anti-interleukin-1 β neutralizing  monoclonal antibody showing in vivo efficacy angeline XH Goh†, Sebastien Bertin-Maghit†, Siok Ping y eo, a drian WS Ho, Heidi Derks, a lessandra Mortellaro   and Cheng-I Wang* Singapore Immunology Network; a gency for Science; Technology and r esearch ( a*STar); Singapore †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Infect Immun 2000; 68:4746- 51; PMID:10899881 ; http://dx.doi.org/10.1128/ IAI.68.8.4746-4751.2000 3.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Infect Dis 2006; 193:1419-26;  PMID:16619190 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Immunol Res 2012; 53:78-90; PMID:22427013 ;  http://dx.doi.org/10.1007/s12026-012-8272-z 6.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Inflamm  Res 2011; 4:39-49; PMID:22096368 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Nat Immunol 2010; 11:897-904; PMID:20835230 ;  http://dx.doi.org/10.1038/ni.1935 8.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Cell Mol Immunol  2011; 8:135-45;  PMID:21258359 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Curr Opin Pharmacol 2004; 4:378-85;  PMID :15251132 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Exp Med 2005; 201:1355-9; PMID:15867089 ;  http://dx.doi.org/10.1084/jem.20050640 11.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Eur J Intern Med 2010; 21:157-63; PMID:20493414 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Biol Chem 2010; 285:20607-14;  PMID:20410301 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Nat Med 2003; 9:47-52; PMID:12483208 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Arthritis Rheum 2008; 58:26-35;  PMID:18163497 ; http://dx.doi.org/10.1002/ art.23176 15.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
"Pediatr Clin North Am 2005; 52:413-42, vi; PMID:15820374 ; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Biochemistry 1990; 29:2679-84;  PMID:2346741 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Mol Biol  1991; 217:133-51;  PMID:1988675 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Hematol Oncol Clin North Am 1999; 13:1117- 25; PMID:10626139 ; http://dx.doi.org/10.1016/ S0889-8588(05)70115-5 25.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Interferon  Cytokine Res 2006; 26:83-95; PMID:16487028 ;  http://dx.doi.org/10.1089/jir.2006.26.83 26.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Mayo Clin Proc  2009; 84:114-22;  PMID:19181644 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Mol Biol 1996; 263:551- 67; PMID:8918938 ; http://dx.doi.org/10.1006/ jmbi.1996.0598 29.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
"Methods Mol Biol 2009; 525:353-76, xiii;  PMID:19252851 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Mol Biol 1999; 293:865- 81; PMID:10543973 ; http://dx.doi.org/10.1006/ jmbi.1999.3192 31.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Biochemistry  1989; 28:4735-49;  PMID:2475171 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Curr Pharm Biotechnol 2000; 1:253-63; PMID:11469383 ;  http://dx.doi.org/10.2174/1389201003378906 34.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Immunity 2012; 36:388-400; PMID:22444631 ;  http://dx.doi.org/10.1016/j.immuni.2012.01.01835.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Mayo Clin Proc  2009; 84:105-7;  PMID:19181642 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Breast Cancer  Res 2011; 13:R54; PMID:21600050 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Immunol  2011; 186:3762-9;  PMID:21296976 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
J Biol Chem 1999; 274:18218-30; PMID:10373423 ;  http://dx.doi.org/10.1074/jbc.274.26.18218 40.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Nucleic Acids Res 2002;  30:E9; PMID:11788735 ; http://dx.doi.org/10.1093/ nar/30.2.e9 41.,OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
Nat Protoc 2007; 2:1269-75;  PMID:17546023 ; http://dx.doi.org/10.1038/ nprot.2007.173,Non-OADS,/arxiv_data1/oa_pdf/14/5c/mabs-6-764.PMC4011920.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/f7/mder-7-083.PMC4011924.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 83–89Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  83ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S6005 4The impact of balloon catheter dilation on  frequency of sinus surgery in the United states chantal E holy1 John M Ellison1 charles schneider1 howard l levine2,3 1health Economics and  Reimbursement, 2Medical affairs,   acclarent inc., a Johnson & Johnson  company, Menlo Park, ca, Usa;   3cleveland nasal-sinus and sleep  center, cleveland, Oh, Usa correspondence: chantal E holy   acclarent inc., 20 Monmouth street,  somerville, Ma, Usa 02143   Tel +1 508 415 4511   Fax +1 617 718 1758   Email choly1@its.jnj.co mPurpose:  Endoscopic sinus surgery for patients with chronic rhinosinusitis (CRS) unrespon - sive to medical therapy has traditionally been performed under general anesthesia and in the  operating room.",Non-OADS,/arxiv_data1/oa_pdf/27/f7/mder-7-083.PMC4011924.pdf
"Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2014:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 89impact of balloon dilation on incidence of sinus surgery Disclosure All authors are employees from Acclarent, Inc., a manufac - turer of balloon dilation devices.",Non-OADS,/arxiv_data1/oa_pdf/27/f7/mder-7-083.PMC4011924.pdf
Available from: http://truvenhealth.com/Portals/0/assets/2012_   Truven_MarketScan_white_paper.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/f7/mder-7-083.PMC4011924.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/56/ndt-10-687.PMC4011925.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 687–693Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  687OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6140 6increased serum dehydroepiandrosterone  sulfate in the first episode but not in subsequent  episodes in male patients with schizophrenia Murat Beyazyüz1 Yakup Albayrak2 elmas Beyazyüz3 cüneyt Ünsal2 erol göka3 1Department of Psychiatry, Gölbaşı  hasvak state hospital, ankara,   2Department of Psychiatry, school   of Medicine, Namık Kemal University,   T ekirdag ˇ, 3Department of Psychiatry,   ankara Numune education and  research hospital, ankara, T urkey Correspondence: Yakup Albayrak   Department of Psychiatry, school   of Medicine, Namık Kemal   University, Tunca Caddesi,   Tekirdag ˇ, 59100, Turkey   Tel +90 505 635 5434   Fax +90 282 250 9950   email dr.fuge@hotmail.co mBackground:  Many studies have investigated the relationship between blood levels of  dehydroepiandrosterone (DHEA) and its sulfate ester (DHEA-S), cortisol, progesterone, and  testosterone and the onset, prognosis, symptom severity, and treatment response of schizo - phrenia.",Non-OADS,/arxiv_data1/oa_pdf/7c/56/ndt-10-687.PMC4011925.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7c/56/ndt-10-687.PMC4011925.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/56/ndt-10-687.PMC4011925.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/6b/ndt-10-681.PMC4011926.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 681–686Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  681Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5805 9Solitary skull metastasis as the first symptom   of hepatocellular carcinoma: case report   and literature review Xieli Guo1,2 Jiangliu Yin3 Yugang Jiang1 1Department of Neurosurgery,  Second Xiangya Hospital of   Central South University, Changsha,  Hunan, People’s Republic of China;  2Department of Neurosurgery,  Jinjiang Hospital of Quanzhou Medical  College, Jinjiang, Fujian, People’s  Republic of China; 3Department   of Neurosurgery, Changsha Central  Hospital, Changsha, Hunan,   People’s Republic of ChinaAbstract:  Skull metastasis from hepatocellular carcinoma (HCC) is reported rarely .",Non-OADS,/arxiv_data1/oa_pdf/17/6b/ndt-10-681.PMC4011926.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/17/6b/ndt-10-681.PMC4011926.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/6b/ndt-10-681.PMC4011926.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/74/72/tcrm-10-305.PMC4011927.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 305–312Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  305ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5968 3Primary or secondary antifungal prophylaxis   in patients with hematological maligancies:   efficacy and damage habip gedik1 Funda Şimşek1 Taner Yıldırmak1 arzu Kantürk1 Deniz Arıca2 Demet Aydın2 naciye Demirel2 Osman Y okuş2 1Department of infectious  Diseases and Clinical Microbiology,   2Department of hematology, Ministry  of Health Okmeydanı Training and  Research hospital, i.stanbul, T urkey Correspondence: habip gedik   Department of infectious Diseases and  Clinical Microbiology, Ministry of health  Okmeydanı Training and Research  Hospital, SB Okmeydanı Eg ˘itim ve  Araştırma Hastanesi Şişli-Istanbul, Turkey   Tel +90 212 314 5555   Fax +90 212 221 7800   email habipgedik@yahoo.co mBackground:  Patients with hematological malignancies often develop febrile neutropenia  (FN) as a complication of cancer chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/74/72/tcrm-10-305.PMC4011927.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/74/72/tcrm-10-305.PMC4011927.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/72/tcrm-10-305.PMC4011927.pdf
Cells 2014; 37(4): 275-285   http://dx.doi.org/10.14348/molcells.2014.2374      eISSN: 0219-1032 The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
"By contrast, alternative/M2 activation is mediated by IL-4, IL-Molecules and Cells http://molcells.org   Established in 1990",Non-OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
Cells http://molcells.org Table 1.,OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
"Cells http://molcells.org      A                                  B                                 C                      2002; Shaughnessy and Swanson, 2007).",Non-OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
"Cells http://molcells.org 2009; Klein et al., 2007; Miura et al., 2012; Obstfeld et al., 2010).",OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
Cells http://molcells.org ges.,OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
"Cells http://molcells.org Peiris, J.S.M., Chu, C.M., Cheng, V.C.C., Chan, K.S., Hung, I.F.N.,  Poon, L.L.M., Law, K.I., Tang, B.S., Hon, T.Y., Chan, C.S., et al.",OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1d/39/molcell-37-4-275-1.PMC4012075.pdf
Cells 2014; 37(4): 286-294  http://dx.doi.org/10.14348/molcells.2014.0002        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
Molecules and Cells http://molcells.org   Established in 1990,OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
"Cells http://molcells.org      A                         B                              PBIP1 p-T78 was verified by the observation that Plk2 and Plk3  failed to phosphorylate and bind to the T78 motif (Lee et al.,  2008; Park et al., 2009).",OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
Cells http://molcells.org            A                           B                            C                        Fig.,Non-OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
"Cells http://molcells.org     Aside from the two above-mentioned possibilities that regu- late the level of available phospho-epitope for PBD binding, a third possibility is to modulate the amount of a PBD-binding  target localized at a confined surface area (e.g., PBIP1 loca- lized at kinetochores).",Non-OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
"Cells http://molcells.org     Hunter, T., and Osada, H. (2004 ).",OADS,/arxiv_data1/oa_pdf/32/49/molcell-37-4-286-2.PMC4012076.pdf
Cells 2014; 37(4): 295-301  http://dx.doi.org/10.14348/molcells.2014.2371        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/c0/40/molcell-37-4-295-3.PMC4012077.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c0/40/molcell-37-4-295-3.PMC4012077.pdf
"In this stud y, we show that SIFa and SIFR  coordinately regulate sleep through SIFa-expressing and sleep- Molecules and Cells http://molcells.org   Established in 1990",OADS,/arxiv_data1/oa_pdf/c0/40/molcell-37-4-295-3.PMC4012077.pdf
Cells http://molcells.org      A                                         B                 C                      D                    E                     F                        G                     H                       I                         Fig.,Non-OADS,/arxiv_data1/oa_pdf/c0/40/molcell-37-4-295-3.PMC4012077.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/40/molcell-37-4-295-3.PMC4012077.pdf
Cells http://molcells.org      A                         B                        C                               D                         E                         F                                Fig.,Non-OADS,/arxiv_data1/oa_pdf/c0/40/molcell-37-4-295-3.PMC4012077.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/40/molcell-37-4-295-3.PMC4012077.pdf
"Cells http://molcells.org     Dilp2 -negative, SIFR-positive PI neurons.",OADS,/arxiv_data1/oa_pdf/c0/40/molcell-37-4-295-3.PMC4012077.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/40/molcell-37-4-295-3.PMC4012077.pdf
Cells 2014; 37(4): 302-306  http://dx.doi.org/10.14348/molcells.2014.2209        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/6c/9c/molcell-37-4-302-4.PMC4012078.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/6c/9c/molcell-37-4-302-4.PMC4012078.pdf
Skin biopsies isolated from the body of the fetus were used to prepare porcine prima- Molecules and Cells http://molcells.org   Established in 1990,Non-OADS,/arxiv_data1/oa_pdf/6c/9c/molcell-37-4-302-4.PMC4012078.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6c/9c/molcell-37-4-302-4.PMC4012078.pdf
Cells http://molcells.org      A                                      B C             D                            A                      B                  C                               development of PA embryos after microinjection with ZFNs mRNA or with scramble mRNA.,Non-OADS,/arxiv_data1/oa_pdf/6c/9c/molcell-37-4-302-4.PMC4012078.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6c/9c/molcell-37-4-302-4.PMC4012078.pdf
"Cells http://molcells.org     J.W., Lucas-Hahn, A., Zhang, L., Meng, X., Gregory, P.D.,  Schwinzer, R., et al.",OADS,/arxiv_data1/oa_pdf/6c/9c/molcell-37-4-302-4.PMC4012078.pdf
Cells 2014; 37(4): 307-313   http://dx.doi.org/10.14348/molcells.2014.2309        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/04/5d/molcell-37-4-307-5.PMC4012079.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/04/5d/molcell-37-4-307-5.PMC4012079.pdf
"RapGAP1 was identified as a specific GAP protein for Rap1 and is involved in the regulation of Rap1 activity in the  anterior of chemotaxing cells to control cell-substratum adhe- sion and myosin II assembly during chemotaxis (Jeon  et al.,  Molecules and Cells http://molcells.org   Established in 1990",OADS,/arxiv_data1/oa_pdf/04/5d/molcell-37-4-307-5.PMC4012079.pdf
Cells http://molcells.org     2007b).,OADS,/arxiv_data1/oa_pdf/04/5d/molcell-37-4-307-5.PMC4012079.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/04/5d/molcell-37-4-307-5.PMC4012079.pdf
"Cells http://molcells.org      A                       B             C                        D                                  E                            Localization of the I/LWEQ domain  The I/LWEQ domain was originally identified on the basis of  sequence similarity in several F-actin binding proteins and has been shown to mediate cytoskeletal localization and F-actin  binding (Brett et al., 2006; McCann and Craig, 1997; Senetar  et  al., 2004).",OADS,/arxiv_data1/oa_pdf/04/5d/molcell-37-4-307-5.PMC4012079.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/04/5d/molcell-37-4-307-5.PMC4012079.pdf
Cells http://molcells.org                                              to the anterior of cells and transient translocation to the cell  cortex in response to chemoattractant stimulation.,Non-OADS,/arxiv_data1/oa_pdf/04/5d/molcell-37-4-307-5.PMC4012079.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/04/5d/molcell-37-4-307-5.PMC4012079.pdf
Cells 2014; 37(4): 314-321  http://dx.doi.org/10.14348/molcells.2014.2360         eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
"Cell lines and transfection  Human cell line A549 (human epithelial, lung carcinoma de- Molecules and Cells http://molcells.org   Established in 1990",Non-OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
"Cells http://molcells.org      A                                                          B C                  D                                                RESULTS AND DISCUSSION   Identification of miRNAs targeting the 3 ′-UTR of CDK2  using a luciferase reporter assay   To identify miRNAs that regulate t he expression of luciferase by  targeting the 3 ′-UTR of CDK2, we constructed a luciferase  reporter plasmid that contains the 3 ′-UTR of CDK2 downstream  of the Renilla  luciferase gene.",OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
"Cells http://molcells.org      A                                                     B                                                                  Growth inhibition by miRNAs that are predicted to target  CDK2 Since CDK2 plays an important role in cell cycle progression,  we examined the effects of miRNAs predicted to target CDK2  on the proliferation of A549 cells by CCK-8 assay.",OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
Cells http://molcells.org     on colony formation.,OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c0/1e/molcell-37-4-314-6.PMC4012080.pdf
Cells 2014; 37(4): 322-329   322http://dx.doi.org/10.14348/molcells.2014.2377      eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
"During this previous study, we noticed  Molecules and Cells http://molcells.org   Established in 1990",OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
"Cells http://molcells.org      A                                     b           a                                      B       a                         b                           of lactate dehydrogenase, 4.0 U of pyruvate kinase, and 0.38  μg of purified NAGK or its mutant proteins.",Non-OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
"Morphometric analyses and quantification were performed using Image J (version 1.45)  software with the simple neurite tracer plug-in (National Institute  of Health, USA) and the Sholl plug-in (http://biology.ucsd.edu/ labs/ghosh/software).",OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
Cells http://molcells.org      A                         B                        C                         D                        the His-tag (3 kDa).,OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
"Cells http://molcells.org          A      a                                                b                    B   a                                                 b                       DISCUSSION    The present study has two main findings; 1) structure-function  analysis using point mutants of NAGK that retained differential  activities supported the previously proposed 3D model structure  (Weihofen et al., 2006), and 2) dendrite upregulation by NAGK  (a non-canonical function) is independent of the kinase activity of NAGK.",Non-OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/26/f4/molcell-37-4-322-7.PMC4012081.pdf
Cells 2014; 37(4): 330-336  http://dx.doi.org/10.14348/molcells.2014.0003      eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/d3/78/molcell-37-4-330-8.PMC4012082.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/d3/78/molcell-37-4-330-8.PMC4012082.pdf
"After rightward looping of the heart, the cardiac jelly overlying  Molecules and Cells http://molcells.org   Established in 1990",Non-OADS,/arxiv_data1/oa_pdf/d3/78/molcell-37-4-330-8.PMC4012082.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d3/78/molcell-37-4-330-8.PMC4012082.pdf
"Cells http://molcells.org      A                  B             C          D                            meabilized with 0.5% TritonX-100 in PBS for 10 min, and  blocked with 1% BSA in PBS.",OADS,/arxiv_data1/oa_pdf/d3/78/molcell-37-4-330-8.PMC4012082.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d3/78/molcell-37-4-330-8.PMC4012082.pdf
Cells http://molcells.org                            (a′-l′) are schematic diagrams of the heart tube region (dashed line)  and the expression patterns of each gene (red line).,OADS,/arxiv_data1/oa_pdf/d3/78/molcell-37-4-330-8.PMC4012082.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d3/78/molcell-37-4-330-8.PMC4012082.pdf
"Cells http://molcells.org     Dube, K.N., Bollini, S., Smart, N., and Riley, P.R.",OADS,/arxiv_data1/oa_pdf/d3/78/molcell-37-4-330-8.PMC4012082.pdf
Cells 2014; 37(4): 337-344  http://dx.doi.org/10.14348/molcells.2014.0021      eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
"After filtration with 100 µm nylon cell strain-er (BD Falcon), ADSCs were centrifuged, re-suspended and  Molecules and Cells http://molcells.org   Established in 1990",OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
Ontology-based  analyses were performed using Panther database (http://www.pan-  therdb.org).,OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
Cells http://molcells.org      A                       B                                      C                                            Fig.,Non-OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
Cells http://molcells.org                                         Fig.,Non-OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
"Cells http://molcells.org     Razidlo, D.F., Zhang, M., Stensgard, B.A., Li, X., Stein, G.S.,  Lian, J.B., and Westendorf, J.J. (2011).",OADS,/arxiv_data1/oa_pdf/fc/eb/molcell-37-4-337-9.PMC4012083.pdf
Cells 2014; 37(4): 345-355  http://dx.doi.org/10.14348/molcells.2014.0046        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
"Recent- ly, we reported that the delayed neuronal death in contusion- Molecules and Cells http://molcells.org   Established in 1990",OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
"Cells  http://molcells.org      induced spinal cord injury is spatially and temporally correlated  with astrocyte death, suggesting that loss of astrocyte function is a critical cause of neuronal death (Min et al., 2012).",OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
"Cells  http://molcells.org       A                       B D                     C                                          Chih and Roberts Jr, 2003; Müller and Seifert, 1982; Olsen et  al., 2006; Raps et al., 1989; Rothstein et al., 1996; Simard and  Nedergaard, 2004; Tsacopoulos and Magistretti, 1996).",OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
Cells  http://molcells.org       A                                    B                                C D                                               Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
Cells  http://molcells.org       A                                  B                                 C                                                  Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
Cells  http://molcells.org      where gliosis occurred (red lines in Figs.,Non-OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/d4/eb/molcell-37-4-345-10.PMC4012084.pdf
Available from: http://www.aapd.org/media/ Policies_Guidelines/G_Pulp.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/2f/CCD-5-106.PMC4012100.pdf
Available  from: http://www.globalforumhealth.org.,Non-OADS,/arxiv_data1/oa_pdf/97/fd/CCD-5-13.PMC4012106.pdf
Available from: http://www.who.int/mediacentre/events/ meetings/forum_rh/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/97/fd/CCD-5-13.PMC4012106.pdf
Available from:  http://www.cohred.org/briefing/cohred_briefing5_April2007.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/fd/CCD-5-13.PMC4012106.pdf
Available  from: http://www.who.int.,Non-OADS,/arxiv_data1/oa_pdf/97/fd/CCD-5-13.PMC4012106.pdf
Available from: http://www.openknowledge.,Non-OADS,/arxiv_data1/oa_pdf/97/fd/CCD-5-13.PMC4012106.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/82/74/CCD-5-20.PMC4012111.pdf
HYPERLINK “http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/2b/90/CCD-5-42.PMC4012116.pdf
Available from: http://www1.whf.org/publication/files/pdf‑1190.,Non-OADS,/arxiv_data1/oa_pdf/5f/6f/CCD-5-49.PMC4012117.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/91/69/CCD-5-6.PMC4012120.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/91/69/CCD-5-6.PMC4012120.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/ce/a7/CCD-5-85.PMC4012125.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/de/83/CCD-5-92.PMC4012127.pdf
"2010;14(3):233-40, http://dx.doi.org/10.1007/s00784- 009-0335-8.",Non-OADS,/arxiv_data1/oa_pdf/05/d6/cln-69-05-319.PMC4012231.pdf
"2010;28(2):73-7, http://dx.doi.org/ 10.4103/0970-4388.66739.",Non-OADS,/arxiv_data1/oa_pdf/05/d6/cln-69-05-319.PMC4012231.pdf
"1973;18(11):1357-64, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/05/d6/cln-69-05-319.PMC4012231.pdf
"1951;30(5):682- 9, http://dx.doi.org/10.1177/00220345510300051201.",Non-OADS,/arxiv_data1/oa_pdf/05/d6/cln-69-05-319.PMC4012231.pdf
"2003;31(6):423-8, http://dx.doi.org/10.1016/S0300-5712(03) 00065-4.",Non-OADS,/arxiv_data1/oa_pdf/05/d6/cln-69-05-319.PMC4012231.pdf
"2003;18(3):160-4, http://dx.doi.org/10.1034/j.1399-302X.2003.00051.x.Chemomechanical caries removal using Papacarie Hgel Motta LJ et al.CLINICS 2014;69(5):319-322 322",Non-OADS,/arxiv_data1/oa_pdf/05/d6/cln-69-05-319.PMC4012231.pdf
"2011;66(2):239-44, http://dx.doi.org/10.1590/S1807- 59322011000200010.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2002;39(10):1623-9, http://dx.doi.org/10.1016/S0735-1097(02) 01814-4.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2009;103(8):1113-9, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2010;3(2):314-25, http://dx.doi.org/10.1161/CIRCHEARTFAILURE.109.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2005;96(6A):11G-17G, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2003;362(9386):767- 71, http://dx.doi.org/10.1016/S0140-6736(03)14283-3.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2010;95(4):518-23, http://dx.doi.org/10.1590/S0066- 782X2010005000112.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"1988;44(4):959-71, http://dx.doi.org/10.2307/2531727.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"1958;53:457-81, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2011;17(5):213-9, http://dx.doi.org/10.1111/j.1751-7133.2011.00235.x.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2003;36(6):771-80, http://dx.doi.org/10.1590/S0100-879X2003000600013.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2012;38(3):359-67, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2012;60(15):1402-9, http://dx.doi.org/ 10.1016/j.jacc.2012.07.011.",OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2011;37(4):619-26, http://dx.doi.org/10.1007/s00134-010- 2113-0.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2000;355 (9210):1126-30, http://dx.doi.org/10.1016/S0140-6736(00)02060-2.",OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2007;49(16):1733-9, http://dx.doi.org/10.1016/j.jacc.2006.10.081.",OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2010; 55(7):645-53, http://dx.doi.org/10.1016/j.jacc.2009.08.078.",OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2009;374(9704):1840-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2010;56(21):1701-8, http://dx.doi.org/10.1016/j.jacc.2010.03.105.",OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2008;14(3):181-8, http://dx.doi.org/10.1016/j.cardfail.2007.11.008.",Non-OADS,/arxiv_data1/oa_pdf/4c/b2/cln-69-05-308.PMC4012233.pdf
"2012;185(4):435-52, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2008;29(6):816-24, http://dx.doi.org/10.1093/eurheartj/ehn048.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2010;16(5):202-7, http://dx.doi.org/10.1111/j.1751-7133.2010.00152.x.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2003;145(2 Supplement):S26-33, http://dx.doi.org/10.1067/mhj.2003.151.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2010;31(7):771-2, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2010;31(7):832- 41, http://dx.doi.org/10.1093/eurheartj/ehp458.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2009;66(9):639-42, http://dx.doi.org/10.1024/0040-5930.66.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2013;6(11):1141-51, http://dx.doi.org/10.1016/j.jcmg.2013.08.004.",OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2002;106(4):416-22, http://dx.doi.org/10.1161/01.CIR.0000025242.79963.4C.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2002;44(4):293-321, http://dx.doi.org/10.1053/pcad.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2013;6(3):461-72, http://dx.doi.org/ 10.1161/CIRCHEARTFAILURE.112.000185.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2011;34(8):968-74, http://dx.doi.org/10.1111/j.1540- 8159.2011.03072.x.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2012;38(4):577-91, http://dx.doi.org/10.1007/s00134-012-2513-4.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2008;52(12):997-1003, http://dx.doi.org/10.1016/j.jacc.2008.04.069.",OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"Curr Heart Fail Rep. 2009;6(2):95-101, http://dx.doi.org/10.1007/s11897-009-0015-7.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/cln-69-05-341.PMC4012234.pdf
"2006;78(19):2179-87, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"1983;33(20):1965-73, http://dx.doi.org/10.1016/0024-3205(83)90734-8.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"1985;7(4):519-24, http://dx.doi.org/10.1161/ 01.HYP.7.4.519.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"1995;22(9):655-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"1995;22(3):185-8, http://dx.doi.org/10.1111/j.1440-1681.1995.tb01977.x.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"Lancet.1981;2(8248):653-6, http://dx.doi.org/10.1016/S0140-6736(81)90995- 8.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"2008;103(12):1979-86, http://dx.doi.org/10.1111/j.1360-0443.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"2003;26:239-66, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"1997;29(6):1278-83, http://dx.doi.org/10.1161/01.HYP.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"2013;48(4):495-504, http://dx.doi.org/10.1093/alcalc/agt040.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"1970;10(3):384-95, http://dx.doi.org/10.1016/0034-5687 (70)90056-3.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"2013;68(3):395-9, http://dx.doi.org/10.6061/clinics/2013(03)OA18.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"1996;730(1-2):182-92, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"1999;100(3):262-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"2002;97(2):177-86, http://dx.doi.org/10.1007/ s003950200009.",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"2004;10(3):236-43, http://dx.doi.org/10.1016/j.cardfail.2003.09.005.",OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"1987;11(1):49-51, http://dx.doi.org/10.1111/j.1530-0277.1987.tb01262.x.Ethanol exposure and ventilation Sabino JPJ et al.CLINICS 2014;69(5):360-366 366",Non-OADS,/arxiv_data1/oa_pdf/46/77/cln-69-05-360.PMC4012235.pdf
"2005;112(17):2735-52, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2005;366(9491):1059-62, http://dx.doi.org/10.1016/S0140-6736(05)67402- 8.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2006;Suppl 1:16S-19S, http://dx.doi.org/10.1038/oby.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2004;53(3):310-7, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2000;20(8):1932-38, http://dx.doi.org/10.1161/01.ATV.20.8.1932.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2002; 10(8):792-8, http://dx.doi.org/10.1038/oby.2002.107.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2001;9(11):696-705, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2005;69(1):52-62, http://dx.doi.org/10.1016/j.diabres.2004.11.001.",OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2002;87(11):5044-51, http://dx.doi.org/10.1210/jc.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2003;26(2):372-9, http://dx.doi.org/10.2337/ diacare.26.2.372.Anthropometric measurements and MetS Sagun G et al.CLINICS 2014;69(5):347-353 352",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"1983;72(3):1150-62, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2007;116(1):39-48, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2009;32(5):956-8, http://dx.doi.org/10.2337/dc08- 1663.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"1985;28(7):412-9, http://dx.doi.org/10.1007/BF00280883.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2003;26(9):2556-61, http://dx.doi.org/10.2337/diacare.26.9.2556.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"1997;5(1):16- 23, http://dx.doi.org/10.1002/j.1550-8528.1997.tb00278.x.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2011; 6(9):e24017, http://dx.doi.org/10.1371/journal.pone.0024017.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"1995;18(4):435-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"2003; 27(5):610-6, http://dx.doi.org/10.1038/sj.ijo.0802259.",Non-OADS,/arxiv_data1/oa_pdf/06/29/cln-69-05-347.PMC4012236.pdf
"The sequencing reactions were then analyzed using the MegaBACE 1000 automatic sequencer (GE Healthcare), and the sequences were analyzed usingChromas software (http://www.technelysium.com.au/ chromas.html, accessed on March 19th, 2011) (Figure 1).",OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2007;448(7152):427-34, http://dx.doi.org/10.1038/ nature06005.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2006;314(5804):1461-3, http://dx.doi.org/ 10.1126/science.1135245.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2007;39(2):207-11, http://dx.doi.org/10.1038/ng1954.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2001;411(6837):599-603, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2001;411(6837):603-6, http://dx.doi.org/10.1038/35079114.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"1996;14(2):199-202, http://dx.doi.org/10.1038/ng1096-199.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2004;13(7):763-70, http://dx.doi.org/10.1093/hmg/ddh090.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2007;13(3):338-55, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2004;75(1):13-33, http://dx.doi.org/10.1016/j.clpt.2003.09.012.",OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2000;118(2):279-88, http://dx.doi.org/10.1016/S0016-5085(00)70210-1.",OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2003;178(3):339-46, http://dx.doi.org/10.1677/joe.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2010;4(1):7-27, http://dx.doi.org/10.1016/j.crohns.2009.12.003.",OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2006;55(6):749-53, http://dx.doi.org/10.1136/gut.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"1980;1(8167):514, http://dx.doi.org/10.1016/S0140-6736(80)92767- 1.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"1998;43(1):29-32, http://dx.doi.org/10.1136/gut.43.1.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"1998;26(15):3577-83, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2004;5(7):530-9, http://dx.doi.org/ 10.1038/sj.gene.6364123.",OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2007;13(5):516-23, http://dx.doi.org/10.1002/ibd.20108.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2006;12(4):263-71, http://dx.doi.org/10.1097/01.MIB.0000209791.98866.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2003;124(1):26-33, http://dx.doi.org/10.1053/gast.2003.50010.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2005;128(2):288-96, http://dx.doi.org/10.1053/j.gastro.2004.11.019.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2005;22(11-12):1129-38, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2001;358(9279):383-4, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2002;12(6):437-50, http://dx.doi.org/10.1097/00008571- 200208000-00004.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2011;17(11):2308-17, http://dx.doi.org/10.1002/ibd.21608.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"1999;60(8):677-87, http://dx.doi.org/ 10.1016/S0198-8859(99)00036-1.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2004;127(1):26-40, http://dx.doi.org/10.1053/j.gastro.2004.04.019.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2002;123(3):679-88, http://dx.doi.org/10.1053/gast.2002.35393.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2010;16(8):1279-85, http://dx.doi.org/10.1002/ibd.21196.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2007;35(4):595-601, http://dx.doi.org/10.1124/dmd.106.011478.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2002;21(13):1945-54, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2009;156(1):172-82, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/32/46/cln-69-05-327.PMC4012237.pdf
"2006;130(1):157- 63, http://dx.doi.org/10.1378/chest.130.1.157.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"1995;91(6):1725-31, http://dx.doi.org/10.1161/01.CIR.91.6.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2000;118(4):1004-9, http://dx.doi.org/10.1378/chest.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2007;28(10):1221-7, http://dx.doi.org/10.1093/eurheartj/ehm131.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2008;134(6):1162-8, http://dx.doi.org/10.1378/chest.08- 0346.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2000;102(1):61-6, http://dx.doi.org/10.1161/01.CIR.102.1.61.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2003;289(2):194-202, http://dx.doi.org/10.1001/jama.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2012;98(1 suppl 1):1-33, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"1996;9(5):736-60, http://dx.doi.org/10.1016/S0894-7317(96) 90076-0.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2009;29(1):44-8, http://dx.doi.org/10.1097/ HCR.0b013e3181927858.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2011;96(3):227-32, http://dx.doi.org/10.1590/S0066-782X2011005000002.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2008;9(6):660-6, http://dx.doi.org/10.1016/j.sleep.2007.06.018.",OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2005;9(6):607-21, http://dx.doi.org/10.1186/ cc3877.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"1998;98(21):2269-75, http://dx.doi.org/10.1161/01.CIR.98.21.2269.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2000;5(4):301-6, http://dx.doi.org/ 10.1023/A:1026503028065.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
"2009;158(4suppl):S45-52, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/21/66/cln-69-05-354.PMC4012238.pdf
Available from: http://www1.inca.gov.,Non-OADS,/arxiv_data1/oa_pdf/81/f5/cln-69-05-367.PMC4012239.pdf
"1998;9(7):717-20, http://dx.doi.org/10.1023/A: 1008265532487.3. International Lymphoma Study Group.",Non-OADS,/arxiv_data1/oa_pdf/81/f5/cln-69-05-367.PMC4012239.pdf
"2011;33(4):317, http://dx.doi.org/10.5581/1516-8484.20110085.",Non-OADS,/arxiv_data1/oa_pdf/81/f5/cln-69-05-367.PMC4012239.pdf
"2000;5(3):238-49, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/81/f5/cln-69-05-367.PMC4012239.pdf
"2007;25(5):579-86, http://dx.doi.org/10.1200/JCO.2006.09.2403.",Non-OADS,/arxiv_data1/oa_pdf/81/f5/cln-69-05-367.PMC4012239.pdf
Available from: https://www.gov.uk/government/uploads/system/ uploads/attachment_data/file/135516/dh_123394.pdf.pdf.,OADS,/arxiv_data1/oa_pdf/81/f5/cln-69-05-367.PMC4012239.pdf
"2012;6:82-8, http://dx.doi.org/10.2174/ 1874306401206010082.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"2006;124(1):10-4, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"2009;193(5):1228-35, http://dx.doi.org/10.2214/AJR.08.2113.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"2013;62 Suppl 1:S11-4, http://dx.doi.org/10.1016/j.metabol.",OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"2010;116(8):1974-80, http://dx.doi.org/10.1002/cncr.24968.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"1996;40(4):687-90, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"2013;40(1):98-103, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"2012;21(6):415-22, http://dx.doi.org/10.3109/13645706.2012.662155.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"2010;65(9):847-50, http://dx.doi.org/10.1590/S1807-59322010000900006.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"2004;126(3):748-54, http://dx.doi.org/10.1378/chest.126.3.748.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"2008;18(7):1356-63, http://dx.doi.org/10.1007/s00330-008- 0893-1.",Non-OADS,/arxiv_data1/oa_pdf/ba/5b/cln-69-05-335.PMC4012240.pdf
"Am Heart J, 1972;84(1):66-71, http://dx.doi.org/ 10.1016/0002-8703(72)90307-9.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2003;14(2):155-61, http://dx.doi.org/10.1097/00019501-200304000-00008.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2003;44(6):907-19, http://dx.doi.org/10.1536/jhj.44.907.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2011;39(6):463-8, http://dx.doi.org/10.5543/tkda.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"1989;20(9):850-7, http://dx.doi.org/10.1016/0046-8177(89)90096-8.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"Blood 2006;107(2):558-65, http://dx.doi.org/10.1182/blood-2005-05-2152.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2010;16(6):628-36, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"1996;93(5):879-88, http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2005;28(3):145-8, http://dx.doi.org/10.1002/clc.4960280310.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2004;59(2):127-33, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2013;71(6):588-94, http://dx.doi.org/10.5603/KP.2013.0122.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2007;58(4):401-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2007;385(1-2):43-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2010;29(3):310-5, http://dx.doi.org/10.1007/ s11239-009-0353-z.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"2009;20(1):23-8, http://dx.doi.org/10.1080/09537100802458969.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"J Exp Med 1990;172:1271-4, http://dx.doi.org/10.1084/jem.172.4.1271.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"1993;91(4):1721-30, http://dx.doi.org/10.1172/JCI116382.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
"1993;147(4):914-20, http://dx.doi.org/10.1164/ajrccm/147.4.914.",Non-OADS,/arxiv_data1/oa_pdf/3e/a7/cln-69-05-323.PMC4012242.pdf
Pathway Commons databa se [http://www.pathw aycommons.,Non-OADS,/arxiv_data1/oa_pdf/e0/70/cjc-30-01-027.PMC4012261.pdf
"Available at: http://www.asco.org/ascov2/  Meetings/Abstracts?&vmview=abst_detai l_view&confID=74&  abstractID=48372  Cohn  AL, Bekaii鄄 Saab TS, Bendell JC, et al.",Non-OADS,/arxiv_data1/oa_pdf/bc/2b/cjc-30-10-682.PMC4012268.pdf
Available at: http://www.asco.org/ascov2/Meetings/  Abstracts?,Non-OADS,/arxiv_data1/oa_pdf/bc/2b/cjc-30-10-682.PMC4012268.pdf
Anatomical Therapeutic Chemical (ATC) Classi ﬁcation http://www.whocc.no/ atcddd 2010.,Non-OADS,/arxiv_data1/oa_pdf/5c/a5/tp201414a.PMC4012279.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Antidepressants related to vitamin D 3 RC Oude Voshaar et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/5c/a5/tp201414a.PMC4012279.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Mitochondrial dysfunction in autism cell lines S Rose et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/6d/01/tp201415a.PMC4012280.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Chronic antipsychotic treatment and PDE10A levels S Natesan et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/cc/ae/tp201417a.PMC4012281.pdf
"Behavioral analyses Statistical analyses of the behavioral data were conducted using SPSS(SPSS, Chicago, IL, USA) and R (http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/5b/22/tp201420a.PMC4012284.pdf
"Regions of interest were the bilateral NAcc (using masks from the Harvard-Oxford Cortical /Subcortical Structural Atlas (http://www.cma.mgh.harvard.edu/fsl_atlas.html), probability threshold = 0.5) and vmPFC.",OADS,/arxiv_data1/oa_pdf/5b/22/tp201420a.PMC4012284.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Parental inconsistency and impulsive choice S Schneider et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/5b/22/tp201420a.PMC4012284.pdf
Statistical analysis FSL ’s Randomise tool (http://www.fmrib.ox.ac.uk/fsl/randomise/index.,Non-OADS,/arxiv_data1/oa_pdf/bc/37/tp201421a.PMC4012285.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)ECT effects on white matter structure H Lyden et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/bc/37/tp201421a.PMC4012285.pdf
"CpG-island position was determined using criteria from UCSC genome browser —that is, a genomic region with a CpG content of 50% or greater, length greater than 200 bp and a ratio greater than 0.6 ofobserved number of CG dinucleotides to the expected number on thebasis of the number of Gs and Cs in the segment (UCSC human February2009 assembly GRCh37/hg19, (http://genome.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/ff/3d/tp201422a.PMC4012286.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)NR3C1 methylation following stressful experiences LJ van der Knaap et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/ff/3d/tp201422a.PMC4012286.pdf
"A selection of genetic variations (see Table 1) under study was made based on (i) their involvement in dopamine and/or opioid regulation and/ or (ii) previous literature showing associations between the selectedvariations and mental disorders associated with a de ﬁcient reward system, such as MDD.45–53Of the selected 32 SNPs, ●Three SNPs could not be included in any of the multiplex assays due to neighbouring SNPs or overlapping sequences (rs11030103 and rs568201086 in the brain-derived neurotrophic factor ( BDNF ) gene and rs1799732 in the dopamine receptor D2 ( DRD2 ) gene); ●One SNP was excluded because according information from the Database of Single Nucleotide Polymorphisms (dbSNP; http://www.ncbi.nlm.nih.gov/SNP/) its variation was suspected to be false positive due to artifacts of the presence of paralogous sequence in the genome or because evidence suggested sequencing error or computationartifacts (rs28722151 in BDNF ); ●One SNP was excluded because it was a multivariate SNP which was unknown at the time of genotyping (rs1799836 in the monoamineoxidase B ( MAO-B ) gene); ●Three SNPs were excluded because they showed no, or minimal, variation: rs12273539 and rs57083135 in BDNF ; rs6267 in the catechol- O- methyltransferase ( COMT ) gene); ●One SNP was excluded because of genotyping failure (that is, call rate o0.90; rs747302 in the dopamine receptor D4 ( DRD4 ) gene).",Non-OADS,/arxiv_data1/oa_pdf/cf/97/tp201423a.PMC4012287.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Overexpression of CRF in CeA diminishes nicotine withdrawal XQ i et al 6 Translational Psychiatry (2014), 1 –6 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/25/9d/tp201425a.PMC4012288.pdf
"To record vocalizations, an ultrasound-sensitivemicrophone —a bat detector (US Mini-2 bat detector, Summit, Birming- ham) tuned in the range of 60 –80 kHz —was suspended above the isolated pup and USVs were recorded for 5 min using Audacity software (http://audacity.sourceforge.net/).",Non-OADS,/arxiv_data1/oa_pdf/43/fa/tp201427a.PMC4012289.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Paternal age and autism across generations S Sampino et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/43/fa/tp201427a.PMC4012289.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/0b/d8/ajg201455a.PMC4012300.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/8c/tacg-7-055.PMC4012343.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2014:7 55–66The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  55Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S5844 4wiskott–Aldrich syndrome: diagnosis, current   management, and emerging treatments David Buchbinder1 Diane J Nugent1 Alexandra H Fillipovich2 1Division of Hematology, Children’s  Hospital of Orange County, Orange,   CA, USA; 2Division of immunology,   Cincinnati Children’s Hospital,   Cincinnati, OH, USA Correspondence: David Buchbinder   Division of Hematology, Children’s   Hospital of Orange County,   1201 La veta, Orange, CA 92868, USA   Tel +1 714 509 8744   Fax +1 714 509 8771   email dbuchbinder@choc.or gAbstract:  Wiskott–Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency  disorder characterized by the triad of eczema, thrombocytopenia, and severe and often recurrent  infections.",Non-OADS,/arxiv_data1/oa_pdf/e5/8c/tacg-7-055.PMC4012343.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/e5/8c/tacg-7-055.PMC4012343.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/8c/tacg-7-055.PMC4012343.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/85/tacg-7-043.PMC4012344.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2014:7 43–53The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  43Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S3999 3Hypothesis of the neuroendocrine cortisol  pathway gene role in the comorbidity of  depression, type 2 diabetes, and metabolic  syndrome Claudia Gragnoli1,2 1Center for Biotechnology and  Department of Biology, College  of Science and T echnology, T emple  University, Philadelphia, PA, USA;   2Molecular Biology Laboratory, Bios  Biotech Multi-Diagnostic Health  Center, Rome, italy Correspondence: Claudia Gragnoli   BioLife Science Bldg, Suite 431, Center  for Biotechnology, College of Science and  Technology, Temple University, 1900 N  12th Street, Philadelphia, PA 19122, USA   Tel +1 508 246 9330   Fax +1 717 482 1123   email claudia.gragnoli@gmail.co mAbstract:  Depression, type 2 diabetes (T2D), and metabolic syndrome (MetS) are often  comorbid.",Non-OADS,/arxiv_data1/oa_pdf/94/85/tacg-7-043.PMC4012344.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/94/85/tacg-7-043.PMC4012344.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/85/tacg-7-043.PMC4012344.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/6e/tacg-7-067.PMC4012345.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2014:7 67–79The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  67Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S4562 0Overview of the genetic determinants   of primary aldosteronism Abdallah Al-Salameh1 Régis Cohen2 Rachel Desailloud3 1Service de Diabétologie,   endocrinologie et Maladies  Métaboliques, Centre Hospitalier  de Creil, Creil, France; 2Service  d’endocrinologie, Centre Hospitalier  de Saint-Denis, Saint-Denis,   France; 3Service d’endocrinologie,   Diabétologie et Nutrition, Centre  Hospitalier Universitaire d’Amiens,   Amiens, France Correspondence: Abdallah Al-Salameh   Service de Diabétologie, endocrinologie,  et Maladies Métaboliques, Centre   hospitalier de Creil (GHPSO),   Boulevard Laënnec, F-60109 Creil cedex,  France   Tel +33 344 616 543   Fax +33 344 616 540   email abdallahalsalameh@hotmail.co mAbstract:  Primary aldosteronism is the most common cause of secondary hypertension.",Non-OADS,/arxiv_data1/oa_pdf/ea/6e/tacg-7-067.PMC4012345.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/ea/6e/tacg-7-067.PMC4012345.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/6e/tacg-7-067.PMC4012345.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/90/pgpm-7-117.PMC4012346.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 117–120Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  117Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PGPM.S5554 8effects of ePhX1 and cYP3a4 polymorphisms on  carbamazepine metabolism in epileptic patients antonietta caruso chiara Bellia alessia Pivetti luisa agnello Federica Bazza concetta scazzone giulia Bivona Bruna lo sasso Marcello ciaccio Department of Biopathology and  Medical and Forensic Biotechnologies,   University of Palermo, Palermo, italy correspondence: Marcello ciaccio   Department of Biopathology and Medical  and Forensic Biotechnologies,   University of Palermo, Via del Vespro,  129, Palermo, italy   Tel +39 09 1655 3296   Fax +39 09 1655 3275   email marcello.ciaccio@unipa.i tBackground:  The aim of this study was to investigate the effect of two genetic polymorphisms  in the coding regions (exon 3 and exon 4) of the EPHX1  gene, ie, 337T .C and 416A .G,  respectively, on the metabolism of carbamazepine (CBZ) 10,11-epoxide (the active metabolite of  CBZ) by evaluating the variation in serum CBZ 10,11-epoxide levels 4 hours after administration  of the drug.",Non-OADS,/arxiv_data1/oa_pdf/87/90/pgpm-7-117.PMC4012346.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/87/90/pgpm-7-117.PMC4012346.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/87/90/pgpm-7-117.PMC4012346.pdf
Available from: http://www.ensembl.,Non-OADS,/arxiv_data1/oa_pdf/87/90/pgpm-7-117.PMC4012346.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/b6/pgpm-7-121.PMC4012347.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 121–127Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  121RaPid Co MMuniC ationopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/PGPM.S6074 7Possible impact of the CYP2D6*10   polymorphism on the nonlinear   pharmacokinetic parameter estimates   of paroxetine in Japanese patients   with major depressive disorders Junji Saruwatari1 Hiroo nakashima1 Shoko tsuchimine2 Miki nishimura1 naoki ogusu1 norio Yasui-Furukori2 1division of Pharmacology and   therapeutics, Graduate School of   Pharmaceutical Sciences, Kumamoto   university, Kumamoto, Japan;    2department of n europsychiatry,    Graduate School of Medicine,    Hirosaki university, Hirosaki, Japan Correspondence: Junji Saruwatari   division of Pharmacology and   therapeutics, Graduate School of   Pharmaceutical Sciences, Kumamoto   university,  5-1 oe-honmachi,   Chuo-ku, Kumamoto  862-0973, Japan   tel +81 96 371 4512  Fax +81 96 371 4512  Email junsaru@gpo.kumamoto-u.ac.j pAbstract:  It has been suggested that the reduced function allele with reduced cytochrome  P450 (CYP)  2D6 activity, CYP2D6*10 , is associated with the interindividual differences in  the plasma paroxetine concentrations, but there is no data presently available regarding the   influence of the CYP2D6*10  polymorphism on the pharmacokinetic parameters, eg, Michaelis– Menten constant (Km) and maximum velocity (Vmax), in Asian populations.",Non-OADS,/arxiv_data1/oa_pdf/b9/b6/pgpm-7-121.PMC4012347.pdf
Available from: http://www.imm.ki.se/cypalleles/cyp2d6.htm.,Non-OADS,/arxiv_data1/oa_pdf/b9/b6/pgpm-7-121.PMC4012347.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/b9/b6/pgpm-7-121.PMC4012347.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b9/b6/pgpm-7-121.PMC4012347.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/52/lra-7-005.PMC4012348.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpLocal and Regional Anesthesia 2014:7 5–9Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  5ORiginAL  ReseARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S5915 8Perineural but not systemic low-dose  dexamethasone prolongs the duration   of interscalene block with ropivacaine:   a prospective randomized trial Ryosuke Kawanishi1 Kaori Yamamoto2 Y oko T obetto2 Kayo nomura2 Michihisa Kato2 Ritsuko go2 Yasuo M Tsutsumi3 Katsuya Tanaka3 Y oshitsugu Takeda4 1Department of Anesthesiology,   T okushima University hospital,   T okushima, 2Division of  Anesthesiology, Tokushima Red cross  hospital, Komatsushima, 3Department  of Anesthesiology, institute of health  Bioscience, University of Tokushima  graduate school, T okushima, 4Division  of Orthopedics, Tokushima Red cross  hospital, Komatsushima, Japan correspondence: Katsuya Tanaka   Department of Anesthesiology, institute  of health Bioscience, University of  Tokushima graduate school, 3-18-15  Kuramoto, Tokushima 770-8503, Japan   Tel +81 88 633 7181   Fax +81 88 633 7182   email katsuya.tanaka@tokushima-u.ac.j pPurpose:  To determine the effects of intravenous and perineural dexamethasone on the  duration of interscalene brachial plexus block (ISB) with ropivacaine in patients undergoing  arthroscopic shoulder surgery.",Non-OADS,/arxiv_data1/oa_pdf/f5/52/lra-7-005.PMC4012348.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/f5/52/lra-7-005.PMC4012348.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/52/lra-7-005.PMC4012348.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/e6/lra-7-011.PMC4012349.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpLocal and Regional Anesthesia 2014:7 11–16Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  11ORiginAL  ReseARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S6158 9Ultrasound-guided transversus abdominis plane  blocks for patients undergoing laparoscopic   hand-assisted nephrectomy: a randomized,  placebo-controlled trial stephen Aniskevich1 c Burcin Taner2 Dana K Perry2 christopher B Robards3 steven B Porter3 colleen s Thomas4 ilana i Logvinov5 steven R clendenen4 1Department of Anesthesia,   Division of Transplant Anesthesia,   2Department of Transplantation,   3Department of Anesthesia, Division  of Regional Anesthesia,  4Division of  health sciences Research, section  of Biostatistics,  5Department of  Anesthesia, M ayo clinic Florida,   Jacksonville, FL, UsA correspondence: stephen Aniskevich   Mayo clinic Florida,  4500 san Pablo Rd,  Jacksonville, FL  32224, UsA   Tel +1 904 953 2000  Fax +1 904 956 3332  email a niskevich.stephen2@mayo.ed uAbstract:  Postoperative pain is a common complaint following living kidney donation or  tumor resection using the laparoscopic hand-assisted technique.",Non-OADS,/arxiv_data1/oa_pdf/2f/e6/lra-7-011.PMC4012349.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/2f/e6/lra-7-011.PMC4012349.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/e6/lra-7-011.PMC4012349.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/fe/lra-7-017.PMC4012350.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpLocal and Regional Anesthesia 2014:7 17–22Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  17Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S6216 0Preventive analgesia for postoperative   pain control: a broader concept Nalini vadivelu1 Sukanya Mitra2 erika Schermer3 vijay Kodumudi4 Alan David Kaye5 Richard D Urman6 1Department of Anesthesiology,   Yale University School of Medicine,   New Haven, CT, USA;  2Department  of Anesthesia and intensive Care,   Government Medical College and  Hospital, Chandigarh, india;  3Yale  College, New Haven,  4School of  Liberal Arts and Science, University of  Connecticut, Storrs, CT,  5Department  of Anesthesiology, Louisiana State  University School of Medicine,   New Orleans, LA,  6Department of  Anesthesiology, Perioperative and  Pain Medicine, Brigham and women’s  Hospital, Boston, MA, USA Correspondence: Richard D Urman   Harvard Medical School, Brigham and  women’s Hospital, 75 Francis Street,  Boston, MA, 02115, USA   Tel +1 617 732 8222  email rurman@partners.or gAbstract :  Pain from surgical procedures occurs as a consequence of tissue trauma and may  result in physical, cognitive, and emotional discomfort.",Non-OADS,/arxiv_data1/oa_pdf/fe/fe/lra-7-017.PMC4012350.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/fe/fe/lra-7-017.PMC4012350.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/fe/lra-7-017.PMC4012350.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/ec/lra-7-023.PMC4012351.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpLocal and Regional Anesthesia 2014:7 23–25Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  23CAse Repo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/LRA.S5944 6Computed tomography-guided bupivacaine   and corticosteroid injection for the treatment   of symptomatic calcification in the great toe tendon omer Karatoprak1 sinan Karaca2 Mehmet Nuri erdem3 ozgur Karaman2 Azmi Hamzaoglu4 1Department of orthopedic surgery,  Kadikoy Florence Nightingale  Hospital, Istanbul, turkey;  2Department of orthopedic surgery,  Fatih sultan Mehmet training  and Research Hospital Atasehir,  Istanbul, turkey; 3Department of  orthopedics and traumatology, Kolan  International Hospital sisli, Istanbul,  turkey; 4Department of orthopedic  surgery, Istanbul Florence Nightingale  Hospital, Istanbul turkey Correspondence: sinan Karaca   Department of orthopedic surgery,   Fatih sultan Mehmet training   and Research Hospital Atasehir,   Istanbul, turkey   tel +90 216 450 0303   Fax +90 216 450 1950   email mdsnn@hotmail.co mBackground:  Calcification in the great toe tendon is a rare disorder that is characterized by  the deposition of calcium on degenerative collagen fibrils.",Non-OADS,/arxiv_data1/oa_pdf/7b/ec/lra-7-023.PMC4012351.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/7b/ec/lra-7-023.PMC4012351.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/ec/lra-7-023.PMC4012351.pdf
Available from: http://mospi.nic.in/mospi_new/upload/elderly_in_india.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/50/JAIM-5-11.PMC4012356.pdf
Available from: http://www.dabur.,Non-OADS,/arxiv_data1/oa_pdf/62/d4/JAIM-5-15.PMC4012357.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/62/d4/JAIM-5-15.PMC4012357.pdf
Available  from: http://www.ayusoft.cdac.in/.,Non-OADS,/arxiv_data1/oa_pdf/4e/1b/JAIM-5-43.PMC4012362.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK138675.,Non-OADS,/arxiv_data1/oa_pdf/4e/1b/JAIM-5-43.PMC4012362.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/14/c9/JAIM-5-50.PMC4012363.pdf
Available from: http://www.scireproject.com/about-scire  [Last accessed on 2013 Apr 10].,Non-OADS,/arxiv_data1/oa_pdf/06/c3/JAIM-5-56.PMC4012364.pdf
Available from: http://www.iwgdf.org/.,Non-OADS,/arxiv_data1/oa_pdf/0d/b2/JAIM-5-60.PMC4012365.pdf
Available from: http://www.jsscpooty.org/assets/pdf/Selected-List-Category-C.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/b2/JAIM-5-60.PMC4012365.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/0d/b2/JAIM-5-60.PMC4012365.pdf
"Another useful solution, for  those familiar with the C language , is to load once ,  through the programmer, a firmware named ""bootloader"",  freely available on the Internet; than , working firmware  can be created with a more simple programming  environment, named ""Pinguino""  (open source by Jean- Pierre Mandon ), and loaded through the USB port ; all th is  procedure is described at  http://wiki.pinguino.cc/index.php/Main_Page .",Non-OADS,/arxiv_data1/oa_pdf/c3/da/tm-09-23.PMC4012370.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/f8/23/mtna201410a.PMC4012396.pdf
"Healthcare in care homes – a special review of the provision of health care to those in care homes, http://www.cqc.org.uk/public/reports-surveys-and-reviews/reviews-and-studies/meeting- health-care-needs-people-care-homes (accessed 28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Report of an expert group on learning from adverseevents in the NHS, http://www.dh.gov.uk/prod_ consum_dh/groups/dh_digitalassets/@dh/@en/docu- ments/digitalasset/dh_4065086.pdf (2000, accessed 28 November 2012).5.",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"National minimum standards, http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4135403.pdf (2003, accessed 28 November 2012).",OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Health and Personal Social Services Act (Northern Ireland) 2002, http://www.legislation.gov.uk/nia/2002/ 9/contents (2002, accessed 28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"British Geriatrics Society, http://www.bgs.org.uk/campaigns/carehomes/quest_quality_care_homes.pdf (2011, accessed 28November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Care Quality Commission, http://www.cqc.org.uk/ (accessed 28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Health and Social Care Act 2008, http://www.dh.gov.",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Care Inspectorate: Scotland, http://www.scswis.com/ (accessed 28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Care and Social Services Inspectorate Wales (CSSIW), http://wales.gov.uk/cssiwsubsite/newcssiw/?lang ¼en (accessed 28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"The Regulation and Quality Improvement Authority (RQIA): Northern Ireland, http://www.rqia.org.uk/ home/ (accessed 28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Governance and quality: Bupa home healthcare’s regu- latory assurance, http://www.bupa.co.uk/healthcare- providers/home-healthcare/bhh-about/governance- quality (accessed 28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"National records of Scotland, Northern Ireland Statistics and Research Agency, http://www.ons.gov.",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"White Paper: pharmacy in England: building on strengths – delivering the future, http://www.dh.gov.",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Department of Health, http://www.cqc.org.uk/reviewsandstudies/Fahrni et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"National Prescribing Centre, http://www.npc.nhs.uk/ repeat_medication/medicines_long_term/ (accessed 28November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"GP prescribing support: a resource document and guide for the New NHS, http://www.npc.nhs.uk/ resources/gp_prescribing_support.pdf (1998, accessed28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"National Prescribing Centre, http://www.npc.nhs.uk/evidence/resources/10_top_tips_ for_gps.pdf (2011, accessed 28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Pharmacy bodies respond to MHRA announcement on dispensing errors, http://www.rpharms.com/what-s- happening-/news_show.asp?id ¼406 (2012, accessed 28 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"National Patient Safety Agency: proposed transfer of the operational management of the National Reporting and Learning System to Imperial College Healthcare NHS Trust, http://www.npsa.nhs.uk/corporate/news/proposed-transfer-of-nrls/ (accessed 28 November 2012) 30.",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Medicines and Healthcare Products Regulatory Agency: care home staff – a one-stop resource forcare home staff, http://www.mhra.gov.uk/Safety information/Healthcareproviders/Carehomestaff/ index.htm (accessed 28 November 2012).6 Journal of the Royal Society of Medicine Open 5(2)",Non-OADS,/arxiv_data1/oa_pdf/d6/5b/10.1177_2042533313515475.PMC4012648.pdf
"Trust Guideline for the Enhanced Recovery Programme for Total Hip and Total KneeReplacement at the Norfolk and Norwich University Hospital 2010, http://www.ukcpa.net/wp-content/ uploads/group-documents/30/1317819839-CA4091_EnhancedRecoveryProgrammeforTotalHipa-ndTotalKneeReplacement.doc (2010, accessed 22 October 2013).",Non-OADS,/arxiv_data1/oa_pdf/2e/c0/10.1177_2042533313516949.PMC4012650.pdf
"Protocol for Enhanced Recovery Orthopaedic Hip and Knee Joint Replacement Patients at Hull and East Yorkshire Hospitals 2012, http://frcaheadstart.org/ ortho_ERAS_CHH.pdf (2012, accessed 22 October2013).",Non-OADS,/arxiv_data1/oa_pdf/2e/c0/10.1177_2042533313516949.PMC4012650.pdf
"Enhanced Recovery Protocol for Elective Hip and Knee Replacements at Doncaster and BassetlawHospitals, http://www.dbh.nhs.uk/Library/Pharmacy_Medicines_Management/Formulary/Formulary_S4/ Enhanced%20Recovery%20Protocol%20- %20Orthopaedics.pdf (last, accessed 22 October 2013).",Non-OADS,/arxiv_data1/oa_pdf/2e/c0/10.1177_2042533313516949.PMC4012650.pdf
"Attention-deficit/hyperactivity disorder (ADHD), http://www.nice.org.uk/nicemedia/pdf/ ADHDFullGuideline.pdf (2009, last accessed 15March 2012).",Non-OADS,/arxiv_data1/oa_pdf/e3/4d/10.1177_2042533313517690.PMC4012651.pdf
"Ministry of Health, Social Services and Equality, http://www.aemps.gob.es/cima/fichasTecnicas.do?",Non-OADS,/arxiv_data1/oa_pdf/e3/4d/10.1177_2042533313517690.PMC4012651.pdf
"Geneva: The World Health Organization, http://www.who.int/whr/1999/en/ whr99_en.pdf (1999, accessed 18 August 2013).",Non-OADS,/arxiv_data1/oa_pdf/c8/3a/10.1177_2042533313517692.PMC4012652.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(5) 1–4 DOI: 10.1177/2042533313517688",Non-OADS,/arxiv_data1/oa_pdf/a3/35/10.1177_2042533313517688.PMC4012655.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(5) 1–11 DOI: 10.1177/2054270414525373",Non-OADS,/arxiv_data1/oa_pdf/ef/7a/10.1177_2054270414525373.PMC4012656.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(5) 1–3 DOI: 10.1177/2054270414527931",Non-OADS,/arxiv_data1/oa_pdf/5c/41/10.1177_2054270414527931.PMC4012657.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(5) 1–3 DOI: 10.1177/2054270414527932",Non-OADS,/arxiv_data1/oa_pdf/bd/82/10.1177_2054270414527932.PMC4012658.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(5) 1–5 DOI: 10.1177/2054270414527934",Non-OADS,/arxiv_data1/oa_pdf/58/15/10.1177_2054270414527934.PMC4012659.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(5) 1–5 DOI: 10.1177/2054270414528894",Non-OADS,/arxiv_data1/oa_pdf/49/58/10.1177_2054270414528894.PMC4012660.pdf
See http://www.nhs.uk/Service Directories/Pages/AcuteTrustListing.aspx (last checked14 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/49/58/10.1177_2054270414528894.PMC4012660.pdf
"See http://articles.mercola.com/sites/articles/archive/2012/01/24/new-evidence-refutes-fraud-findings-in-dr-wake-field-case.aspx (2012, last checked 14 October 2013).",Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2054270414523408.PMC4012664.pdf
"See http://www.who.int/mediacentre/factsheets/fs286/en/ (2012, last checked 14 October 2013).",Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2054270414523408.PMC4012664.pdf
"See http://www.searo.who.int/Li nkFiles/Measles_and_MNT_ SEA_Regional_Guideline s_M&R_Surveillance_and_ Outbreak_Investigation.pdf (2009, last checked 14October 2013).",OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2054270414523408.PMC4012664.pdf
See http://www.hpa.org.,Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2054270414523408.PMC4012664.pdf
See http://www.bupa.,Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2054270414523408.PMC4012664.pdf
"See http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/ HPAweb_C/1195733833790 (2013, last checked 14October 2013).",Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2054270414523408.PMC4012664.pdf
See http://www.hpa.org.uk/ ProductsServices/LocalServices/NorthWest/NorthWestPressReleases/nwest120613merseysidemeaslesvacc/ (last checked 14 October 2013).,Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2054270414523408.PMC4012664.pdf
"See http://www.hpa.org.uk/web/HPAweb&HPAweb Standard/HPAweb_C/1223019390211 (2013, lastchecked 14 October 2013).",Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2054270414523408.PMC4012664.pdf
"See http://www.bbc.co.uk/news/uk-wales-23168519(2013, last checked 13 January 2014).",Non-OADS,/arxiv_data1/oa_pdf/e2/9a/10.1177_2054270414523408.PMC4012664.pdf
"The Internet Classics Archive, http://classics.mit.edu/ Hippocrates/epidemics.2.ii.html (accessed 26 April 2012).",Non-OADS,/arxiv_data1/oa_pdf/a0/29/10.1177_2054270414523410.PMC4012665.pdf
"The Internet Classics Archive, http://classics.mit.edu/ Hippocrates.aphorisms.html (accessed 12 June 2012).",Non-OADS,/arxiv_data1/oa_pdf/a0/29/10.1177_2054270414523410.PMC4012665.pdf
"CRUK Cancer Statistics, see: http://www.cancer researchuk.org/cancer-info/cancerstats/childhood cancer/follow-up/childhood-cancer-statistics-trends (accessed 24 February 2014).",Non-OADS,/arxiv_data1/oa_pdf/74/6f/10.1177_2054270414524567.PMC4012666.pdf
"CRUK Cancer Statistics, see: http://www.cancer researchuk.org/cancer-info/cancerstats/childhood cancer/survival/childhood-cancer-survival-statistics (accessed 24 February 2014).",Non-OADS,/arxiv_data1/oa_pdf/74/6f/10.1177_2054270414524567.PMC4012666.pdf
"Royal College of Radiologists e-publication 2013 , see: http://www.rcr.ac.",Non-OADS,/arxiv_data1/oa_pdf/74/6f/10.1177_2054270414524567.PMC4012666.pdf
"Scottish Intercollegiate Guidelines Network number 132March 2013 , http://www.sign.ac.uk/pdf/sign132.pdf (accessed 24 February 2014).4 Journal of the Royal Society of Medicine Open 5(4)",Non-OADS,/arxiv_data1/oa_pdf/74/6f/10.1177_2054270414524567.PMC4012666.pdf
Available from: http://www.canalys.com/newsroom/ smart-phones-overtake-client-pcs-2011 (last accessed11 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/89/51/10.1177_2042533313515861.PMC4012668.pdf
"Consumer price indices – RPI indices: 1987–2013, http://www.ons.gov.uk/ons/datasets-and-tables/data-selector.html?cdid=CHAW &dataset=mm23&table-id=2.1 (last updated 14 January 2014).",OADS,/arxiv_data1/oa_pdf/39/44/10.1177_2042533313518914.PMC4012671.pdf
/C15http://grants.nih.gov/grants/grant_tips.htm /C15http://www.wellcome.ac.uk /C15http://www.mrc.ac.uk/Fundingopportunities/index.htm /C15http://www.rcseng.ac.uk/surgical_awards_and_grants /C15http://www.academicmedicine.ac.uk /C15http://rdfunding.org.uk Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/06/24/10.1177_2042533313505512.PMC4012679.pdf
See http://www.hesonline.nhs.uk/ Ease/servlet/ContentServer?siteID=1937& categoryID=207 (last checked 15 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/06/24/10.1177_2042533313505512.PMC4012679.pdf
See http://www.academicmedicine.ac.uk/uploads/A-pocket-guide.pdf (last checked 15 November 2013).Chan et al.,Non-OADS,/arxiv_data1/oa_pdf/06/24/10.1177_2042533313505512.PMC4012679.pdf
See http://guidance.nice.org.uk/CG57/Guidance/pdf/English (last checked 3 December 2013).Fingleton et al.,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/10.1177_2042533313509263.PMC4012680.pdf
Available from: http://www.noo.org.uk/uploads/doc/vid_8774_NOOBariatric Surgery for Obesity FINAL MG 011210.pdf (last accessed 22 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/ae/4e/10.1177_2042533313512479.PMC4012682.pdf
Available from: http://www.nice.org.uk/media/87F/65/Bariatric SurgeryFINALPlusNewToolUpdates.pdf (last accessed 22 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/ae/4e/10.1177_2042533313512479.PMC4012682.pdf
Available from: http://www.esds.ac.uk/findingData/snDescription.asp?sn=5809 (last accessed 22 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/ae/4e/10.1177_2042533313512479.PMC4012682.pdf
Available from: http://www.hscic.gov.uk/catalogue/ PUB01213 (last accessed 22 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/ae/4e/10.1177_2042533313512479.PMC4012682.pdf
Available from: http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk–england- and-wales–scotland-and-northern-ireland/population- estimates-timeseries-1971-to-current-year/index.html(last accessed 22 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/ae/4e/10.1177_2042533313512479.PMC4012682.pdf
Available from: http://www.who.int/whr/ 2008/08_chap1_en.pdf (last accessed 16 August 2012).,OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://dx.doi.org/ 10.1787/health_glance-2010-en (last accessed 12 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
"Available from: http://www.moh.gov.cy/MOH/ MOH.nsf/EEBCAF0CDB3C0C4FC22577BB0026941E/ $file/E/C28–sia%20Eky""sZ%202010.pdf (last accessed 21 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://www.euro.who.int/ __data/assets/pdf_file/0017/174041/Health-Systems- in-Transition_Cyprus_Healt h-system-review.pdf (last accessed 12 April 2013).,OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://www.euro.who.int/__data/assets/ pdf_file/0003/103845/E88526.pdf (last accessed 16 May2012).8.,OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from http://search.proquest.com.newproxy.rsm.ac.uk/ professional/healthcare/docview/1031227534/abstract/1396D75C70A8A23802E/9?accountid ¼138535# (last accessed 27 September 2012).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://eur-lex.europa.eu/LexUriServ/ site/en/oj/2006/c_146/c_14620060622en00010003.pdf(last accessed 25 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://apps.who.int/gb/ebwha/pdf_files/ WHA66/A66_7-en.pdf (last accessed 11 May 2013).,OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://ec.europa.eu/health-eu/doc/ whitepaper_en.pdf (last accessed 25 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Elsevier Ireland Ltd. Availablefrom: http://www.contratualizacao.min-saude.pt/ Downloads_Contrat/Informa%C3%A7%C3%A3o% 20T%C3%A9cnica%20Online/Empowerment%20Chronic%20Patient.pdf (last accessed 8 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://www.biomedcentral.com/1472-6963/12/157 (last accessed 9 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://search.proquest.com.newproxy.,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://www.healthknowledge.org.uk/public- health-textbook/disease-causation-diagnostic/2e-health- social-behaviour/social-behavioural-determinants (lastaccessed 12 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://www.bant.org.uk/bant/jsp/ index.faces (last accessed 19 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://journals.lww.com/ academicmedicine/Fulltext/2010/09000/Nutrition_ Education_in_U_S__Medical_Schools_.30.aspx (lastaccessed 17 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://www.who.int/whr/2006/ 06_chap3_en.pdf (last accessed 11 May 2012).,OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://ec.europa.eu/health/workforce/docs/health_workforce_study_ 2012_report_en.pdf (last accessed 26 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://ec.eu ropa.eu/health/ph_determi- nants/life_style/nutrition/d ocuments/nutrition_gp_en.pdf (last accessed 17 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://jn.nutrition.org/content/131/4/ 1319.full.pdf (last accessed 19 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/2d/a1/10.1177_2042533313515860.PMC4012684.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/9b/7b/JBCP-5-19.PMC4012703.pdf
Available from: http://www.wsmi.org/news/news_113.htm.,Non-OADS,/arxiv_data1/oa_pdf/9b/7b/JBCP-5-19.PMC4012703.pdf
Available from: http://www.abimip.org.br/uploads/material_de_ apoio/1296056417_792.pdf/.,Non-OADS,/arxiv_data1/oa_pdf/9b/7b/JBCP-5-19.PMC4012703.pdf
Available from: http://www.thelancetstudent.,Non-OADS,/arxiv_data1/oa_pdf/9b/7b/JBCP-5-19.PMC4012703.pdf
Available from: http://www.wsmi.org/pdf/storyofselfcare_bdpage.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/7b/JBCP-5-19.PMC4012703.pdf
Available from: http://www.apps.who.int.,Non-OADS,/arxiv_data1/oa_pdf/9b/7b/JBCP-5-19.PMC4012703.pdf
Available from: http://www.apps.who.int.,Non-OADS,/arxiv_data1/oa_pdf/9b/7b/JBCP-5-19.PMC4012703.pdf
Available from: http://www.pharmahost.org.,Non-OADS,/arxiv_data1/oa_pdf/9b/7b/JBCP-5-19.PMC4012703.pdf
Available	 from	http://www.indiaoppi.com/IndiaOTCpharmaProfile2011.,Non-OADS,/arxiv_data1/oa_pdf/9b/7b/JBCP-5-19.PMC4012703.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/0d/eht511.PMC4012708.pdf
http://www.pacemaker-register.de .,Non-OADS,/arxiv_data1/oa_pdf/dc/0d/eht511.PMC4012708.pdf
"The mission of the ITHS (https://www.iths.org/) was to enhance translational research capabilities at the University of Washington (UW), the Fred Hutchinson Cancer Research Center, Seattle Children’s Hospital, Group Health Research Institute, and the Benaroya Research Institute at Virginia Mason Hospital.",Non-OADS,/arxiv_data1/oa_pdf/71/ea/10.1177_0163278713500984.PMC4012871.pdf
Retrieved from http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/71/ea/10.1177_0163278713500984.PMC4012871.pdf
"Retrieved from https://www.ctsacen- tral.org/sites/default/files/files/CTSANationalEval_FinalReport_20120416.pdf Iribarne, A., Easterwood, M. R., Russo, M. J., & Wang, Y. C. (2011).",Non-OADS,/arxiv_data1/oa_pdf/71/ea/10.1177_0163278713500984.PMC4012871.pdf
"Retrieved from http://grants.nih.gov/grants/guide/rfa- files/RFA-RM-06-002.html Renger, R., & Hurley, C. (2006) From theory to practice: Lessons learned in the application of the ATM approach to developing logic models.",Non-OADS,/arxiv_data1/oa_pdf/71/ea/10.1177_0163278713500984.PMC4012871.pdf
"Mobile Genetic Elements 2014; 4:e28807; http://dx.doi.org/10.4161/mge.28807 *Correspondence to: Corentin Claeys Bouuaert;  Email: claeysbc@mskcc.org Commentary to: Liu D, Chalmers R. Hyperactive mariner transposons are created by mutations that disrupt allosterism and increase the rate of transposon end synapsis.",Non-OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Nucleic Acids Res 2014; 42:2637–45; PMID:24319144 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Nucleic Acids Res 2010; 38:4207-17;  PMID:20215432 ; http://dx.doi.org/10.1093/nar/ gkq140 2.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Genetica   2000 ; 108:229-37; PMID:11294609 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Genetics  2005 ; 169:1033 -43; PMID :15731520 ;  http://dx.doi.org/10.1534/genetics.104.031211 4.,Non-OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Annu Rev Genet  2008 ; 42:269-86; PMID:18680433 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Mol Cell  2011 ; 44:989-96;  PMID:22195971 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Mol Biol Evol   1996 ; 13:549-55; PMID:8882498 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Elife 2013 ; 2:e00668 ; PMID:23795293 ;  http://dx.doi.org/10.7554/eLife.00668 9.,Non-OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Cell  1986 ; 45:793-800; PMID:3011279 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
J Biol Chem 2001 ; 276:4373 - 81; PMID:11084034 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Curr Opin Genet Dev  1991 ; 1:404-11; PMID:1668651 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Nucleic  Acids Res 2014 ; 42:2637 -45; PMID:24319144 ;  http://dx.doi.org/10.1093/nar/gkt1218 17.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Cell 2009 ; 138:1096 - 108; PMID:19766564 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Nucleic Acids Res  2014 ; 42: http://dx.doi.org/10.1093/nar/gku172 ;  PMID:24623810 19.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Genetica  2010 ;  138:499-508; PMID:19711186 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Nucleic Acids Res 2010 ;  38:190-202; PMID:19858101 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Genetica   2010 ; 138:485-98; PMID:20084428 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
Mol Cell   2003 ; 11:225-35; PMID:12535535 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
EMBO J 2006 ; 25:1324 -34; PMID :16511570 ;  http://dx.doi.org/10.1038/sj.emboj.7601018,Non-OADS,/arxiv_data1/oa_pdf/8c/ab/mge-4-e28807.PMC4013102.pdf
"Cellular Logistics 2014; 4:e28217;  http://dx.doi.org/10.4161/cl.28217Unique and conserved features of the plant  ER-shaping GTPase RHD3 Giovanni Stefano and Federica Brandizzi* MSU- doe Plant r esearch Lab; Michigan State University; e ast Lansing, M i USA Keywords:  ER, Root Hair Defective 3 (RHD3), dynamin-like GTPases, Arabidopsis",Non-OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Biochem Soc Trans 2010; 38:747-53;   PMID:20491660 ; http://dx.doi.org/10.1042/ BST0380747 2.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Plant Cell  2009; 21:3937-49;  PMID:20040535 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Curr Opin Cell Biol 2013; 25:428- 33; PMID:23478217 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
New Phytol 2013; 197:481-9;  PMID:23163512 ;  http://dx.doi.org/10.1111/nph.12038 7.,Non-OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
J Cell Sci 2011; 124:2241- 52; PMID:21652628 ; http://dx.doi.org/10.1242/ jcs.0846248.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Cell 2009; 138:549- 61; PMID:19665976 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Plant J  2012; 69:957-66;  PMID:22082223 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Nature  2009; 460:978-83;  PMID:19633650 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Plant Physiol 2013; 163:713-20;  PMID:23922269 ;  http://dx.doi.org/10.1104/pp.113.224501 12.,Non-OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Proc Natl Acad Sci U S A  2011; 108:2216-21;  PMID:21220294 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Plant Physiol 2013; 163:713-20;  PMID:23922269 ;  http://dx.doi.org/10.1104/pp.113.224501 14.,Non-OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Plant Signal Behav 2011; 6:1710- 3; PMID:22057320 ; http://dx.doi.org/10.4161/ psb.6.11.17477 15.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
EMBO J 2013; 32:369- 84; PMID:23334294 ; http://dx.doi.org/10.1038/ emboj.2012.35316.,Non-OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Proc Natl Acad Sci U S A 2012;  109:E2146-54;  PMID:22802620 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Plant Cell 2002; 14:1293-309;  PMID:12084828 ;  http://dx.doi.org/10.1105/tpc.001586 19.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Methods Cell Biol 2013; 118:69-83;   PMID:24295301 ; http://dx.doi.org/10.1016/ B978-0-12-417164-0.00005-720.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Cell Commun Signal 2010; 8:8;  PMID:20509869 ;  http://dx.doi.org/10.1186/1478-811X-8-8 22.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
Bioinformatics  2008; 24:2101-2;  PMID:18662927 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ff/cl-4-e28217.PMC4013103.pdf
"Mobile Genetic Elements 2014; 4:e28914; http://dx.doi.org/10.4161/mge.28914A case of horizontal gene transfer   from Wolbachia  to Aedes albopictus  C6/36 cell line Qing h ou,1,† Ji h e1,2,†,* Jing Yu,1 Yuting Ye,1 Dan Zhou,1 Yan s un,1 Donghui Zhang,1 Lei Ma,1 Bo s hen,1 and c hangliang Zhu1,* 1Department of Pathogen Biology; Nanjing Medical University; Nanjing, Jiangsu People’s Republic of c hina; 2state Key Laboratory of s urveillance and Detection for Medical  Vectors; Xiamen e ntry– exit Inspection and Quarantine Bureau; Xiamen, Fujian People’s Republic of c hina; †These authors contributed equally to this work.",OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
25Analysis and prediction of protein sequence and structure The 3D structure of the protein was constructed using Phyre2  server (protein homology/analogy recognition engine).41 Protein  function was predicted using the Phyre2 server SMART software  (http://smart.embl-heidelberg.de/) and Myhits Motif Scan (http://myhits.isb-sib.ch/cgi-bin/motif_scan).,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Cell Mol Life Sci 2005; 62:1182-97; PMID :15761667 ;  http://dx.doi.org/10.1007/s00018-005-4539-z 2.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Annu Rev Microbiol  2009 ; 63:177-93; PMID:19575565 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Science  2007 ; 317:1753 - 6; PMID:17761848 ; http://dx.doi.org/10.1126/ science.1142490 4.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Proc Biol Sci 2009 ; 276:3791 - 8; PMID:19692404 ; http://dx.doi.org/10.1098/ rspb.2009.1022 6.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
FEMS Microbiol Lett 2008 ;  281:215-20; PMID:18312577 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Nature  2011 ; 476:454- 7 ; PMID:21866160 ; http://dx.doi.org/10.1038/ nature10356 10.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Cell 2009 ;  139:1268 -78; PMID:20064373 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Science  2011 ; 334:990- 2; PMID:22021671 ; http://dx.doi.org/10.1126/ science.1209609 12.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
J Invertebr Pathol 2003 ; 84:24-9;  PMID:13678709 ; http://dx.doi.org/10.1016/ S0022-2011(03)00082-X 13.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
PLoS Negl Trop Dis  2013 ; 7:e2030 ; PMID:23383354 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
PLoS One   2009 ; 4:e6763 ; PMID:19707544 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Curr Opin Infect Dis 2010 ;  23:438-44; PMID:20581669 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
J Invertebr Pathol  1973 ; 22:242-50; PMID:4206296 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Langmuir  2009 ; 25:12101 - 13; PMID:19670831 ; http://dx.doi.org/10.1021/ la9018426 19.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Exp Parasitol   1995 ; 81:284-91; PMID:7498425 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Genome Res 2008 ; 18:272-80; PMID:18073380 ;  http://dx.doi.org/10.1101/gr.7144908 21.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Exp Parasitol  2007 ;  115:369-78; PMID:17092499 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Appl Environ Microbiol  2006 ; 72:7098 - 110; PMID:16936055 ; http://dx.doi.org/10.1128/ AEM.00731-06,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Proc Biol Sci 1998 ; 265:509- 15; PMID:9569669 ; http://dx.doi.org/10.1098/ rspb.1998.0324 25.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
BMC Genomics   2009 ; 10:33; PMID :19154594 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Mol Biol Evol  2009 ; 26:367- 74; PMID:18988686 ; http://dx.doi.org/10.1093/ molbev/msn253 29.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Nature  2000 ; 405:299-304; PMID:10830951 ;  http://dx.doi.org/10.1038/35012500 30.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Nat Struct Biol   1999 ; 6:157-65; PMID:10048928 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Protein Sci  2005 ; 14:1274 -81; PMID :15802643 ;  http://dx.doi.org/10.1110/ps.04118410532.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Nature  1987 ;  329:651-4; PMID:2821408 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Annu Rev Genet 2008 ; 42:683- 707; PMID:18713031 ; http://dx.doi.org/10.1146/ annurev.genet.41.110306.130354 34.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Antimicrob Agents Chemother  2006 ; 50:596- 9; PMID :16436715 ; http://dx.doi.org/10.1128/ AAC.50.2.596-599.2006 36.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Mol Microbiol   1995 ; 17:109-21; PMID:7476197 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
PLoS Pathog  2009 ; 5:e1000656 ; PMID:19911047 ;  http://dx.doi.org/10.1371/journal.ppat.1000656 39.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Science   2008 ; 322:702; PMID:18974344 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
PLoS Pathog  2010 ;  6:e1000833 ; PMID:20368968 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Nucleic Acids Res 2000 ; 28:231- 4; PMID:10592234 ; http://dx.doi.org/10.1093/ nar/28.1.231 43.,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
Nucleic  Acids Res 2007 ; 35(Web Server issue ):W433-7 ;  PMID:17545200 ; http://dx.doi.org/10.1093/nar/ gkm352,OADS,/arxiv_data1/oa_pdf/d3/c9/mge-4-e28914.PMC4013104.pdf
"For example, ATR signaling likely regulates the integrity of the replisome  *Correspondence to: David Cortez; Email: david.cortez@vanderbilt.edu Submitted: 11/07/2013; Accepted: 11/08/2013; Published Online: 02/18/2014http://dx.doi.org/10.4161/cc.28212Comment on: Couch FB, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
"Genes Dev 2013; 27:1610-23; PMID:23873943; http://dx.doi.org/10.1101/gad.214080.113Fork reversal, too much of a good thing Frank B Couch and d avid Cortez* department of Biochemistry; Vanderbilt u niversity s chool of Medicine; Nashville, t N usa",Non-OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
Mol Oncol 2011; 5:368-73;  PMID:21820372 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
Genes Dev 2013; 27:1610-23;  PMID:23873943 ; http://dx.doi.org/10.1101/ gad.214080.113 3.,OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
Genes Dev 2013; 27:2259-73; PMID:24142876 ; http://dx.doi.org/10.1101/ gad.223180.113 4.,OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
Genes Dev 2012; 26:151-62;  PMID:22279047 ; http://dx.doi.org/10.1101/ gad.178459.111 5.,OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
Cell Rep 2013; 3:1958-69; PMID:23746452 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
Nucleic Acids Res 2009; 37:3475- 92; PMID:19406929 ; http://dx.doi.org/10.1093/ nar/gkp244 7.,Non-OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
Genes Dev 2009; 23:2415-25; PMID:19793862 ; http://dx.doi.org/10.1101/ gad.1832309 8.,OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
Genes Dev 2009; 23:2405- 14; PMID:19793861 ; http://dx.doi.org/10.1101/ gad.1839909 Figure 1.  atr maintains a balance between too much and too little sMarCal1 activity.,Non-OADS,/arxiv_data1/oa_pdf/cd/31/cc-13-1049.PMC4013150.pdf
"2 In summary, our study identified a  conserved murine and human hepatic progenitor that expresses KDR, which acts as a functional receptor to promote hepatic fate in a cell autonomous fashion, and hepatic cell maturation in a non-cell  *Correspondence to: Valerie Gouon-Evans; Email: valerie.gouon-evans@mssm.edu Submitted: 12/06/2013; Accepted: 12/06/2013; Published Online: 02/18/2014http://dx.doi.org/10.4161/cc.28213Comment on: Goldman O, et al.",Non-OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
"Cell Stem Cell 2013; 12:748-60; PMID:23746980; http://dx.doi.org/10.1016/j.stem.2013.04.026Liver progenitor cell and KDR songyan Han†, orit Goldman†, and Valerie Gouon-Evans* department of d evelopmental and r egenerative Biology; Black Family s tem Cell i nstitute; i cahn s chool of Medicine at Mount s inai; New y ork, N y usa †these authors contributed equally to this work.",OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
J Stem Cell Res Ther 2012; S10:008;  http://dx.doi.org/10.4172/2157-7633.S10-008 2.,Non-OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
Science 2001; 294:559-63; PMID :11577199 ; http://dx.doi.org/10.1126/ science.1063889 3.,Non-OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
Stem Cells 2011; 29:217-28;  PMID:21732480 ; http://dx.doi.org/10.1002/ stem.576 4.,Non-OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
Cell Stem Cell 2013; 12:748- 60; PMID:23746980 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
Blood 2006; 107:111-7; PMID:16166582 ; http://dx.doi.org/10.1182/ blood-2005-05-1970 6.,Non-OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
Cell Signal 2007; 19:2003-12; PMID:17658244 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
Nat Biotechnol 2006; 24:1402- 11; PMID:17086172 ; http://dx.doi.org/10.1038/ nbt1258 8.,OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
Curr Opin Virol 2012; 2:14-9;  PMID:22440961 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/b6/cc-13-1051.PMC4013151.pdf
"However, drug resistance occurs even to this category of therapeutics, regardless  *Correspondence to: Paul S Mischel; Email: pmischel@ucsd.edu Submitted: 12/09/2013; Accepted: 12/14/2013; Published Online: 02/28/2014http://dx.doi.org/10.4161/cc.28377Comment on: Masui K, et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
"Cell Metab 2013; 18:726-39; PMID:24140020; http://dx.doi.org/10.1016/j.cmet.2013.09.013mTORC2 dictates Warburg effect and drug  resistance Kenta Masui1, Webster K Cavenee1,2, and Paul s Mischel1,2,3,* 1ludwig i nstitute for Cancer r esearch; u niversity of California, s an d iego; l a Jolla, C a usa ; 2Moores Cancer Center; u niversity of California, s an d iego; l a Jolla, C a usa ;  3department of Pathology; u niversity of California, s an d iego; l a Jolla, C a usa",Non-OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
Science 1956; 123:309-14;  PMID:13298683 ; http://dx.doi.org/10.1126/ science.123.3191.309 2.,Non-OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
Cell 2012; 149:274-93;  PMID:22500797 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
Cancer Discov 2011; 1:524-38;  PMID:22145100 ; http://dx.doi.org/10.1158/2159- 8290.CD-11-0124 4.,Non-OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
Cell Metab 2013; 18:726-39;  PMID:24140020 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
Clin Cancer Res 2009; 15:6479-83;  PMID:19861459 ; http://dx.doi.org/10.1158/1078- 0432.CCR-09-0889 6.,Non-OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
Cell Metab 2013; 17:1000-8;  PMID:23707073 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
Annu Rev Pathol 2014; 9:1- 25; PMID:23937436; http://dx.doi.org/10.1146/ annurev-pathol-011110-130324 8.,Non-OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
Carcinogenesis 2013; 34:725-38;  PMID:23455378 ; http://dx.doi.org/10.1093/carcin/ bgt086 Figure 1.  mtor C2 is a kingpin of the Warburg effect and drug resistance.,Non-OADS,/arxiv_data1/oa_pdf/5e/2f/cc-13-1053.PMC4013152.pdf
"For instance, whether overexpression of SIRT6 promotes keratinocyte tumor  *Correspondence to: G Paolo Dotto; Email: paolo.dotto@unil.ch; Karine Lefort; Email: karine.lefort@unil.ch Submitted: 11/13/2013; Accepted: 12/14/2013; Published Online: 02/28/2014http://dx.doi.org/10.4161/cc.28378Comment on: Lefort K, et al.",Non-OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
"EMBO J 2013; 32:2248-63; PMID:23860128; http://dx.doi.org/10.1038/emboj.2013.156miR-34a/SIRT6 in squamous differentiation and  cancer G Paolo d otto1,2 and Karine lefort1,3 1department of Biochemistry; u niversity of l ausanne; Épalinges, s witzerland; 2Cutaneous Biology r esearch Center Massachusetts General Hospital; Charlestown, M a usa ;  3department of d ermatology; u niversity Hospital CH uV; lausanne, s witzerland",Non-OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
EMBO J 2013; 32:2248-63;  PMID:23860128 ; http://dx.doi.org/10.1038/ emboj.2013.156 2.,OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
Nature 2008; 452:225-9; PMID:18311128 ;  http://dx.doi.org/10.1038/nature06642 3.,Non-OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
Hermeking H. Nat Rev Cancer 2012; 12:613-26; PMID:22898542 ; http://dx.doi.org/10.1038/ nrc3318 4.,Non-OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
Front Pharmacol 2012; 3:22;  PMID:22363287 ; http://dx.doi.org/10.3389/ fphar.2012.00022 5.,Non-OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
Nat Cell Biol 2012; 14:1203-11; PMID:23041974 ; http://dx.doi.org/10.1038/ ncb2590 6.,OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
Cell 2012; 151:1185-99;  PMID:23217706 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
Nat Cell Biol 2011; 13:1353-60;  PMID:22020437 ; http://dx.doi.org/10.1038/ ncb2366 8.,OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
J Biol Chem 2013; 288:18439-47; PMID:23653361 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/4e/33/cc-13-1055.PMC4013153.pdf
"It will be imperative for future studies to  *Correspondence to: Hesham A Sadek; Email: hesham.sadek@utsouthwestern.edu Submitted: 10/18/2013; Accepted: 12/14/2013; Published Online:  02/27/2014http://dx.doi.org/10.4161/cc.28379Comment on: Mahmoud AI, et al.",Non-OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
Nature 2013; 497:249-53; PMID:23594737; http://dx.doi.org/10.1038/nature12054Cardiomyocyte cell cycle Meis-ing something?,Non-OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
Circ Res 2002; 90:1044-54;  PMID:12039793 ; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
Nature 2013; 493:433-6;  PMID:23222518 ; http://dx.doi.org/10.1038/ nature11682 3.,Non-OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
Proc Natl Acad Sci U S A 2013;  110:187-92;  PMID :23248315 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
Nature 2013; 497:249-53;  PMID:23594737 ; http://dx.doi.org/10.1038/ nature12054 5.,Non-OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
Pines J. Semin Cancer Biol 1995; 6:63-72; PMID:7647308 ; http://dx.doi.org/10.1006/ scbi.1995.0009 6.,Non-OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
2005;1:2005  0022; http://dx.doi.org/10.1038/msb4100030 7.,Non-OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
Cell Stem Cell 2010; 7:380-90; PMID:20804973 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
Blood 2012; 120:4963-72; PMID:22995899 ; http://dx.doi.org/10.1182/ blood-2012-05-432260 Figure 1.  the diverse roles of Meis1.,Non-OADS,/arxiv_data1/oa_pdf/ff/7b/cc-13-1057.PMC4013154.pdf
"Cell Cycle 2014; 13:399–407;   PMID:24240188; http://dx.doi.org/10.4161/cc.27143 Karine  Jacquet  and Jacques  Côté *; Laval University Cancer Research Center; CHU de Québec Research Center-Oncology; Quebec City Quebec, Canada;   *Correspondence to: jacques.cote@crhdq.ulaval.ca; http://dx.doi.org/10.4161/cc.28383 Chromatin is a highly dynamic structure  regulated by different factors, such as ATP- dependent remodeling complexes, incorpo - ration of histone variants, post-translational modifications, and histones chaperones.",Non-OADS,/arxiv_data1/oa_pdf/1f/04/cc-13-1059.PMC4013155.pdf
Biochim Biophys Acta 2013; 1819:290- 302; PM iD:24459731; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/04/cc-13-1059.PMC4013155.pdf
J Cell Biol 2010; 191:31-43; PM iD:20876283;  http://dx.doi.org/10.1083/jcb.201001160 3.,OADS,/arxiv_data1/oa_pdf/1f/04/cc-13-1059.PMC4013155.pdf
J Cell Biol 2012; 199:1067-81; PM iD:23266955; http://dx.doi.org/10.1083/ jcb.201205059 4.,OADS,/arxiv_data1/oa_pdf/1f/04/cc-13-1059.PMC4013155.pdf
Mol Cell 2012; 48:723-33; PM iD:23122415;  http://dx.doi.org/10.1016/j.molcel.2012.09.026 5.,OADS,/arxiv_data1/oa_pdf/1f/04/cc-13-1059.PMC4013155.pdf
Nat s truct Mol Biol 2013; 20:317- 25; PM iD:23377543; http://dx.doi.org/10.1038/ nsmb.2499 7.,OADS,/arxiv_data1/oa_pdf/1f/04/cc-13-1059.PMC4013155.pdf
Pl os Genet 2010; 6:e1000983;  PMiD:20548951; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/1f/04/cc-13-1059.PMC4013155.pdf
Nature 2014; 505:648-53;  PMiD:24463511; http://dx.doi.org/10.1038/ nature12922,Non-OADS,/arxiv_data1/oa_pdf/1f/04/cc-13-1059.PMC4013155.pdf
"Cell Cycle 2014; 13:772–81;  PMID: 24398561 http://dx.doi.org/10.4161/cc.27679 Aurora Esquela-Kerscher ; Department of Microbiology & Molecular Cell Biology; Leroy T. Canoles Jr. Cancer Research Center; Eastern  Virginia Medical School; Norfolk, VA USA; Correspondence to: kerschae@evms.edu; http://dx.doi.org/10.4161/cc.28384 MicroRNAs (miRNAs) are full of surprises.",OADS,/arxiv_data1/oa_pdf/30/26/cc-13-1060.PMC4013156.pdf
i nt J Biochem Cell Biol 2010;  42:1316-29; PM iD:19800023; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/26/cc-13-1060.PMC4013156.pdf
Cell Cycle 2014; 13; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/26/cc-13-1060.PMC4013156.pdf
Ambros V. Curr Opin Genet Dev 2000; 10:428- 33; PM iD:10889059; http://dx.doi.org/10.1016/ s0959-437X(00)00108-8 4.,OADS,/arxiv_data1/oa_pdf/30/26/cc-13-1060.PMC4013156.pdf
Dev Biol 2010; 348:210-21;  PMiD:20937268; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/26/cc-13-1060.PMC4013156.pdf
Genes Dev 2008; 22:2520-34; PMiD:18794349; http://dx.doi.org/10.1101/ gad.1678808 6.,OADS,/arxiv_data1/oa_pdf/30/26/cc-13-1060.PMC4013156.pdf
Proc Natl Acad s ci U s A 2008;  105:1608-13; PM iD:18227514; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/26/cc-13-1060.PMC4013156.pdf
Nat Rev Cancer  2006; 6:259-69; PM iD:16557279; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/26/cc-13-1060.PMC4013156.pdf
"Cell Cycle 2014; 13:1015–29;  PMID:24552809; http://dx.doi.org/10.4161/cc.27920 Monica M  Olcina  and Ester M Hammond *; The Gray Institute for Radiation Oncology and Biology; Department of Oncology; University  of Oxford; Oxford, UK; *Correspondence to: ester.hammond@oncology.ox.ac.uk; http://dx.doi.org/10.4161/cc.28385 initiation of DNA damage response (DDR)  signaling receives significant interest, in par - ticular the biological consequences of p53 acti - vation.",Non-OADS,/arxiv_data1/oa_pdf/79/e2/cc-13-1062.PMC4013157.pdf
Nat Genet 2004; 36:343-50;  PMiD:14991053; http://dx.doi.org/10.1038/ng1317 2.,OADS,/arxiv_data1/oa_pdf/79/e2/cc-13-1062.PMC4013157.pdf
"Front Biosci 2012; 17:1480-98; http://dx.doi.org/10.2741/3999 3. s akai, H., et al.",OADS,/arxiv_data1/oa_pdf/79/e2/cc-13-1062.PMC4013157.pdf
Cell Cycle 2014: 13:1015–29;  PMiD:24552809; http://dx.doi.org/10.4161/ cc.27920  4.,OADS,/arxiv_data1/oa_pdf/79/e2/cc-13-1062.PMC4013157.pdf
Nat Cell Biol 2003; 5:741-7;  PMiD:12855956; http://dx.doi.org/10.1038/ncb1024 5.,OADS,/arxiv_data1/oa_pdf/79/e2/cc-13-1062.PMC4013157.pdf
Oncogene 2013; 32:5129-43;  PMiD:23416979; http://dx.doi.org/10.1038/ onc.2012.640 6.,Non-OADS,/arxiv_data1/oa_pdf/79/e2/cc-13-1062.PMC4013157.pdf
"Genes Dev 2010; 24:2463-79; PMiD:21078816; http://dx.doi.org/10.1101/ gad.1971610 7. s higenaga MK, et al.",OADS,/arxiv_data1/oa_pdf/79/e2/cc-13-1062.PMC4013157.pdf
Free Radic Biol Med  1991; 10:211-6; PM iD:1650737; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/e2/cc-13-1062.PMC4013157.pdf
Cancer Res 2010; 70:4112-22;  PMiD:20460517; http://dx.doi.org/10.1158/0008- 5472.CAN-09-4244,Non-OADS,/arxiv_data1/oa_pdf/79/e2/cc-13-1062.PMC4013157.pdf
"Indeed, the survival rate of offspring in circumstances of short- term adverse changes in the environment will be minimal,  so it is to evolutionary advantage to reallocate resources to  extended longevity of adults, which can start breeding after the *Correspondence to: Alexey A Moskalev; Email: amoskalev@list.ru Submitted: 02/07/2014; Accepted: 03/04/2014; Published Online: 03/06/2014 http://dx.doi.org/10.4161/cc.28433Genetics and epigenetics of aging and longevity Alexey A Moskalev1,2,3,*, Alexander M Aliper1,2, Zeljka Smit-McBride4, Anton Buzdin1,5,6,7, and Alex Zhavoronkov1,5,8 1Moscow i nstitute of Physics and Technology; Moscow, Russian Federation; 2institute of Biology; Komi Science Center of Russian Academy of Sciences; Syktyvkar,   Russian Federation; 3Syktyvkar State University; Syktyvkar, Russian Federation; 4Department of Ophthalmology and v ision Science; School of Medicine; University of California  at Davis; Davis, CA USA; 5Federal Clinical Research Center of Pediatric Hematology, Oncology, and i mmunology; Moscow, Russian Federation; 6Shemyakin-Ovchinnikov  institute of Bioorganic Chemistry; Moscow, Russian Federation; 7First Oncology Research and Advisory Center; Moscow, Russian Federation;   8The Biogerontology Research Foundation; London, UK Keywords:  aging, epigenetics, evolution, genetics, longevity evolutionary theories of aging predict the existence of  certain genes that provide selective advantage early in life  with adverse effect on lifespan later in life (antagonistic  pleiotropy theory) or longevity insurance genes (disposable  soma theory).",Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Evolution 1957; 11:398-411;  http://dx.doi.org/10.2307/2406060 7.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
ScientificWorldJournal   2002 ; 2:339-56; PMID:12806021 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
J Genet   2008 ; 87:363-71; PMID:19147926 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature   1977 ; 270:301-4; PMID:593350 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature  2000 ;  408:255-62; PMID:11089983 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Proc Natl Acad Sci U S A  1995 ; 92:7540 - 4; PMID:7638227 ; http://dx.doi.org/10.1073/ pnas.92.16.7540 12.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nat Rev Genet  2005 ; 6:866- 72; PMID:16304601 ; http://dx.doi.org/10.1038/ nrg1706 13.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Cell 2005 ; 120:461-72;  PMID:15734679 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Cell 2013 ; 152:806-17; PMID :23415228 ;  http://dx.doi.org/10.1016/j.cell.2013.01.020 16.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Immun Ageing   2013 ; 10:15; PMID:23618527 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Ageing Res Rev   2008 ; 7:63-78; PMID:17964227 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Biogerontology  2007 ; 8:499-504; PMID:17380421 ;  http://dx.doi.org/10.1007/s10522-007-9090-x 21.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Biogerontology  2011 ; 12:253-63;  PMID:21234801 ; http://dx.doi.org/10.1007/ s10522-011-9320-0 22.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Biogerontology  2011 ; 12:211-26; PMID :21153055 ;  http://dx.doi.org/10.1007/s10522-010-9311-6 23.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Cell 2013 ;  153:1194 -217; PMID:23746838 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Philos Trans R Soc Lond B Biol Sci   2011 ; 366:6-8; PMID:21115524 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Science   2010 ; 328:321-6; PMID:20395504 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature  2010 ;  464:504-12; PMID:20336132 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Philos  Trans R Soc Lond B Biol Sci  2010 ; 365:147-54;  PMID:20008392 ; http://dx.doi.org/10.1098/ rstb.2009.0222 28.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
J Mol Med (Berl)  2012 ;  90:1361 -89; PMID:23090008 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Diabetes  2012 ; 61:1315 -22; PMID:22618766 ;  http://dx.doi.org/10.2337/db11-1300 31.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
J Exp Biol  2007 ; 210:1607 - 12; PMID:17449826 ; http://dx.doi.org/10.1242/ jeb.004887 32.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Cell Cycle  2008 ; 7:3338 - 43; PMID:18948730 ; http://dx.doi.org/10.4161/ cc.7.21.7012 34.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
ScientificWorldJournal  2010 ; 10:161-77;  PMID:20098959 ; http://dx.doi.org/10.1100/ tsw.2010.8 35.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Proc Natl Acad Sci U S A  2008 ;  105:3438 -42; PMID:18316725 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature  2003 ; 421:182- 7; PMID:12483226 ; http://dx.doi.org/10.1038/ nature01298 38.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Science  2001 ;  292:104-6; PMID:11292874 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
FASEB J   2008 ; 22:807-18; PMID:17928362 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
"Science  2007 ; 317:369- 72; PMID:17641201 ; http://dx.doi.org/10.1126/ science.1142179overexpression of effector longevity genes involved in stress  response to DNA, protein, or other cellular damages (e.g., Hsps,  Sod, GADD45, ATGs) prolongs lifespan.",Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Aging Cell   2008 ; 7:13-22; PMID:17996009 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Genes Dev   2005 ; 19:2435 -46; PMID:16230533 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Biochimie  2008 ; 90:838- 42; PMID:18394430 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Trends Endocrinol Metab   2009 ; 20:216-22; PMID:19394247 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Cell Cycle  2012 ; 11:4222 -41;  PMID:23095639 ; http://dx.doi.org/10.4161/ cc.22545 47.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Ageing Res  Rev 2012 ; 11:51-66; PMID:21986581 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Science   2005 ; 309:1829 -33; PMID:16123266 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Proc Natl Acad Sci U S A   2005 ; 102:3105 -10; PMID :15708981 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Diabetes  2011 ;  60:2265 -73; PMID:21810600 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Peptides  2011 ; 32:2229 -35; PMID:21781995 ;  http://dx.doi.org/10.1016/j.peptides.2011.07.003 53.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Diabetes Metab  2010 ;  36:443-9; PMID:20739208 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Trends Endocrinol Metab  2012 ; 23:488-95;  PMID:22633959 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
PLoS Genet  2009 ; 5:e1000752 ;  PMID:19997628 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Exp Gerontol  2003 ; 38:415- 22; PMID:12670628 ; http://dx.doi.org/10.1016/ S0531-5565(02)00210-3 57.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
J Cell Biochem  2004 ; 93:312- 26; PMID :15368358 ; http://dx.doi.org/10.1002/ jcb.20158 58.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Mech Ageing Dev  1997 ; 93:131- 44; PMID:9089578 ; http://dx.doi.org/10.1016/ S0047-6374(96)01837-4 59.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Oxid Med  Cell Longev  2012 ; 2012 :854502 ; PMID:22997544 ;  http://dx.doi.org/10.1155/2012/854502 60.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
PLoS Biol  2006 ; 4:e113;  PMID:16602826 ; http://dx.doi.org/10.1371/ journal.pbio.0040113 61.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Exp Gerontol   2010 ; 45:149-57; PMID:19941948 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Cell Cycle  2010 ; 9:269- 73; PMID:20023409 ; http://dx.doi.org/10.4161/ cc.9.2.10433 63.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Curr Biol  2006 ; 16:674- 9; PMID :16581512 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
PLoS Biol  2008 ;  6:e237 ; PMID:18816166 ; http://dx.doi.org/10.1371/ journal.pbio.0060237 66.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Science   2009 ; 326:140-4; PMID:19797661 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature  2007 ;  447:550-5; PMID:17476212 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Mech Ageing Dev  2007 ; 128:412- 4; PMID:17452047 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Mech Ageing Dev  2010 ; 131:144-55;  PMID:20080121 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Trends Genet  2008 ; 24:604- 12; PMID:18992957 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Mol Cell Biol   2009 ; 29:1095 -106; PMID:19075009 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Dev Cell   2007 ; 12:235-46; PMID:17276341 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nat Cell Biol  2009 ; 11:852-8;  PMID:19543272 ; http://dx.doi.org/10.1038/ ncb1893 80.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Int J Biochem Cell Biol   2009 ; 41:516-20; PMID:18793745 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Mech Ageing Dev   2012 ; 133:338-47; PMID:22475988 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Eur J Cancer  2009 ;  45(Suppl 1 ):211-6; PMID:19775620 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Dev Cell  2011 ; 21:783- 95; PMID:22014527 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Dev Cell  2003 ; 5:811- 6; PMID:14602080 ; http://dx.doi.org/10.1016/ S1534-5807(03)00323-X,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Ann N Y Acad Sci   2010 ; 1201 :65-71; PMID:20649541 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature  1999 ; 402:309-13;  PMID:10580504 ; http://dx.doi.org/10.1038/46311 89.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Aging Cell  2008 ;  7:552-60; PMID:18505478 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Biochim Biophys Acta  2012 ;  1818 :1466 -76; PMID:22020053 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Cell  2008 ; 132:1025 -38; PMID:18358814 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
J Biol  Chem  2009 ; 284:29454 -61; PMID:19720829 ;  http://dx.doi.org/10.1074/jbc.M109.028027 94.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Biochem J   2009 ; 419:437-45; PMID:19128239 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Neurobiol  Learn Mem  2007 ; 87:372-84; PMID:17129739 ;  http://dx.doi.org/10.1016/j.nlm.2006.10.003 96.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Exp  Gerontol  2000 ; 35:1157-64; PMID:11113599 ;  http://dx.doi.org/10.1016/S0531-5565(00)00117-0 97.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Circulation  2009 ; 119:2789 - 97; PMID:19451351 ; http://dx.doi.org/10.1161/ CIRCULATIONAHA.108.822403 98.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nucleic Acids Res  2012 ; 40:6477 -94;  PMID:22495928 ; http://dx.doi.org/10.1093/nar/ gks312 100.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
PLoS Genet  2012 ; 8:e1002629 ; PMID:22532803 ;  http://dx.doi.org/10.1371/journal.pgen.1002629101.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nucleic Acids Res  2002 ; 30:2365 -73;  PMID:12034823 ; http://dx.doi.org/10.1093/ nar/30.11.2365 104.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
FASEB J  2000 ; 14:1715 -24; PMID:10973920 ;  http://dx.doi.org/10.1096/fj.99-0926com 105.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Mutat Res   1990 ; 237:131-46; PMID:1700292 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Cell 2003 ;  113:703-16; PMID:12809602 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Mol  Cell Biochem  2003 ; 252:33-43; PMID:14577574 ;  http://dx.doi.org/10.1023/A:1025548623524 108.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Biogerontology  2010 ; 11:679-86; PMID:20467811 ;  http://dx.doi.org/10.1007/s10522-010-9279-2 109.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Cell Mol Life Sci   2010 ; 67:1165 -76; PMID:20049504 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Drug  Discov Today  2012 ; 17:269-76; PMID:22314100 ;  http://dx.doi.org/10.1016/j.drudis.2012.01.019 112.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Crit Rev Oncog  2013 ; 18:373- 90; PMID:23614622 ; http://dx.doi.org/10.1615/ CritRevOncog.2013007197 113.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature  2013 ; 495:107-10;  PMID:23426265 ; http://dx.doi.org/10.1038/ nature11919114.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Front Genet  2013 ; 4:121; PMID :23805154 ;  http://dx.doi.org/10.3389/fgene.2013.00121 116.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
J Invest Dermatol  2013 ;  133:394-402; PMID:22931923 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Aging Cell  2013 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Genome Res  2005 ; 15:603- 15; PMID :15837805 ; http://dx.doi.org/10.1101/ gr.3274805 119.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
PLoS  Genet  2008 ; 4:e24; PMID:18282106 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Mol Biol Cell  2004 ; 15:657- 64; PMID:14668486 ; http://dx.doi.org/10.1091/ mbc.E03-07-0532 121.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature  2003 ;  426:620; PMID:14668850 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
PLoS Genet   2011 ; 7:e1002235 ; PMID:21909281 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Proc Natl Acad Sci U S A  2005 ; 102:4494 - 9; PMID:15767565 ; http://dx.doi.org/10.1073/ pnas.0500749102 125.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Free Radic Biol Med  2011 ;  51:1575 -82; PMID:21839827 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Proc Natl Acad Sci U S A  2004 ; 101:15998 -6003 ;  PMID :15520384 ; http://dx.doi.org/10.1073/ pnas.0404184101 127.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Science  2001 ; 292:107- 10; PMID:11292875 ; http://dx.doi.org/10.1126/ science.1057987,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Biochem J  2005 ; 391:277-84; PMID:15954861 ;  http://dx.doi.org/10.1042/BJ20041872 130.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature  2007 ; 448:375- 9; PMID:17637672 ; http://dx.doi.org/10.1038/ nature05949 133.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Nature   2012 ; 483:218-21; PMID:22367546 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Genes Dev   2005 ; 19:1986 -99; PMID:16107615 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Oncogene  2007 ; 26:6160 - 6; PMID:17420720 ; http://dx.doi.org/10.1038/ sj.onc.1210451 136.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
PLoS One  2011 ; 6:e22597 ;  PMID:21799912 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
Adv Gerontol  2011 ; 1:112-21; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/79/cc-13-1063.PMC4013158.pdf
"6 We have recently characterized a novel human spindle MAP  named ASAP or MAP9.9 MAP9 overexpression induces aberrant  spindles in mitosis, and its depletion by RNA interference results  *Correspondence to: Dominique Giorgi; Email: giorgi@igh.cnrs.fr Submitted: 06/04/2013; Revised: 01/20/2014; Accepted: 01/21/2014; Published Online: 02/04/2014http://dx.doi.org/10.4161/cc.27944Microtubule-associated protein 9 (Map9/Asap)  is required for the early steps of zebrafish  development Laura Fontenille1,2,†, Sylvie Rouquier1, Georges Lutfalla3, and Dominique Giorgi1,* 1Institute of Human Genetics; U pR 1142; CNRS; Montpellier, France; 2Université de Montpellier 1; Montpellier, France; 3Dynamique des Interactions Membranaires Normales et  pathologiques; UMR 5235; CNRS; Universités de Montpellier 1&2; Montpellier, France †Current affiliation: DIMN p; UMR 5235; CNRS; Universités de Montpellier 1&2; Montpellier, France Keywords:  microtubule-associated protein, microtubules, zebrafish, knockdown, mitosis, yolk syncytial layer, epiboly,   gastrulation, development Abbreviations:  ASAP, aster-associated protein; aurka , aurora kinase a; bon , bonnie and clyde; cyc , cyclops; dnah9 , dynein,  axonemal, heavy polypeptide 9; eomesa b , eomesodermins a, b; foxa2 , forkhead box A2; gata5 , gata-binding protein 5; GFP,  green fluorescent protein; gsc , goosecoid; hpf, hours post-fecondation; igu , iguana; KV, Küpffer’s vesicle; LR, left-right; MAP,  microtubule-associated protein; ISH, in situ hybridization; LPM, lateral plate mesoderm; MO, morpholino oligonucleotide;  MT, microtubule; nipbla b , nipped-b-like homologs a, b; ntla , no tail a; oep , one-eyed pinhead; ORF, open reading frame; PBS,  phosphate-buffered saline; plk1 4 , polo-like kinases 1, 4; shha , sonic hedgehog a; smo , smoothened; s ox32 and sox17 , SRY-box  containing genes 32 and 17; spaw , southpaw; sqt , squint; tp53 , tumor protein 53; TUNEL, terminal deoxynucleotidyl transferase- mediated fluorescein-dUTP nick-end labeling assay; YFP, yellow fluorescent protein; YSL, yolk syncytial layer Microtubules are structural components of the cell cytoskeleton and key factors for mitosis and ciliogenesis in  eukaryotes.",Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
"1108 Cell Cycle Volume 13 Issue 7overexpressed with respect to controls.44-46 By screening the  Targetscan database (http://www.targetscan.org/fish_62/), we  found that only plk4  is a potential miR-430 target, and we show  here that it displays a significant increase in morphants (~ ×1.62).",OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
"Furthermore, rescue experiments of mutants defective for miR-430 show that the expression of these genes is not modified, indicating that they are most likely not regulated by the expression of other miR-430-dependent genes (GEO profiles, GDS1771 from Giraldez lab, http://www.ncbi.nlm.nih.gov/geoprofiles/?term=GDS1771).",OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
PLoS One 2011; 6:e20489;  PMID:21647379 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Mol Cell Proteomics  2005 ; 4:35-43;  PMID:15561729 ; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Science  2001 ; 294:543-7; PMID:11641489 ;  http://dx.doi.org/10.1126/science.1063488 4.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Protoplasma  2011 ; 248:439-46; PMID:20830494 ;  http://dx.doi.org/10.1007/s00709-010-0205-x6.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Trends Cell Biol  2010 ; 20:586-92; PMID:20674361 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Development  2009 ; 136:1305 -15; PMID:19279138 ;  http://dx.doi.org/10.1242/dev.026922 8.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Bioarchitecture  2011 ; 1:216-20; PMID:22754611 ;  http://dx.doi.org/10.4161/bioa.18116 9.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Hum Mol Genet  2008 ; 17:215-24; PMID:17925329 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
J  Biol Chem  2010 ; 285:29556 -68; PMID :20615875 ;  http://dx.doi.org/10.1074/jbc.M110.144220 12.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Cell Cycle  2012 ; 11:2380 -90;  PMID:22672907 ; http://dx.doi.org/10.4161/ cc.20858,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Nat Genet 2010 ; 42:840-50;  PMID:20835237 ; http://dx.doi.org/10.1038/ng.662 14.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Mol  Cell Proteomics  2007 ; 6:1299 -317; PMID:17494944 ;  http://dx.doi.org/10.1074/mcp.M700054-MCP200 15.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Nat Genet 2006 ; 38:961-2; PMID:16940995 ;  http://dx.doi.org/10.1038/ng0906-961 17.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
BMC Genomics   2008 ; 9:406; PMID:18782428 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
PLoS Genet   2005 ; 1:260-76; PMID:16132083 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Dev Dyn 1995 ; 203:253-310;  PMID:8589427 ; http://dx.doi.org/10.1002/ aja.1002030302 22.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Maternal control of  vertebrate development before the midblastula transition: mutants from the zebrafish I. Dev Cell   2004 ; 6:771-80; PMID :15177026 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Hum Mol Genet  2012 ; 21:1272 -86; PMID:22121117 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Dev Biol  2001 ; 240:123-42;  PMID:11784051 ; http://dx.doi.org/10.1006/ dbio.2001.0432 27.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
FEBS J 2013 ; 280:1518 - 30; PMID:23351126 ; http://dx.doi.org/10.1111/ febs.1215328.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Mol Biosyst  2010 ; 6:1463 - 8; PMID:20625580 ; http://dx.doi.org/10.1039/ b919743e 29.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
J Cell Biol 2001 ; 152:669- 82; PMID:11266459 ; http://dx.doi.org/10.1083/ jcb.152.4.669 30.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Int J Dev Biol  2010 ; 54:1213 - 28; PMID:20712002 ; http://dx.doi.org/10.1387/ ijdb.093028sl 33.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Curr Opin Genet Dev 2006 ; 16:433- 41; PMID:16797963 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Differential regulation of epiboly initiation and  progression by zebrafish Eomesodermin A. Dev Biol   2012 ; 362:11-23; PMID:22142964 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Development  2009 ; 136:3143 -52; PMID:19700618 ;  http://dx.doi.org/10.1242/dev.031492 36.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Dev Cell   2011 ; 20:663-76; PMID :21571223 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Curr Opin Genet Dev  2003 ; 13:393-400; PMID:12888013 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Genes Dev 2001 ; 15:1493 -505; PMID:11410530 ;  http://dx.doi.org/10.1101/gad.892301 39.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Development  2005 ; 132:1247 -60; PMID :15716348 ;  http://dx.doi.org/10.1242/dev.01663 42.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Development  2004 ; 131:1741-53; PMID :15084459 ;  http://dx.doi.org/10.1242/dev.0107043.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
PLoS Biol  2011 ; 9:e1001181 ;  PMID:22039349 ; http://dx.doi.org/10.1371/ journal.pbio.1001181 44.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Science   2012 ; 336:233-7; PMID:22422859 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Science  2005 ; 308:833- 8; PMID:15774722 ; http://dx.doi.org/10.1126/ science.1109020 46.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Science  2006 ; 312:75-9;  PMID:16484454 ; http://dx.doi.org/10.1126/ science.1122689 47.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Cell  Death Differ 2006 ; 13:1128 -37; PMID:16282981 ;  http://dx.doi.org/10.1038/sj.cdd.4401797 50.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Dev Dyn  2010 ; 239:2980 -8; PMID:20925124 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
BMC Dev Biol  2007 ; 7:22; PMID:17391517 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Dev Biol  2007 ;  310:363-78; PMID:17850782 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Nature   1998 ; 395:181-5; PMID:9744277 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Cell Mol Life Sci 2012 ; 69:3069 -77;  PMID:22527718 ; http://dx.doi.org/10.1007/ s00018-012-0985-6 55.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Dev Dyn 2008 ; 237:3640 - 7; PMID:18985756 ; http://dx.doi.org/10.1002/ dvdy.21771 56.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
BMC Biol   2010 ; 8:102; PMID:20687907 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Nat Rev Genet 2010 ; 11:331-44; PMID:20395968 ;  http://dx.doi.org/10.1038/nrg2774,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Dev Biol   2005 ; 287:378-89; PMID:16229832 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Dev Cell  2008 ; 15:801- 12; PMID:19081070 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Curr Top Dev Biol 2003 ; 53:1-114; PMID:12509125 ;  http://dx.doi.org/10.1016/S0070-2153(03)53002-2 61.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Nat Rev Mol Cell Biol 2007 ; 8:451- 63; PMID:17505520 ; http://dx.doi.org/10.1038/ nrm2180 62.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Trends Genet  2011 ; 27:307-15;  PMID:21680046 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
J Cell Sci 2010 ;  123:1414 -26; PMID:20392737 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
PLoS Genet  2009 ; 5:e1000650 ; PMID:19763162 ;  http://dx.doi.org/10.1371/journal.pgen.1000650 65.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Science  2005 ; 310:1782 - 6; PMID:16357253 ; http://dx.doi.org/10.1126/ science.1116238 66.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Dev Biol  1997 ; 187:154- 70; PMID:9242414 ; http://dx.doi.org/10.1006/ dbio.1997.8605 68.,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
Genome Biol  2007 ; 8:R19; PMID:17291332 ;  http://dx.doi.org/10.1186/gb-2007-8-2-r19,OADS,/arxiv_data1/oa_pdf/1b/34/cc-13-1101.PMC4013161.pdf
"In fact, MYC induces DNA damage through reactive oxygen species (ROS) production 15 and replicative stress.16 The DDR is a network of signaling pathways involved in  DNA damage repair, cell cycle checkpoints, and apoptosis.17 The  *Correspondence to: Yuko Murakami-Tonami; Email: ytona@aichi-cc.jp; Kenji Kadomatsu; Email: kkadoma@med.nagoya-u.ac.jp Submitted: 01/13/2014; Accepted: 01/23/2014; Published Online: 02/07/2014http://dx.doi.org/10.4161/cc.27983Inactivation of SMC2 shows a synergistic lethal  response in MYCN -amplified neuroblastoma cells Yuko Murakami- tonami1,†,*, Satoshi Kishida1, Ichiro t akeuchi2, Yuki Katou3, John M Maris4, Hitoshi Ichikawa5, Yutaka Kondo6,7,  Yoshitaka Sekido6, Katsuhiko Shirahige3, Hiroshi Murakami8, and Kenji Kadomatsu1,* 1Department of Molecular Biology; Nagoya University Graduate School of Medicine; Nagoya, Japan; 2Department of Computer Science/Scientific and e ngineering Simulation;  Nagoya Institute of t echnology; Nagoya, Japan; 3Laboratory of Genome Structure & Function; Institute of Molecular and Cellular Biosciences; t he University of t okyo; t okyo,  Japan; 4Department of p ediatrics and Center for Childhood Cancer Research; Children’s Hospital of p hiladelphia; University of p ennsylvania; p hiladelphia, p A USA; 5Division of  Genetics; National Cancer Institute; t okyo, Japan; 6Division of Molecular o ncology; Aichi Cancer Center Research Institute; Nagoya, Japan; 7Division of e pigenomics;   Aichi Cancer Center Research Institute; Nagoya, Japan; 8Department of Biological Science; Faculty of Science and e ngineering; Chuo University; t okyo, Japan †Current affiliation: Aichi Cancer Center Research Institute; Division of Molecular o ncology; Kanokoden, Chikusa-ku Nagoya, Japan Keywords:  condensin complex, DNA damage response, MYCN, neuroblastoma, synergistic lethal response the condensin complex is required for chromosome condensation during mitosis; however, the role of this com - plex during interphase is unclear.",Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
"Mini-ontology of genes correlated with SMC2 expression from published human  neuroblastoma expression array data sets (GS e16476, GS e3960, GS e13136) created using the R2  bioinformatic platform (http://r2.amc.nl) (continued) GSE16476 SMC2(204240_s_at) Group InSet total % pval All 560 8139 6.90% 1 DNA repair 63 208 30.30% 1.40e-40 tF 48 715 6.70% 0.86 apoptosis 38 595 6.40% 0.63 cell cycle 134 478 28.00% 1.40e-74 development 86 1421 6.10% 0.22 diff 39 585 6.70% 0.84 drugtarget 50 1056 4.70% 5.90e-03 kinase 39 615 6.30% 0.6 membrane 187 4123 4.50% 2.70e-09 sign transd 134 2469 5.40% 4.30e-03 transcription regulator Act 74 1093 6.80% 0.89 transcriptional repressor Act 13 174 7.50% 0.76 SMC2(213253_st) Group InSet total % pval All 271 8139 3.30% 1 DNA repair 45 208 21.60% 5.20e-49 tF 17 715 2.40% 0.16 apoptosis 17 595 2.90% 0.52 cell cycle 96 478 20.10% 1.20e-92 development 33 1421 2.30% 0.03 diff 18 585 3.10% 0.73 drugtarget 28 1056 2.70% 0.22 kinase 26 615 4.20% 0.21 membrane 65 4123 1.60% 3.50e-10 sign transd 52 2469 2.10% 7.00e-04 transcription regulator Act 28 1093 2.60% 0.16 transcriptional repressor Act 0 174 0.00% 0.01 GSE3960 SMC2(37502_at) Group InSet total % pval All 392 5635 7.00% 1 DNA repair 43 155 27.70% 2.70e-24 tF 38 573 6.60% 0.76 apoptosis 31 476 6.50% 0.7 cell cycle 93 362 25.70% 1.30e-44 development 48 1153 4.20% 1.90e-04 diff 20 480 4.20% 0.02 drugtarget 42 945 4.40% 2.40e-03 kinase 32 478 6.70% 0.82",Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
"Table  1 shows mini- ontology data of 3 cohorts, which are available at the R2 microarray analysis and visualization platform (http://r2.amc.nl).",OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
"Mini-ontology of genes correlated with SMC2 expression from published human  neuroblastoma expression array data sets (GS e16476, GS e3960, GS e13136) created using the R2  bioinformatic platform (http://r2.amc.nl) (continued) GSE3960 membrane 121 2635 4.60% 1.80e-06 sign transd 101 1911 5.30% 4.10e-03 transcription regulator Act 74 848 8.70% 0.04 transcriptional repressor Act 17 136 12.50% 0.01 GSE13136 SMC2(204240_s_at) DNA repair 16 205 7.80% 1.90e-16 tF 8 670 1.20% 0.81 apoptosis 5 572 0.90% 0.37 cell cycle 67 473 14.20% 6.70e-135 development 6 1337 0.40% 6.10e-03 diff 2 546 0.40% 0.05 drugtarget 8 994 0.80% 0.17 kinase 14 600 2.30% 0.03 membrane 7 3887 0.20% 7.30e-10 sign transd 19 2343 0.80% 0.04 transcription regulator Act 10 1042 1.00% 0.33 transcriptional repressor Act 0 172 0.00% 0.13 SMC2(213253_st) DNA repair 0 205 0.00% 0.78 tF 0 670 0.00% 0.61 apoptosis 0 572 0.00% 0.64 cell cycle 2 473 0.40% 2.30e-05 development 0 1337 0.00% 0.47 diff 0 546 0.00% 0.64 drugtarget 0 994 0.00% 0.53 kinase 0 600 0.00% 0.63 membrane 0 3887 0.00% 0.22 sign transd 1 2343 0.00% 0.93 transcription regulator Act 0 1042 0.00% 0.52 transcriptional repressor Act 0 172 0.00% 0.8",Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
"49 During zebrafish development, smc2  and smc4 are expressed in some regions of the central ner - vous system,50 and a mutation in the microcephalin gene  disregulates condensin II and causes autosomal reces - sive primary microcephaly.51 Therefore, we re-analyzed  mouse expression array data published in ArrayExpress (E-GEOD-11356, http://www.ebi.ac.uk/microarray-as/ae/).",Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Table  S2 shows mini- ontology data of three cohorts available at the R2 bio - informatic platform (http://r2.amc.nl).,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
The data described in this manuscript have been deposited in the Gene Expression Omnibus database of NCBI (http://www.ncbi.nlm.nih.gov/geo) under the accession number GSE43419.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
The data described in this manuscript have been deposited in the Sequence Read Archive database of NCBI (http://www.ncbi.nlm.nih.gov/sra) under the accession number SR A081723.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Genes Dev  2012; 26:1659-78;  PMID:22855829 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nature 2002; 417:197-202;  PMID:12000964 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Open Biol 2011; 1:110023; PMID:22645654 ; http://dx.doi.org/10.1098/ rsob.110023 5.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
"Leukemia Research Fund, UK 2006; 20:1261-9; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Genes Dev 2008; 22:2215- 27; PMID:18708580 ; http://dx.doi.org/10.1101/ gad.1675708 7.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
J Cell Biol 2010;  188:491-503;  PMID:20176923 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Genes Dev 2003; 17:1115- 29; PMID:12695333 ; http://dx.doi.org/10.1101/ gad.1067003 10.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
J  Biol Chem 2003; 278:19286-91; PMID:12637527 ;  http://dx.doi.org/10.1074/jbc.M212043200 12.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Cell  2009; 136:823-37;  PMID:19269363 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Science 2008; 319:1352-5; PMID:18323444 ;  http://dx.doi.org/10.1126/science.114073515.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Mol Cell 2002; 9:1031- 44; PMID:12049739 ; http://dx.doi.org/10.1016/ S1097-2765(02)00520-8 16.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nat Rev Cancer 2009; 9:441-4; PMID:19461668 ;  http://dx.doi.org/10.1038/nrc2640 17.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Genes Dev 2011; 25:409- 33; PMID:21363960 ; http://dx.doi.org/10.1101/ gad.2021311 18.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Mol Cell 2012; 47:497-510; PMID:22920291 ;  http://dx.doi.org/10.1016/j.molcel.2012.07.029 19.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nat Rev Cancer  2005; 5:689-98;  PMID:16110319 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nature 2005; 434:917-21;  PMID :15829967 ;  http://dx.doi.org/10.1038/nature03445 21.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nature 2005; 434:913-7; PMID :15829966 ;  http://dx.doi.org/10.1038/nature03443 22.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Proc Natl Acad Sci U S A 2011; 108:3336-41;  PMID:21289283 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Cell Cycle  2011; 10:3598-607;  PMID:22030621 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nat Struct Mol Biol 2011; 18:1331-5;  PMID:22120667 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Cancer Cell 2009; 15:67-78; PMID:19111882 ;  http://dx.doi.org/10.1016/j.ccr.2008.12.00528.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
J Biol Chem 2007; 282:12503-16;  PMID:17327229 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Science 2012; 335:348- 53; PMID :22157079 ; http://dx.doi.org/10.1126/ science.1212728 31.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Cancer  Cell 2004; 5:501-12; PMID :15144957 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nature  2008; 455:975-8;  PMID:18923525 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nature 2008; 455:967- 70; PMID:18923523 ; http://dx.doi.org/10.1038/ nature07398 34.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nature  2008; 455:930-5;  PMID:18724359 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nature 2008; 455:971-4; PMID:18923524 ;  http://dx.doi.org/10.1038/nature07399 36.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Lancet 2007; 369:2106-20;  PMID:17586306 ; http://dx.doi.org/10.1016/ S0140-6736(07)60983-0 37.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nat Rev Cancer 2013; 13:397-411; PMID:23702928 ;  http://dx.doi.org/10.1038/nrc3526 38.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
EMBO J  1997; 16:2985-95;  PMID:9214616 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Proc Natl Acad Sci U S A  2004; 101:12664-9;  PMID :15314226 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nat Rev Mol Cell Biol  2011; 12:90-103;  PMID:21252998 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nat Rev Cancer 2008; 8:957-67;  PMID:19005492 ; http://dx.doi.org/10.1038/ nrc2523 43.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
J Nucleic Acids  2010; 2010;  PMID:20811617 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
EMBO J 1999; 18:1397- 406;  PMID:10064605 ; http://dx.doi.org/10.1093/ emboj/18.5.1397 45.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Cancer Cell 2009; 15:328- 40; PMID:19345331 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Cancer Res 2006; 66:6050-62;  PMID:16778177 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Oncogene 2007; 26:7432-44;  PMID:17533364 ; http://dx.doi.org/10.1038/ sj.onc.1210552 48.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Genes Dev 2010; 24:1236- 41; PMID:20551172 ; http://dx.doi.org/10.1101/ gad.192031049.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nature 2012; 483:589- 93; PMID:22367537 ; http://dx.doi.org/10.1038/ nature10910 50.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Gene Expr Patterns  2009; 9:586-94;  PMID:19723591 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Cell Cycle 2011; 10:2967-77;  PMID :21857152 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Mol Biol Cell 2003; 14:685-97; PMID:12589063 ;  http://dx.doi.org/10.1091/mbc.E01-11-0117 54.,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Genome Biol 2008; 9:R150;  PMID:18851746 ; http://dx.doi.org/10.1186/ gb-2008-9-10-r150 57.,OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
Nature 2011; 469:216- 20; PMID:21124317 ; http://dx.doi.org/10.1038/ nature09609,Non-OADS,/arxiv_data1/oa_pdf/f1/27/cc-13-1115.PMC4013162.pdf
"33 In vertebrate systems, dynein -dynactin interacts with an evo - lutionarily conserved protein complex at the cell cortex, which  *Correspondence to: René H Medema; Email: r.medema@nki.nl Submitted: 01/17/2014; Accepted: 01/28/2014; Published Online: 02/10/2014http://dx.doi.org/10.4161/cc.28031Astral microtubules control redistribution   of dynein at the cell cortex to facilitate spindle  positioning Mihoko A t ame1, Jonne A Raaijmakers1, Bram van den Broek1, Arne Lindqvist2, Kees Jalink1, and René H Medema1,* 1Division of Cell Biology; t he Netherlands Cancer Institute; Amsterdam, t he Netherlands; 2Department of Cell and Molecular Biology; Karolinska Institutet; Stockholm, Sweden Keywords:  dynein, spindle orientation, micropattern, microtubules, mitosis Cytoplasmic dynein is recruited to the cell cortex in early mitosis, where it can generate pulling forces on astral micro - tubules to position the mitotic spindle.",OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Curr Opin Cell Biol 1997; 9:815-23;  PMID:9425346 ; http://dx.doi.org/10.1016/ S0955-0674(97)80082-8 2.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nat Rev Mol Cell Biol  2008; 9:355-66;  PMID:18431399 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nat Rev Mol Cell Biol 2010; 11:849- 60; PMID:21102610 ; http://dx.doi.org/10.1038/ nrm30105.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Dev Cell 2011; 21:102- 19; PMID:21763612 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Annu Rev Cell Dev Biol 1997; 13:83-117;  PMID:9442869 ; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nature 2003; 422:753-8; PMID:12700769 ; http://dx.doi.org/10.1038/ nature01600 8.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Dev Cell 2005; 8:461-5;  PMID :15809029 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Cell 2011;  144:414-26;  PMID:21295701 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nature  2001; 409:630-3;  PMID:11214323 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Science 2003; 301:518- 21; PMID:12881570 ; http://dx.doi.org/10.1126/ science.1086560 12.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
PLoS One  2010; 5:e12301;  PMID:20808841 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol  1997; 138:629-41;  PMID:9245791 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2000; 149:863- 74; PMID:10811827 ; http://dx.doi.org/10.1083/ jcb.149.4.863 15.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2000; 151:1337-44; PMID:11121446 ;  http://dx.doi.org/10.1083/jcb.151.6.1337 16.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 1999; 147:135-50; PMID:10508861 ;  http://dx.doi.org/10.1083/jcb.147.1.135 17.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2007; 179:15- 22; PMID:17908918 ; http://dx.doi.org/10.1083/ jcb.200707085 18.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nat Cell Biol  2007; 9:1294-302;  PMID:17922003 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nature 2011; 470:353-8; PMID:21331036 ; http://dx.doi.org/10.1038/ nature09793 20.,Non-OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2012; 199:97-110; PMID:23027904 ;  http://dx.doi.org/10.1083/jcb.201203166 22.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Annu Rev Cell Dev Biol 2004; 20:759-79;  PMID:15473859 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nat Rev Mol Cell Biol 2009; 10:854-65; PMID:19935668 ; http://dx.doi.org/10.1038/ nrm2804 24.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2013; 201:201-15; PMID:23589491 ;  http://dx.doi.org/10.1083/jcb.201208098 25.,Non-OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2013; 202:15-23; PMID:23836927 ;  http://dx.doi.org/10.1083/jcb.201304099 26.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Curr Opin Cell Biol 2002; 14:44-9; PMID:11792543 ;  http://dx.doi.org/10.1016/S0955-0674(01)00292-7 27.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Cell 2012; 148:502-14; PMID:22304918 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Cell Cycle 2012; 11:3750-7;  PMID:22895049 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Bioarchitecture 2011; 1:209-15; PMID:22754610 ; http://dx.doi.org/10.4161/ bioa.18103 30.,Non-OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Curr Biol 2003; 13:364-72;  PMID:12620184 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Curr Biol 2009; 19:196-205;  PMID:19185494 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Dev Cell 2011; 20:639-51; PMID:21571221 ;  http://dx.doi.org/10.1016/j.devcel.2011.04.011 33.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Cell 2013; 153:1526-36;  PMID:23791180 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Cell 2004; 119:503-16; PMID:15537540 ;  http://dx.doi.org/10.1016/j.cell.2004.10.028 35.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2012; 199:97-110; PMID:23027904 ;  http://dx.doi.org/10.1083/jcb.201203166 36.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Cell 2013; 154:391-402; PMID:23870127 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
EMBO J 2013; 32:2517- 29; PMID :23921553 ; http://dx.doi.org/10.1038/ emboj.2013.172 38.,Non-OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Cell Cycle 2014; 13:177-8;  PMID:24241204 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nat Cell Biol  2005; 7:947-53;  PMID:16179950 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nature 2007; 447:493- 6; PMID:17495931 ; http://dx.doi.org/10.1038/ nature05786 41.,Non-OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nat Cell Biol 2011; 13:771-8; PMID:21666685 ;  http://dx.doi.org/10.1038/ncb2269 42.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2013;  200:773-87;  PMID:23509069 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Cell Cycle 2013; 12:1457- 71; PMID :23574715 ; http://dx.doi.org/10.4161/ cc.24602 44.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Biol Chem  2008; 283:4983-92;  PMID:18079118 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Mol Cell Biol 2009; 29:2816-27; PMID:19273597 ;  http://dx.doi.org/10.1128/MCB.01713-08 46.,Non-OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Dev Cell 2007; 13:796-811;  PMID :18061563 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nat Methods 2008; 5:409- 15; PMID:18391959 ; http://dx.doi.org/10.1038/ nmeth.1199 48.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nature  1996; 382:420-5;  PMID:8684481 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2005; 171:229- 40; PMID:16247025 ; http://dx.doi.org/10.1083/ jcb.200505107 50.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Cell Cycle 2013; 12:2643-55;  PMID:23907121 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
J Cell Biol 2002 ; 156 :959-68 ;  PMID:11889140 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Curr Biol 2007; 17:1173-9; PMID:17600710 ;  http://dx.doi.org/10.1016/j.cub.2007.05.077 53.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Mol Biol Cell 2011; 22:3070-80; PMID:21737685 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Nat Cell Biol 2009; 11:365- 74; PMID:19337318 ; http://dx.doi.org/10.1038/ ncb0409-365 56.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Curr Biol 1998; 8:541-4; PMID:9560347 ;  http://dx.doi.org/10.1016/S0960-9822(98)70208-8 57.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Mol Biol Cell  2012; 23:3380-90;  PMID:22809624 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Mol Biol Cell 2013; 24:901-13; PMID:23389635 ; http://dx.doi.org/10.1091/ mbc.E12-06-0458 59.,Non-OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
EMBO J  2012; 31:4179-90;  PMID:23034402 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
Lab Chip 2009; 9:1640-2; PMID:19458875 ;  http://dx.doi.org/10.1039/b821581m,Non-OADS,/arxiv_data1/oa_pdf/38/87/cc-13-1162.PMC4013166.pdf
"11,12 Cytoplasmic factors contributing  *Correspondence to: Petr Svoboda; Email: svobodap@img.cas.cz Submitted: 12/17/2013; Revised: 02/03/2014; Accepted: 02/04/2014; Published Online: 02/11/2014http://dx.doi.org/10.4161/cc.28107An oocyte-specific ELAVL2 isoform   is a translational repressor ablated   from meiotically competent antral oocytes Katerina Chalupnikova1, petr Solc2, Vadym Sulimenko1, Radislav Sedlacek1, and p etr Svoboda1,* 1Institute of Molecular Genetics AS CR; p rague, Czech Republic; 2Institute of Animal p hysiology and Genetics AS CR; Libechov, Czech Republic Keywords:  ELAVL2, NSN, SN, chromatin, oocyte, ARE Abbreviations:  ELAVL2, embryonic lethal abnormal vision like 2 protein; NSN, non-surrounded nucleolus; SN, surrounded  nucleolus; ARE, AU-rich element; OET, oocyte-to-embryo transition; GV, germinal vesicle; CPE, cytoplasmic polyadenylation  element; CPEB, CPE binding protein; SCMC, subcortical maternal complex; AUBP, ARE binding protein; MII, metaphase II;  WT, wild type; TG, transgenic mouse; RRM, RNA recognition motif; RL, Renilla  luciferase; FL, firefly luciferase At the end of the growth phase, mouse antral follicle oocytes acquire full developmental competence.",Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Mol Hum Reprod 2009 ; 15:1-9;  PMID:19019837 ; http://dx.doi.org/10.1093/molehr/ gan069 3.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Mol Reprod Dev 1990 ; 25:374-83; PMID:1691651 ;  http://dx.doi.org/10.1002/mrd.1080250411 5.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Hum Reprod  2008 ; 23:1377 - 84; PMID:18367455 ; http://dx.doi.org/10.1093/ humrep/den096 6.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Zygote  2002 ; 10:73-8; PMID:11964094 ;  http://dx.doi.org/10.1017/S0967199402002101 7.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Cell Cycle  2010 ; 9:1942 - 50; PMID:20436284 ; http://dx.doi.org/10.4161/ cc.9.10.11599 8.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Dev Biol  2004 ; 275:447-58; PMID:15501230 ;  http://dx.doi.org/10.1016/j.ydbio.2004.08.028 9.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Science  2003 ; 300:633- 6; PMID:12714744 ; http://dx.doi.org/10.1126/ science.108181310.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Cell Cycle  2012 ;  11:2833 -42; PMID:22801551 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Cell Cycle  2013 ; 12:1928 - 38; PMID:23673344 ; http://dx.doi.org/10.4161/ cc.24991 14.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Dev Cell  2008 ; 15:416-25;  PMID:18804437 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Biol Reprod   2010 ; 82:1008 -17; PMID:20075394 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Biol Reprod  2013 ;  88:2; PMID:23136301 ; http://dx.doi.org/10.1095/ biolreprod.112.103887 17.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Cell 2008 ; 132:434-48; PMID:18267074 ;  http://dx.doi.org/10.1016/j.cell.2007.12.038 18.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Development   2006 ; 133:4527 -37; PMID:17050619 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Methods  Enzymol  2008 ; 448:119-38; PMID:19111174 ;  http://dx.doi.org/10.1016/S0076-6879(08)02607-4 20.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Nature  2008 ; 452:1017-21; PMID:18385675 ;  http://dx.doi.org/10.1038/nature06809 21.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Nat Rev Mol Cell Biol  2001 ; 2:521-9; PMID:11433366 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Trends  Biochem Sci  2007 ; 32:279-85; PMID:17481902 ;  http://dx.doi.org/10.1016/j.tibs.2007.04.004 23.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
EMBO J 2002 ;  21:1833 -44; PMID:11927567 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Nucleic  Acids Res 2006 ; 34:D111 -4; PMID:16381826 ;  http://dx.doi.org/10.1093/nar/gkj052 25.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Nucleic Acids Res 2005 ; 33:7138 -50;  PMID:16391004 ; http://dx.doi.org/10.1093/nar/ gki1012 26.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Nat Rev Mol Cell Biol  2007 ; 8:113-26; PMID:17245413 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Cell Mol Life Sci 2008 ; 65:3168 - 81; PMID:18581050 ; http://dx.doi.org/10.1007/ s00018-008-8252-6 31.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Biochem Biophys Res Commun  1999 ; 256:263- 8; PMID:10079173 ; http://dx.doi.org/10.1006/ bbrc.1999.0282 32.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Proc Natl Acad Sci U S  A 1998 ; 95:15293 -8; PMID:9860962 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Proc Natl Acad Sci U S A 2000 ; 97:14085 - 90; PMID:11121017 ; http://dx.doi.org/10.1073/ pnas.97.26.14085 34.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Neuron  2012 ; 75:1067 - 80; PMID:22998874 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Semin Cell Dev Biol 1997 ; 8:577- 84; PMID:9642172 ; http://dx.doi.org/10.1006/ scdb.1997.0183 36.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
PLoS One  2011 ; 6:e20773 ;  PMID:21695151 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Zygote  2008 ; 16:161- 8; PMID:18405437 ; http://dx.doi.org/10.1017/ S096719940700456X 38.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Reproduction   2011 ; 142:689-98; PMID:21846809 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Mol Cell Biol  2005 ;  25:9028 -39; PMID:16199879 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
J Biol Chem 2009 ; 284:19982 -92;  PMID:19458392 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Dev Biol  2003 ; 256:187- 93; PMID:12654301 ; http://dx.doi.org/10.1016/ S0012-1606(02)00122-742.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Proc Natl Acad Sci U S A  2002 ; 99:4465 -70; PMID:11904358 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
RNA   2004 ; 10:1518 -25; PMID:15337849 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Curr Top Microbiol Immunol  2008 ; 320:225-56; PMID:18268847 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
J Biochem  2012 ; 151:423-37; PMID:22368252 ;  http://dx.doi.org/10.1093/jb/mvs010 48.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Cell Mol Life Sci 2012 ; 69:501- 17; PMID:21909784 ; http://dx.doi.org/10.1007/ s00018-011-0810-7 49.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Nucleic Acids Res 2013 ; 41:5049 -61;  PMID:23525460 ; http://dx.doi.org/10.1093/nar/ gkt166 50.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Mol Cell Biol  2010 ; 30:1397 -410; PMID:20086103 ;  http://dx.doi.org/10.1128/MCB.01373-09 52.,Non-OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Cell Mol Life Sci 2001 ; 58:266-77; PMID:11289308 ;  http://dx.doi.org/10.1007/PL0000085454.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Curr Opin Genet Dev  2013 ; 23:35-43; PMID:23312841 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Genes Dev 2011 ; 25:755- 66; PMID:21460039 ; http://dx.doi.org/10.1101/ gad.2028911 57.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Nucleic Acids Res  2012 ; 40:399-413; PMID:21908396 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
J Biol Chem 2008 ; 283:35186 -98;  PMID:18854321 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Methods  2011 ; 53:136-41;  PMID:20708690 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Nat Protoc  2006 ; 1:577-80; PMID:17406284 ;  http://dx.doi.org/10.1038/nprot.2006.82 61.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
Dev Biol  1987 ;  121:489-98; PMID:3034703 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
BMC Biotechnol   2004 ; 4:33; PMID:15619330 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/fc/cc-13-1187.PMC4013169.pdf
(Archived at http://www.webcitation.org/6NUCprnHl on 18 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/1d/add0109-0904.PMC4013225.pdf
Available at: http://www.cdc.gov/std/stats/ (accessed14 February 2014).,OADS,/arxiv_data1/oa_pdf/91/1d/add0109-0904.PMC4013225.pdf
(Archived at http://www.webcitation.org/6NNvHHKJd on 14 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/1d/add0109-0904.PMC4013225.pdf
Available at: http://www.cdc.gov/ nchs/nvss/bridged_race/data_documentation.htm(accessed 24 May 2013).,OADS,/arxiv_data1/oa_pdf/91/1d/add0109-0904.PMC4013225.pdf
(Archived at http://www.webcitation.org/6NNvQvEhz on 14 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/1d/add0109-0904.PMC4013225.pdf
(Archived at http://www.webcitation.org/6NNus7kaK on 14 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/1d/add0109-0904.PMC4013225.pdf
Available at: http://quickfacts.census.gov/ qfd/states/17/17031.html (accessed 4 June 2013).,OADS,/arxiv_data1/oa_pdf/91/1d/add0109-0904.PMC4013225.pdf
(Archived at http://www.webcitation.org/6NNvZPPVV on14 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/1d/add0109-0904.PMC4013225.pdf
Obesity trend data were from the CDC Behavioral Risk Factor Surveillance System (http://www.cdc.gov/brfss/).,OADS,/arxiv_data1/oa_pdf/c5/83/nyas1306-0001.PMC4013291.pdf
"Jane Foster (McMaster Univer- sity, Canada) has been using conventional and GF mice to study the gut–brain axis, which involves the complex interplay between the autonomic and en- bSee http://www.patho-ngen-trace.eu/teric nervous systems, pituitary and gut hormones, and the gut inﬂammatory systems (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c5/83/nyas1306-0001.PMC4013291.pdf
From Wikipedia: http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/c5/83/nyas1306-0001.PMC4013291.pdf
org/wiki/File:Esperanza_de_vida.PNG; and World Health Ranking s for death rates: http://www.worldlifeexpectancy.com/cause- of-death/malnutrition/by-country/.,Non-OADS,/arxiv_data1/oa_pdf/c5/83/nyas1306-0001.PMC4013291.pdf
http://www.nyas.org/events/Detail.,Non-OADS,/arxiv_data1/oa_pdf/c5/83/nyas1306-0001.PMC4013291.pdf
http://www.gutmicrobiota forhealth.com/.,Non-OADS,/arxiv_data1/oa_pdf/c5/83/nyas1306-0001.PMC4013291.pdf
Guidance for Industry: Investigational New Drug Ap- plications (INDs) http://www.fda.gov/downloads/Drugs/ Guidances/UCM229175.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/83/nyas1306-0001.PMC4013291.pdf
Guidance for Industry: Early Clinical Trials with Live Biotherapeutic Products http://www.fda.gov/downloads/ BiologicsBloodVaccines/GuidanceComplianceRegulatory- Information/Guidances/General/UCM292704.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/83/nyas1306-0001.PMC4013291.pdf
Available at http://www.doh.gov.tw/.,Non-OADS,/arxiv_data1/oa_pdf/6f/5a/cjc-30-11-757.PMC4013298.pdf
References  http://en.wikipedia.org/wiki/Gene_therapy.,Non-OADS,/arxiv_data1/oa_pdf/e0/f5/cjc-30-03-182.PMC4013314.pdf
"Clin CancerRes, 2006,12(15):4702-4713.  http://www.sibiono.com/en/introduce.html.",Non-OADS,/arxiv_data1/oa_pdf/e0/f5/cjc-30-03-182.PMC4013314.pdf
"Gene Ther, 2009,17(3):360-369.  http://clinicaltrials.gov/ct2/show/NCT00406939.",Non-OADS,/arxiv_data1/oa_pdf/e0/f5/cjc-30-03-182.PMC4013314.pdf
Available at: http://www.dur.ac.uk/news/newsitem/?itemno=  5235.,Non-OADS,/arxiv_data1/oa_pdf/e2/e8/cjc-30-02-085.PMC4013337.pdf
Available at: http://jasss.soc.surrey.ac.uk/2/3/4.html.,Non-OADS,/arxiv_data1/oa_pdf/e2/e8/cjc-30-02-085.PMC4013337.pdf
Available at: http://www.healthinfonet.ecu.,Non-OADS,/arxiv_data1/oa_pdf/e2/e8/cjc-30-02-085.PMC4013337.pdf
Available at http://arxiv.org/pdf/1001.5244.,Non-OADS,/arxiv_data1/oa_pdf/e2/e8/cjc-30-02-085.PMC4013337.pdf
"CommonlyusedEBVantibodyindicatorsinclude  VCA/IgAandEA/IgAexaminedbyimmuneenzymatic  methods.ForsubjectswithapositiveresultofEBV  antibodydetectionandheadandneckabnormality,  nasopharyngealfiberendoscopyisperformedand  pathologicalbiopsyisundertakenforconfirmationof  diagnosiswhereindicated.Inrecentyears,theeffectson  thediagnosisofNPCbyavarietyofEBV­related  indicatorswerecomprehensivelyevaluated,andithas  emergedthatthecombineddetectionofVCA/IgAand  EBNA1/IgAbyELISAissuperiortothetraditional  detectionofVCA/IgAandEA/IgAbytheimmune  enzymaticmethod.Thesenewindicatorshavebeen  usedinaclusterrandomizedcontrolledpopulation  screeningstudyinhigh­incidenceareasofNPCin  Guangdongprovince(http://clinicaltrials.gov/ct2/show/  NCT00941538?term=nasopharyngeal+carcinoma&rank=5).",Non-OADS,/arxiv_data1/oa_pdf/c8/01/cjc-30-02-114.PMC4013340.pdf
http://nobelprize.org/  nobel _prizes/chemistry/laureates/1972/anfinsen鄄 lecture.pdf  Levin thal C. Are there p athways for p rotein folding?,Non-OADS,/arxiv_data1/oa_pdf/7a/a6/cjc-30-02-124.PMC4013342.pdf
"2004 Nobel Lecture,  http://nobelprize.org/nobel _prizes/chemistry/laureates/2004/  ciechanover鄄 lecture.html.",Non-OADS,/arxiv_data1/oa_pdf/7a/a6/cjc-30-02-124.PMC4013342.pdf
"2004 Nobe l  Lecture, http://nobelprize.org/nobel _prizes/chemistry/laureates/  2004/hershko鄄 lecture.html.",Non-OADS,/arxiv_data1/oa_pdf/7a/a6/cjc-30-02-124.PMC4013342.pdf
"Picard D. 2009, http://www.picard.ch/downloads/Hsp90interacto rs.",Non-OADS,/arxiv_data1/oa_pdf/7a/a6/cjc-30-02-124.PMC4013342.pdf
expressionandmethylation  datawereobtainedfromTheCancerGenomeAtlas  (TCGA)publicdatabase(http://www.cancergenome.,OADS,/arxiv_data1/oa_pdf/b0/7d/cjc-30-04-247.PMC4013351.pdf
"MethylationwasalmostthreetimeshigheratM­4613868  (45.6%)thanatM­4615380(12.6%).BothM­4613868(  = ­0.133, =0.03)andM­4615380( = ­0.226, <  0.001)exhibitedaninversecorrelationwith  expression(Figure3Cand3D).Inamannersimilarto  theonedepictedinFigure3A,wesplitthepatientsinto  twogroups(144withlowmethylationand109withhigh  methylation)basedontheirvaluesatM­4615380using  thesamecutoffof15%.Consistently,patientsinthelow  CH3group(median ­1.479)exhibitedhigher  expressionthanthoseinthehighCH3group(median  ­1.718)withstatisticalsignificance( <0.001)(Figure  3E).MethylationatM­4613868wascomparativelyhigh,  anditwasdifficulttosplitthepatientsintotwodistinct  groupsbasedonthesameCH3cutoff.Inall,we  experimentallyandcomputationallyobserveda  statisticallysignificantcorrelationbetweenmethylationof  the  promoterand  expression.Usingan  independentdatasetof343gliomasamplesprofiledinthe  REMBRANDTapplication(http://rembrandt.nci.nih.gov) [26] , wedeterminedtheassociationbetween  expression  andsurvival(Figure4).Thisrelationshipindicatesthat  the geneproductaffectsgliomaprogression [18] .",Non-OADS,/arxiv_data1/oa_pdf/b0/7d/cjc-30-04-247.PMC4013351.pdf
e-mail: pokoh@gnu.ac.kr ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a9/54/jvms-76-313.PMC4013356.pdf
e-mail: gen@obihiro.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b3/a8/jvms-76-323.PMC4013357.pdf
There was no signal peptide in the BboDHODH  sequence as predicted by signalP 4.1 server (http://www.cbs.dtu.dk/services/SignalP/).,OADS,/arxiv_data1/oa_pdf/b3/a8/jvms-76-323.PMC4013357.pdf
(Bovine babesio- sis: http://www.oie.int/fr/nomes/mmanual/A_00059.htm).,Non-OADS,/arxiv_data1/oa_pdf/b3/a8/jvms-76-323.PMC4013357.pdf
e-mail:tnakade@rakuno.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/fc/b9/jvms-76-331.PMC4013358.pdf
e-mail: nakamuta@iwate-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e5/14/jvms-76-339.PMC4013359.pdf
e-mail: sugiyama@muses.tottori-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ec/11/jvms-76-347.PMC4013360.pdf
e-mail: piotr.szweda@wp.pl ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/99/c6/jvms-76-355.PMC4013361.pdf
e-mail: jatuporn@mut.ac.th ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/37/2a/jvms-76-363.PMC4013362.pdf
e-mail: xswu@yzu.edu.cn ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/72/c0/jvms-76-369.PMC4013363.pdf
Amino acid sequence alignment was analyzed by ClustalW2 online software (http://www.ebi.ac.uk/Tools/msa/clust- alw2/).,OADS,/arxiv_data1/oa_pdf/72/c0/jvms-76-369.PMC4013363.pdf
Gene functional domains were predicted by online  software CDD (http://www.ncbi.nlm.nih.gov/Structure/ lexington/lexington.cgi).,OADS,/arxiv_data1/oa_pdf/72/c0/jvms-76-369.PMC4013363.pdf
Pairwise linkage disequilibrium  (LD) between SNPs was calculated by r 2 value using SHEsis  online software (http://analysis.bio-x.cn/myAnalysis.php)  [20].,OADS,/arxiv_data1/oa_pdf/72/c0/jvms-76-369.PMC4013363.pdf
e-mail: a-shimada@azabu-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c6/2d/jvms-76-377.PMC4013364.pdf
e-mail: seitaik@shinshu-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e1/e8/jvms-76-389.PMC4013365.pdf
e-mail: nnonaka@cc.miyazaki-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/df/c1/jvms-76-395.PMC4013366.pdf
e-mail: inokuma@obihiro.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4f/8a/jvms-76-401.PMC4013367.pdf
Nucleotide sequence results were checked using  the BLAST search program (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) for comparison with other known sequences  and aligned using CLUSTAL W software (http://www.ge- nome.jp/tools/clustalw/).,OADS,/arxiv_data1/oa_pdf/4f/8a/jvms-76-401.PMC4013367.pdf
e-mail: h-ohta@vetmed.hokudai.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5e/fa/jvms-76-409.PMC4013368.pdf
Available online at:  http://dx.doi.org/10.1016/j.vetimm.2013.07.006.,OADS,/arxiv_data1/oa_pdf/5e/fa/jvms-76-409.PMC4013368.pdf
e-mail: ktani@yamaguchi-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c7/68/jvms-76-415.PMC4013369.pdf
e-mail: toshiito@muses.tottori-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b3/8a/jvms-76-423.PMC4013370.pdf
e-mail: masaaki@iwate-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/52/bb/jvms-76-431.PMC4013371.pdf
e-mail: shirota@azabu-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f1/be/jvms-76-435.PMC4013372.pdf
e-mail: koie.hiroshi@nihon-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f3/64/jvms-76-439.PMC4013373.pdf
National Health and  Nutrition Survey 2011 http://www.mhlw.go.jp/bunya/kenkou/ eiyou/dl/h23-houkok u-05.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/f3/64/jvms-76-439.PMC4013373.pdf
e-mail: orca@affrc.go.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f7/8f/jvms-76-447.PMC4013374.pdf
e-mail: amao@nvlu.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ec/d0/jvms-76-453.PMC4013375.pdf
e-mail: k9236024@kadai.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5b/da/jvms-76-457.PMC4013376.pdf
e-mail:k-murata@brs.nihon-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8f/d5/jvms-76-461.PMC4013377.pdf
"Infectious, A. S. R. 2010. http://idsc.nih.go.jp/iasr/26/310/kj3102.html.",OADS,/arxiv_data1/oa_pdf/8f/d5/jvms-76-461.PMC4013377.pdf
e-mail: fulvio.laus@unicam.it ©2014 the Japanese society of Veterinary science this is an open-access article distributed under the terms of the cre- ative commons attribution non-commercial no derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/34/8c/jvms-76-467.PMC4013378.pdf
e-mail: mizutaku@yamaguchi-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cc/b0/jvms-76-471.PMC4013379.pdf
e-mail: mauehara@shinshu-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Cre- ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6d/a4/jvms-76-477.PMC4013380.pdf
Available at: http://utm-ext01a.mdacc.,Non-OADS,/arxiv_data1/oa_pdf/0a/c4/cjc-30-05-303.PMC4013395.pdf
"N Engl  J Med, 2001,344(11):783-792.  http://nobelprize.org/nobel_p rizes/medicine/laureates/1989.",Non-OADS,/arxiv_data1/oa_pdf/3d/18/cjc-30-06-363.PMC4013409.pdf
"Am J Med Genet A,  2003,122A(4):303-314.  http://www.cancer.org/cancer/stomachcancer/ov erviewgu ide/  stomach鄄 cancer鄄 overview鄄 survival鄄 rates.",Non-OADS,/arxiv_data1/oa_pdf/3d/18/cjc-30-06-363.PMC4013409.pdf
"Alexandria VA: American Society of Clinical Oncology,  2006:8013.  http://ClinicalTrials.gov.",Non-OADS,/arxiv_data1/oa_pdf/7b/25/cjc-30-07-463.PMC4013421.pdf
"30 Issue 7 www.cjcsys u.com Statistical analysis  ValuesofLD 50 andplasmahalf­life(T 1/2 )ofCycT  andCycwerecalculatedwiththeGraphPadPrism  software.Theresultswerecomparedusingunpaired  Student爷s ­test,with valuesof<0.05indicating  statisticallysignificantdifference.Poweranalysisfor  animalstudieswasperformedwiththeStatisticalPower  CalculatorfromDSSResearch(http://www.dssresearch.",Non-OADS,/arxiv_data1/oa_pdf/65/5e/cjc-30-07-472.PMC4013422.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/d4/5f/mtna201413a.PMC4013433.pdf
Cited 17 Oct 2013. http://oig.hhs.gov/oei/reports/oei-06-09- 00091.pdf .,OADS,/arxiv_data1/oa_pdf/c0/f5/40264_2014_Article_155.PMC4013443.pdf
Cited 25 Nov 2013. http://dannybrown.me/2012/06/06/52-cool-facts-social- media-2012/ .,Non-OADS,/arxiv_data1/oa_pdf/c0/f5/40264_2014_Article_155.PMC4013443.pdf
Cited 25 Nov 2013. http://temp.beevolve.com/twitter-statistics/#c1 .,Non-OADS,/arxiv_data1/oa_pdf/c0/f5/40264_2014_Article_155.PMC4013443.pdf
Cited 25 Nov 2013. http://www.cdc.gov/vaccinesafety/Activities/vaers.html .,Non-OADS,/arxiv_data1/oa_pdf/c0/f5/40264_2014_Article_155.PMC4013443.pdf
Cited 12 March 2014. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid= 4c55ccfb-c4cf-11df-851a-0800200c9a66 .,OADS,/arxiv_data1/oa_pdf/c0/f5/40264_2014_Article_155.PMC4013443.pdf
Cited 18 Oct 2013. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10db92f9-2300-4a80-836b-673e1ae91610#nlm34084-4 .,OADS,/arxiv_data1/oa_pdf/c0/f5/40264_2014_Article_155.PMC4013443.pdf
2012. http://www.who.int/mental_health/management/depression/ deﬁnition/en/ .,Non-OADS,/arxiv_data1/oa_pdf/c0/94/40273_2014_Article_138.PMC4013445.pdf
Depression; 2012. http://www.dbsalliance.org/site/PageServer?pagename= education_depression .,Non-OADS,/arxiv_data1/oa_pdf/c0/94/40273_2014_Article_138.PMC4013445.pdf
Guidelines for pharmacoeconomic evaluations in Belgium; 2008. http://www.ispor.org/peguidelines/source/Belgium_Guide lines-for-Pharmacoeconomics-Evaluation-in-Belgium_2008_English.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c0/94/40273_2014_Article_138.PMC4013445.pdf
The evolution of the general index and the main sub-indices of the Belgian HICP; 2011. http://statbel.fgov.be/ en/modules/publications/statistics/economy/downloads/harmonised_ index_of_consumer_prices.jsp .,Non-OADS,/arxiv_data1/oa_pdf/c0/94/40273_2014_Article_138.PMC4013445.pdf
2012. http://www.inami.fgov.be/drug/fr/drugs/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/c0/94/40273_2014_Article_138.PMC4013445.pdf
Visits costs; 2012. http://www.inami.fgov.be/insurer/fr/ rate/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/c0/94/40273_2014_Article_138.PMC4013445.pdf
2012. http://www.math.umt.edu/ patterson/549/Delta.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c0/94/40273_2014_Article_138.PMC4013445.pdf
http://www.medicine.ox.ac.uk/bandolier/ painres/download/whatis/What_is_sens_analy.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c0/94/40273_2014_Article_138.PMC4013445.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2014, 6: 23977 - http://dx.doi.org/10.3402/jom.v6.23977 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1f/fc/JOM-6-23977.PMC4013489.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23977 - http://dx.doi.org/10.3402/jom.v6.23977",Non-OADS,/arxiv_data1/oa_pdf/1f/fc/JOM-6-23977.PMC4013489.pdf
"The prevalence of nine bacterial species in individuals and at sampled sites Bacterial speciesPrevalence of specific bacterial species at subject level* given in%, n/C3098Prevalence of specific bacterial species at site level given in%, ( n/C30392)Mean number of cells/C29104when present ( 9SD) A. actinomycetemcomitans 49.6 45.3 1.1 ( 91.1) C. rectus 89.8 84.2 3.1 ( 92.8) F. nucleatum 100 84.8 14.4 ( 98.4) F. alocis 89.8 79.4 6.8 ( 913.3) P. endodontalis 95.9 86.0 11.5 ( 911.9) P. gingivalis 87.8 59.1 8.5 ( 911.3) P. intermedia 99.0 78.2 19.0 ( 916.7) T. denticola 73.5 44.1 1.8 ( 91.8) T. forsythia 78.6 48.4 3.0 ( 93.2) *Based on the presence in at least one of four samples.Subgingival bacteria and periodontal progression Citation: Journal of Oral Microbiology 2014, 6: 23977 - http://dx.doi.org/10.3402/jom.v6.23977 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1f/fc/JOM-6-23977.PMC4013489.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23977 - http://dx.doi.org/10.3402/jom.v6.23977",Non-OADS,/arxiv_data1/oa_pdf/1f/fc/JOM-6-23977.PMC4013489.pdf
"Relationship between con- version of localized juvenile periodontitis-suceptible childrenSubgingival bacteria and periodontal progression Citation: Journal of Oral Microbiology 2014, 6: 23977 - http://dx.doi.org/10.3402/jom.v6.23977 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1f/fc/JOM-6-23977.PMC4013489.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23977 - http://dx.doi.org/10.3402/jom.v6.23977",Non-OADS,/arxiv_data1/oa_pdf/1f/fc/JOM-6-23977.PMC4013489.pdf
*Correspondence: david.lyons@ed.ac.uk http://dx.doi.org/10.1016/j.devcel.2013.05.013 .,Non-OADS,/arxiv_data1/oa_pdf/39/30/emss-58231.PMC4013507.pdf
SUPPLEMENTAL INFORMATION  Supplemental Information includes three figures and five movies and can be found with this article online at http://dx.doi.org/10.1016/j.devcel.2013.05.013 .Europe PMC Funders Group Author Manuscript Dev Cell.,Non-OADS,/arxiv_data1/oa_pdf/39/30/emss-58231.PMC4013507.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Wif1 regulates cloaca septation RC-L Ng et al 989 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/8e/7f/cdd201420a.PMC4013516.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Endodermal b-catenin in the pathogenesis of ARM S Miyagawa et al 997 Cell Death and Differentiation,OADS,/arxiv_data1/oa_pdf/d1/12/cdd201421a.PMC4013517.pdf
"Unless otherwise noted, all alleles are described (http://www.wormbase.org/).",Non-OADS,/arxiv_data1/oa_pdf/d2/48/cdd201423a.PMC4013519.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)CDC-42 promotes engulfment in C. elegans LJ Neukomm et al 853 Cell Death and Differentiation,Non-OADS,/arxiv_data1/oa_pdf/d2/48/cdd201423a.PMC4013519.pdf
Published by Elsevier B.V. http://dx.doi.org/10.1016/j.molonc.2014.01.009MOLECULAR ONCOLOGY 8 (2014) 633 e641 Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/b0/08/MOL2-8-633.PMC4013555.pdf
Data was acquired randomly as deter-mined by list randomizer ( http://www.random.org/lists/ ).,OADS,/arxiv_data1/oa_pdf/b0/08/MOL2-8-633.PMC4013555.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2014.01.009 .,OADS,/arxiv_data1/oa_pdf/b0/08/MOL2-8-633.PMC4013555.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4889 | DOI: 10.1038/srep04889 4",Non-OADS,/arxiv_data1/oa_pdf/8b/57/srep04889.PMC4013928.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2e/fa/srep04892.PMC4013930.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4892 | DOI: 10.1038/srep04892 6",Non-OADS,/arxiv_data1/oa_pdf/2e/fa/srep04892.PMC4013930.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4888 | DOI: 10.1038/srep04888 6",Non-OADS,/arxiv_data1/oa_pdf/ff/f3/srep04888.PMC4013934.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4894 | DOI: 10.1038/srep04894 10",Non-OADS,/arxiv_data1/oa_pdf/7c/58/srep04894.PMC4013936.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/srep04882.PMC4013938.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4882 | DOI: 10.1038/srep04882 8",Non-OADS,/arxiv_data1/oa_pdf/d5/f5/srep04882.PMC4013938.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ca/b6/srep04895.PMC4013939.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4895 | DOI: 10.1038/srep04895 9",Non-OADS,/arxiv_data1/oa_pdf/ca/b6/srep04895.PMC4013939.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/55/68/srep04887.PMC4013940.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4887 | DOI: 10.1038/srep04887 8",Non-OADS,/arxiv_data1/oa_pdf/55/68/srep04887.PMC4013940.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cb/3c/srep04881.PMC4013941.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4881 | DOI: 10.1038/srep04881 12",Non-OADS,/arxiv_data1/oa_pdf/cb/3c/srep04881.PMC4013941.pdf
"Internal parasite  of horses, V453 http://www.ag.ndsu.nodak.edu.",Non-OADS,/arxiv_data1/oa_pdf/77/06/jes-23-001.PMC4013976.pdf
"OpenEpi: open source epidemiologic statistics for public health, version 2.3.1. http://www.openepi.com.",Non-OADS,/arxiv_data1/oa_pdf/77/06/jes-23-001.PMC4013976.pdf
http://www.frontrangefrenzy.com/horseparasites.,Non-OADS,/arxiv_data1/oa_pdf/77/06/jes-23-001.PMC4013976.pdf
http://www.soas.ac.uk/history/confer - ences/donkey-conference/.,Non-OADS,/arxiv_data1/oa_pdf/e2/6c/jes-23-047.PMC4013980.pdf
http://www.soas.ac.uk/history/conferences/donkey-conference/.,Non-OADS,/arxiv_data1/oa_pdf/e2/6c/jes-23-047.PMC4013980.pdf
"Their age rang was 3–29 years  Received: September 11, 2013 Accepted: October 21, 2013*Corresponding author: e-mail: takasu@gifu-u.ac.jp ©2013 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.",Non-OADS,/arxiv_data1/oa_pdf/c5/07/jes-24-075.PMC4013988.pdf
e-mail: bannai@epizoo.equinst.go.jp ©2013 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/10/6a/jes-24-071.PMC4013989.pdf
e-mail: miyake@kais.kyoto-u.ac.jp ©2013 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/34/81/jes-24-063.PMC4013990.pdf
e-mail: nishida@azabu-u.ac.jp ©2013 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/f3/69/jes-24-057.PMC4013991.pdf
"Materials and methods Preparation of FDL tendon allografts FDL tendon grafts were aseptically dissected from donors  (C57Bl/6 mice) and lyophilized as previously described.15  The grafts were then digitally imaged to determine their  surface area (Image J software, http://rsb.info.nih.gov/ij).",Non-OADS,/arxiv_data1/oa_pdf/3a/1b/10.1177_2041731414528736.PMC4014079.pdf
"However, while rAA V represents a class  of gene delivery viral vectors with an acceptable safety  profile and is being clinically tested in numerous of FDA- approved protocols (http://www.clinicaltrials.gov), there  are currently no approved viral vectors for wide orthopedic  use.",Non-OADS,/arxiv_data1/oa_pdf/3a/1b/10.1177_2041731414528736.PMC4014079.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/74/nst011.PMC4014092.pdf
"This is an Open Access article distributed under the terms ofthe Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/30/nst032.PMC4014105.pdf
"Voxel-based morphometry The MR images were first segmented for GM and white matter using the segmentation tools in SPM8 (http://www.fil.ion.ucl.ac.uk/spm).Subsequently, we performed Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra in SPM8 for inter-subject regis- tration of the GM images.",OADS,/arxiv_data1/oa_pdf/b5/30/nst032.PMC4014105.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/6c/rrt131.PMC4014154.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/c4/rrt135.PMC4014158.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/e0/rrt145.PMC4014168.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/ad/bhs418.PMC4014178.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/d3/ad/bhs418.PMC4014178.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/28/bht003.PMC4014180.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/d7/28/bht003.PMC4014180.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/13/bht015.PMC4014181.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/5b/13/bht015.PMC4014181.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/53/bht018.PMC4014183.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/66/53/bht018.PMC4014183.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/30/ijwh-6-437.PMC4014358.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 437–449International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  437RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S3766 0etiology, diagnosis, and clinical management   of vulvodynia Leslie A Sadownik University of British Columbia,   Department of Obstetrics and  Gynecology, vancouver, BC, Canada Correspondence: Leslie A Sadownik   Sixth Floor, Department of Gynecology,  Gordon and Leslie Diamond Health Care  Center, 2775 Laurel Street, vancouver,   BC, Canada v5Z 1M9   Tel +1 604 875 4260   Fax +1 604 875 4869   email leslie.sadownik@vch.c aAbstract:  Chronic vulvar pain or discomfort for which no obvious etiology can be found,  ie, vulvodynia, can affect up to 16% of women.",Non-OADS,/arxiv_data1/oa_pdf/42/30/ijwh-6-437.PMC4014358.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/42/30/ijwh-6-437.PMC4014358.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/30/ijwh-6-437.PMC4014358.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/a8/ppa-8-603.PMC4014359.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 603–612Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  603Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S4278 9Efficacy and tolerability of agomelatine   in the treatment of depression Blanka Kores Plesničar Ljubljana University Psychiatric  Hospital, Ljubljana, Slovenia Correspondence: Blanka Kores Plesničar   Ljubljana University Psychiatric Hospital,  Studenec 48, 1260 Ljubljana Polje,  Slovenia   Tel +386 1 5872 461   Fax +386 1 5294 111   email blanka.kores@psih-klinika.s iAbstract:  Depression is a severe and usually recurrent mental disorder which often leads to a  significant impairment of everyday functioning, a reduced quality of life, and also great suffer - ing of the patients.",Non-OADS,/arxiv_data1/oa_pdf/cd/a8/ppa-8-603.PMC4014359.pdf
Available at: http://www.nice.org.uk/CG9 0.,Non-OADS,/arxiv_data1/oa_pdf/cd/a8/ppa-8-603.PMC4014359.pdf
Available at: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/cd/a8/ppa-8-603.PMC4014359.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/cd/a8/ppa-8-603.PMC4014359.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/a8/ppa-8-603.PMC4014359.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/08/clep-6-147.PMC4014360.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2014:6 147–154Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  147REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S4426 7Epidemiology of visceral leishmaniasis Paul D Ready Disease Control Department,    Faculty of infectious and Tropical  Diseases, London School of Hygiene  and Tropical Medicine, London, UK Correspondence: Paul D Ready   Disease Control Department, Faculty   of infectious and Tropical Diseases,   London School of Hygiene and   Tropical Medicine, Keppel Street,   London wC1E 7HT, UK   Tel +44 20 7927 2164   Fax +44 20 7927 2918   Email p aul.ready@lshtm.ac.u kAbstract:  Leishmania  species are the causative agents of leishmaniasis, a neglected tropical  disease.",Non-OADS,/arxiv_data1/oa_pdf/bb/08/clep-6-147.PMC4014360.pdf
"AmBisome (Gilead, Foster, CA, USA), a liposome  formulation of amphotericin B, is now a standard treat - ment for VL, especially against L. donovani  in Bihar, and a  single dose treatment has been successfully trialed in rural  public hospitals in Bangladesh ( http://www.who.int/tdr/ news/201 3).",Non-OADS,/arxiv_data1/oa_pdf/bb/08/clep-6-147.PMC4014360.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/bb/08/clep-6-147.PMC4014360.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/78/mder-7-107.PMC4014361.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 107–114Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  107REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S4694 3The clinical utility of FibroScan® as a noninvasive   diagnostic test for liver disease Julius wilder1,2 Keyur Patel1,2 1Division of Gastroenterology,    Duke University School of   Medicine,  2Duke Clinical Research   institute, Durham, NC, USA Correspondence: Keyur Patel   Duke Clinical Research institute,   PO Box  17969, DUMC  3850,  Durham, NC  27715, USA   Tel +1 919 668 7802  Fax +1 919 668 7164  Email keyur.patel@duke.ed uAbstract:  An important aspect of managing chronic liver disease is assessing for evidence  of fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/6b/78/mder-7-107.PMC4014361.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/6b/78/mder-7-107.PMC4014361.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/0b/nss-6-057.PMC4014362.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNature and Science of Sleep 2014:6 57–63Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  57OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NSS.S5313 2Armodafinil-induced wakefulness in animals   with ventrolateral preoptic lesions ramalingam Vetrivelan clifford B Saper Patrick M Fuller Department of Neurology,    Harvard Medical School and Beth  Israel Deaconess Medical Center,   Boston, MA, USA Correspondence: Patrick M Fuller   Department of Neurology,   Beth Israel Deaconess Medical Center,   3 Blackfan Avenue, E/CLS 707,   Boston, MA 02215, USA   Tel +1 617 735 2811   Fax +1 617 735 2910   email pfuller@bidmc.harvard.ed uAbstract:  Armodafinil is the pharmacologically active R-enantiomer of modafinil, a widely  prescribed wake-promoting agent used to treat several sleep-related disorders including exces - sive daytime sleepiness associated with narcolepsy, shift work sleep disorder, and obstructive  sleep apnea/hypopnea syndrome.",Non-OADS,/arxiv_data1/oa_pdf/a2/0b/nss-6-057.PMC4014362.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/a2/0b/nss-6-057.PMC4014362.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/0b/nss-6-057.PMC4014362.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/ott-7-645.PMC4014363.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 645–654OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  645Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5998 3stage-dependent prognostic impact of molecular  signatures in clear cell renal cell carcinoma Thomas Weber1,2 Matthias Meinhardt3 stefan Zastrow1 andreas Wienke4 Kati erdmann1 Jörg hofmann1 susanne Fuessel1 Manfred P Wirth1 1Department of Urology, Technische  Universität Dresden, Dresden,   germany;  2Department of Oncology  and hematology, Martin-luther- University halle-Wittenberg, halle  (saale), germany;  3institute of  Pathology, T echnische Universität  Dresden, Dresden, germany;  4institute  of Medical epidemiology, Biostatistics,   and informatics, Martin-luther- University halle-Wittenberg, halle  (saale), germany correspondence: Thomas Weber   Department of Oncology and   hematology, Martin-luther-University   halle-Wittenberg, ernst-grube-strasse 40,   06120 halle (saale), germany   Tel +49 345 557 7285  Fax +49 345 557 7247  email thomas.weber@medizin.uni-halle.",Non-OADS,/arxiv_data1/oa_pdf/6e/9e/ott-7-645.PMC4014363.pdf
"Statistical analysis was accomplished with PASW   18.0 (IBM Corporation, Armonk, NY , USA) and R  2.15.1   (http://www.r-project.or g).",OADS,/arxiv_data1/oa_pdf/6e/9e/ott-7-645.PMC4014363.pdf
"Available from:  http://www.uroweb.org/gls/pdf/10_Renal_Cell_Carcinoma_LRV2.pd f.  Accessed December  30, 2013.",Non-OADS,/arxiv_data1/oa_pdf/6e/9e/ott-7-645.PMC4014363.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6e/9e/ott-7-645.PMC4014363.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/9e/ott-7-645.PMC4014363.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/68/ott-7-637.PMC4014364.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 637–643OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  637Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6045 8involvement of c-KIT mutation in the development  of gastrointestinal stromal tumors through  proliferation promotion and apoptosis inhibition Ying-Yu Ma1 sheng Yu2 Xu-Jun he1 Yuan Xu2 Fang Wu2 Ying-Jie Xia1 Kun guo2 hui-Ju Wang1 Zai-Yuan Ye1,3 Wei Zhang3 hou-Quan Tao1,3 1Key laboratory of gastroenterology  of Zhejiang Province, Zhejiang  Provincial People’s hospital,   hangzhou,  2Wenzhou Medical college,   Wenzhou, Zhejiang,  3Department of  gastrointestinal surgery, Zhejiang  Provincial People’s hospital,   hangzhou, People’s republic of china correspondence: hou-Quan Tao   Key laboratory of gastroenterology   of Zhejiang Province, hangzhou,    310014 Zhejiang, People’s   republic of china   Tel +86 571 8589 3781  Fax +86 571 8513 1448  email taohouquan2008@aliyun.co m    Wei Zhang   Department of gastrointestinal surgery,  Zhejiang Provincial People’s hospital,   158 shangtang road, hangzhou,   Zhejiang  310014, People’s   republic of china   Tel +86 571 8589 3013  Fax +86 571 8513 1448  email hzzhangwei@yeah.ne tAbstract:  The aim of this study was to discuss the role of c-KIT mutation in the pathogenesis of  gastrointestinal stromal tumors (GISTs) and analyze its correlation with proliferation and apopto - sis.",Non-OADS,/arxiv_data1/oa_pdf/1c/68/ott-7-637.PMC4014364.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1c/68/ott-7-637.PMC4014364.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/68/ott-7-637.PMC4014364.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/cd/opth-8-857.PMC4014365.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 857–867Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  857Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4874 5Journal name: Clinical Ophthalmology Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Van Bergen et al Running head recto: Current perspectives on wound modulation after glaucoma filtration surgery DOI: http://dx.doi.org/10.2147/OPTH.S48745 improving patient outcomes following glaucoma  surgery: state of the art and future perspectives Tine van Bergen1 Sarah van de velde1 evelien vandewalle3 Lieve Moons2 ingeborg Stalmans1,3 1Laboratory of Ophthalmology,    KU Leuven, 2Unit Animal Physiology   and Neurobiology, KU Leuven,   3Department of Ophthalmology,   University Hospitals Leuven,    Leuven, BelgiumAbstract:  Of all the treatments currently used to lower intraocular pressure in glaucoma  patients, filtration surgery is known to be the most effective.",Non-OADS,/arxiv_data1/oa_pdf/f4/cd/opth-8-857.PMC4014365.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f4/cd/opth-8-857.PMC4014365.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 867Current perspectives on wound modulation after glaucoma filtration surgery  111.,Non-OADS,/arxiv_data1/oa_pdf/f4/cd/opth-8-857.PMC4014365.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/72/ppa-8-613.PMC4014366.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 613–619Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  613OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S6313 3Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Spivey et al Running head recto: Medication Access Program DOI: http://dx.doi.org/10.2147/PPA.S63133 serving underserved transplant recipients:  experience of the Medication Access Program christina  A spivey1 Marie A chisholm-Burns1 charlene garrett2 Kenneth M Duke2 1University of Tennessee college  of Pharmacy, Memphis, Tn , UsA;   2University of georgia college   of Pharmacy, Athens, gA, UsAObjective:  Programs have been established to help underserved, solid-organ transplant  recipients  and other patient populations address the burden of medication regimen costs.",Non-OADS,/arxiv_data1/oa_pdf/29/72/ppa-8-613.PMC4014366.pdf
"Available from:  http://publications.milliman.com/research/health-rr/pdfs/201 1-us- organ-tissue.pd f. Accessed October 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/29/72/ppa-8-613.PMC4014366.pdf
Available  from: http://www.medicare.gov/Pubs/pdf/10128.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/72/ppa-8-613.PMC4014366.pdf
Available from: http://www.medicare.gov/cover - age/prescription-drugs-outpatient-limited-coverage.html.,Non-OADS,/arxiv_data1/oa_pdf/29/72/ppa-8-613.PMC4014366.pdf
Available from: http://www.mapuga.com/index.,Non-OADS,/arxiv_data1/oa_pdf/29/72/ppa-8-613.PMC4014366.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/29/72/ppa-8-613.PMC4014366.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/3b/mder-7-099.PMC4014367.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 99–105Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  99REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S6059 4Self-expanding stents and aortoiliac occlusive  disease: a review of the literature Joost A Bekken1 Hidde Jongsma1 Jean-Paul PM de vries2 Bram Fioole1 1Department of vascular Surgery,   Maasstad Hospital, Rotterdam, the  Netherlands; 2Department of vascular  Surgery, St Antonius Hospital,   Nieuwegein, the Netherlands Correspondence: Bram Fioole   Maasstad Hospital, Maassstadweg 21,  3079 DZ Rotterdam, the Netherlands   T el +31 10 291 1247   Email fiooleb@maasstadziekenhuis.n lAbstract:  The treatment of symptomatic aortoiliac occlusive disease has shifted from open to  endovascular repair.",Non-OADS,/arxiv_data1/oa_pdf/54/3b/mder-7-099.PMC4014367.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2014:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 105Self-expanding stents and aortoiliac occlusive disease  42.,Non-OADS,/arxiv_data1/oa_pdf/54/3b/mder-7-099.PMC4014367.pdf
Available at: http://www.cebm.net/index.,Non-OADS,/arxiv_data1/oa_pdf/54/3b/mder-7-099.PMC4014367.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/e7/amep-5-107.PMC4014368.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 107–113Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  107OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S5756 9Empathy levels among health professional  students: a cross-sectional study at two  universities in Australia Brett Williams1 T ed Brown2 lisa McKenna3 Malcolm J Boyle1 claire Palermo4 Debra nestel5 richard Brightwell6 louise Mccall7 Verity russo1 1Department of community  Emergency health and Paramedic  Practice, 2Department of  Occupational Therapy, 3school of  nursing and Midwifery, 4Department  of nutrition and Dietetics, 5school of  rural Medicine, Monash University,   Melbourne, Vic , 6school of Medical  sciences, Edith cowan University,   Perth, WA, 7Faculty of Medicine,   nursing and health sciences, Monash  University, Melbourne, Vic , Australia correspondence: Brett Williams   Department of community Emergency  health and Paramedic Practice, Monash  University – Peninsula campus,   PO Box 527, McMahons road, Frankston,  Melbourne, Vic 3199, Australia   Tel +61 3 9904 4283   Fax +61 3 9904 4168   Email brett.williams@monash.ed uBackground:  Empathy is paramount in the health care setting, optimizing communication  and rapport with patients.",Non-OADS,/arxiv_data1/oa_pdf/d6/e7/amep-5-107.PMC4014368.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d6/e7/amep-5-107.PMC4014368.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/e7/amep-5-107.PMC4014368.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/a4/jpr-7-237.PMC4014369.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 237–242Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  237 ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6131 2Pain severity is associated with muscle   strength and peak oxygen uptake in adults   with fibromyalgia W Michael hooten1,2 Jolene M smith3 Jason s eldrige1 David a Olsen3 W David Mauck1 susan M Moeschler1 1Department of anesthesiology,   2Department of Psychiatry and  Psychology, Mayo clinic college   of Medicine, 3Mayo school of   graduate Medical education,    Rochester, M n, Usa correspondence: W Michael hooten   Department of anesthesiology, Mayo   clinic college of Medicine, 200 First   st sW, Rochester, Mn 55905, Usa   Tel +1 507 266 9877   email hooten.william@mayo.ed uBackground:  The associations between pain, lower extremity strength, and aerobic conditioning  have not been widely investigated in adults with fibromyalgia (FM).",Non-OADS,/arxiv_data1/oa_pdf/71/a4/jpr-7-237.PMC4014369.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/71/a4/jpr-7-237.PMC4014369.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/a4/jpr-7-237.PMC4014369.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/f9/copd-9-431.PMC4014371.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 431–439International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  431OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5932 2long-acting bronchodilator use after  hospitalization for COPD: an observational   study of health insurance claims data Christine l Baker1 Kelly h Zou1 Jun su2 1Pfizer Inc., new Y ork, nY,   Usa; 2Boehringer-Ingelheim  Pharmaceuticals Inc., ridgefield,    CT, Usa Correspondence: Jun su   Boehringer-Ingelheim Pharmaceuticals  Inc., 900 Ridgebury Road, Ridgefield,   CT 06877, Usa   Tel +1 203 798 4788   Fax +1 203 837 4788   email jun.su@boehringer-ingelheim.co mBackground:  Treatment of s table  chronic obstructive pulmonary disease (COPD) with  long-acting bronchodilator (LABD) medications is recommended by the 2014 Global initiative  for chronic Obstructive Lung Disease (GOLD) guidelines.",Non-OADS,/arxiv_data1/oa_pdf/b0/f9/copd-9-431.PMC4014371.pdf
"Available from: http://www.who.int/respiratory/ copd/burden/en/index.htm l. Accessed February 11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b0/f9/copd-9-431.PMC4014371.pdf
Available from: http://www.qualityforum.,Non-OADS,/arxiv_data1/oa_pdf/b0/f9/copd-9-431.PMC4014371.pdf
"Available  from: http://www.goldcopd.co m. Accessed February 11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b0/f9/copd-9-431.PMC4014371.pdf
"Available from: http://www.cdc.gov/nchs/icd/icd9cm.ht m. Accessed  Febrary 11, 2014.",OADS,/arxiv_data1/oa_pdf/b0/f9/copd-9-431.PMC4014371.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b0/f9/copd-9-431.PMC4014371.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/f9/copd-9-431.PMC4014371.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/16/ijwh-6-451.PMC4014372.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 451–467International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  451RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S3860 3Current perspectives on the etiology   and manifestation of the “silent” component   of the Female Athlete Triad Rebecca J Mallinson Mary Jane De Souza Department of Kinesiology, Women’s  Health and exercise Laboratory in  Noll Laboratory, Pennsylvania State  University, University Park, PA, USA Correspondence: Rebecca J Mallinson   206 Noll Laboratory, Department of   Kinesiology, Penn State University,   University Park, PA 16802, USA   Tel +1 814 867 2510   Fax +1 814 865 4602   email rjt199@psu.ed uAbstract:  The Female Athlete Triad (Triad) represents a syndrome of three interrelated  conditions that originate from chronically inadequate energy intake to compensate for energy  expenditure; this environment results in insufficient stored energy to maintain physiological  processes, a condition known as low energy availability.",Non-OADS,/arxiv_data1/oa_pdf/24/16/ijwh-6-451.PMC4014372.pdf
Available from: http://www.iom.edu/ ∼/media/Files/ Report%20Files/2010/Dietary-Reference-Intakes-for-Calcium- and-Vitamin-D/Vitamin%20D%20and%20Calcium%202010%20 Report%20Brief.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/16/ijwh-6-451.PMC4014372.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/24/16/ijwh-6-451.PMC4014372.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/16/ijwh-6-451.PMC4014372.pdf
"Available from: http://www.accessdata.fda.gov/ scripts/cder/drugsatfda/index.cfm?fuseaction =Search.DrugDetail s.  Accessed January 26, 2014.",OADS,/arxiv_data1/oa_pdf/24/16/ijwh-6-451.PMC4014372.pdf
"Available from: http://www.accessdata.fda.gov/ scripts/cder/drugsatfda/index.cfm?fuseaction =Search.SearchActio n&searchTerm =denosumab&SearchType =BasicSearc h. Accessed   January 26, 2014.",OADS,/arxiv_data1/oa_pdf/24/16/ijwh-6-451.PMC4014372.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/15/dmso-7-139.PMC4014373.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 139–144Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  139Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S5965 2Prevalence of diagnosed and undiagnosed   diabetes mellitus in adults aged  19 years   and older in Basrah, iraq abbas ali Mansour ahmed a al-Maliky Bashar Kasem abdulsatar Jabar Khalid abdulabass Mosbeh al-Faiha Diabetes endocrine and  Metabolism center (FDeM c) Basrah,   iraq correspondence: abbas ali Mansour   Diabetes, endocrine and Metabolism  Division, Basrah college of Medicine,  hattin, PO Box  142, Basrah  61013, iraq   Tel +964 78 0140 3706  email aambaam@gmail.co mBackground:  Six of the top ten countries in the world with the highest prevalence of diabetes  mellitus are in the Middle East.",Non-OADS,/arxiv_data1/oa_pdf/60/15/dmso-7-139.PMC4014373.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/60/15/dmso-7-139.PMC4014373.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/15/dmso-7-139.PMC4014373.pdf
"Available  from: http://www.novonordisk.com/images/about_us/changing-diabetes/ PDF/Leadership%20forum%20pdfs/MENA%20Forum/MENA_Diabe - tes_briefing_book_EN.pd f. Accessed April 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/60/15/dmso-7-139.PMC4014373.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/8b/ijgm-7-211.PMC4014374.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 211–218International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  211RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S6179 5Automating and estimating glomerular filtration  rate for dosing medications and staging chronic  kidney disease Katy e Trinkley1 S Michelle Nikels2 Robert L Page II1 Melanie S Joy1 1Skaggs School of Pharmacy and  Pharmaceutical Sciences, 2School of  Medicine, University of Colorado,   Aurora, CO, USA  Correspondence: Katy e Trinkley   Department of Clinical Pharmacy, Skaggs  School of Pharmacy and Pharmaceutical  Sciences, University of Colorado  Anschutz Medical Campus, 12850 east  Montview Boulevard, Mail Stop C238,  Aurora, CO 80045, USA   Tel +1 303 724 6563   Fax +1 303 724 0979   email k aty.trinkley@ucdenver.ed uObjective:  The purpose of this paper is to serve as a review for primary care providers on the  bedside methods for estimating glomerular filtration rate (GFR) for dosing and chronic kidney  disease (CKD) staging and to discuss how automated health information technologies (HIT) can  enhance clinical documentation of staging and reduce medication errors in patients with CKD.",Non-OADS,/arxiv_data1/oa_pdf/cf/8b/ijgm-7-211.PMC4014374.pdf
"Available  from: http://www.kidney.org/professionals/kls/pdf/12-10-4004_KBB_ FAQs_AboutGFR-1.pd f. Accessed April 12, 2013.",OADS,/arxiv_data1/oa_pdf/cf/8b/ijgm-7-211.PMC4014374.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/cf/8b/ijgm-7-211.PMC4014374.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/8b/ijgm-7-211.PMC4014374.pdf
"Available from:  http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatory Information/Guidances/ucm072127.pd f. Accessed February 2, 2013.",Non-OADS,/arxiv_data1/oa_pdf/cf/8b/ijgm-7-211.PMC4014374.pdf
"Available from:  http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulat oryInformation/Guidances/UCM204959.pd f. Accessed February 24,  2013.",Non-OADS,/arxiv_data1/oa_pdf/cf/8b/ijgm-7-211.PMC4014374.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/98/ott-7-655.PMC4014375.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 655–662OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  655open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S4523 2ORIGINAL RESEARCH Exome sequencing reveals a potential   mutational trajectory and treatments   for a specific pancreatic cancer patient James Cotterell1,2 1Center for Genomic Regulation,   Barcelona, Spain; 2Garvan Institute  for Medical Research, Sydney, NSW,   Australia Correspondence: James Cotterell   Garvan Institute, 384 Victoria St,   Darlinghurst, NSW 2010, Australia   Email j.cotterell@garvan.org.a uAbstract : Pancreatic cancer is the fourth biggest killer, and has one of the worst prognoses,  of any cancer type.",Non-OADS,/arxiv_data1/oa_pdf/cf/98/ott-7-655.PMC4014375.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cf/98/ott-7-655.PMC4014375.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/98/ott-7-655.PMC4014375.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/34/amep-5-115.PMC4014376.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 115–123Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  115REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6216 5Clinical performance feedback and quality  improvement opportunities for perioperative  physicians Alan David Kaye1 Olutoyin J Okanlawon2 Richard D Urman2 1Department of Anesthesiology,   Louisiana State University School  of Medicine, New Orleans, LA,   2Department of Anesthesiology,   Perioperative and Pain Medicine,   Brigham and women’s Hospital,   Boston MA, USA Correspondence: Richard D Urman   Department of Anesthesiology,  Perioperative and Pain Medicine, Brigham  and women’s Hospital, 75 Francis Street,  Boston, MA 02115, USA   Tel +1 617 732 8222  Email rurman@partners.or gAbstract:  Clinical performance feedback is an important component of the ongoing develop - ment and education of health care practitioners.",Non-OADS,/arxiv_data1/oa_pdf/79/34/amep-5-115.PMC4014376.pdf
"Available from: http://www.iom.edu/ ∼/media/ Files/Report%20Files/2001/Crossing-the-Quality-Chasm/Quality%20 Chasm%202001%20%20report%20brief.pd f. Accessed March  28,  2013.",Non-OADS,/arxiv_data1/oa_pdf/79/34/amep-5-115.PMC4014376.pdf
Available from: http://www.rand.org/pubs/working_papers/WR38 1.,Non-OADS,/arxiv_data1/oa_pdf/79/34/amep-5-115.PMC4014376.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/79/34/amep-5-115.PMC4014376.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/34/amep-5-115.PMC4014376.pdf
Available from: https://www.aqihq.org /.,Non-OADS,/arxiv_data1/oa_pdf/79/34/amep-5-115.PMC4014376.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/35/ppa-8-621.PMC4014377.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 621–629Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  621OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6077 1Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Espanol et al Running head recto: Views of PID patients on immunoglobulin therapy and quality of life DOI: http://dx.doi.org/10.2147/PPA.S60771 improving current immunoglobulin therapy   for patients with primary immunodeficiency:  quality of life and views on treatment T eresa espanol1 Johan Prevot2 Jose Drabwell2 seema sondhi3 laurence Olding4 1immunology Unit, Vall d’ hebron  University hospital, Barcelona, spain;   2international Patient Organisation  for Primary immunodeficiencies,   cornwall, UK; 3Baxter healthcare sA,   Zurich, switzerland; 4Bryter,    london, UKBackground:  Subcutaneous or intravenous immunoglobulin replacement is the mainstay of  treatment for most patients with primary immunodeficiency disease (PID).",Non-OADS,/arxiv_data1/oa_pdf/b6/35/ppa-8-621.PMC4014377.pdf
"Available from: http://www.qual - itymetric.com/WhatWeDo/SFHealthSurveys/SF12v2 HealthSurve y/ tabid/186/Default.asp x. Accessed May 7, 2013.",Non-OADS,/arxiv_data1/oa_pdf/b6/35/ppa-8-621.PMC4014377.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b6/35/ppa-8-621.PMC4014377.pdf
Available from:  http://www.qualitymetric.com/WhatWeDo/PediatricHealthSurveys/ SF10HealthSurveyforChildren/tabid/195/Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b6/35/ppa-8-621.PMC4014377.pdf
Available from: http://www.euroqol.,Non-OADS,/arxiv_data1/oa_pdf/b6/35/ppa-8-621.PMC4014377.pdf
Available  from: http://primaryimmune.org/about-primary-immunodeficiency- diseases/idf-publications?aid-1264&pid =275&sa=1.,Non-OADS,/arxiv_data1/oa_pdf/b6/35/ppa-8-621.PMC4014377.pdf
Available from: http://primaryimmune.org/ wp-content/uploads/2011/04/Clinical-Update-in-Immunoglobulin- Therapy-for-Primary-Immunodeficiency-Diseases.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/35/ppa-8-621.PMC4014377.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/d5/ndt-10-695.PMC4014378.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 695–701Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  695Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5287 5Comprehensive cognitive and cerebral  hemodynamic evaluation after cranioplasty Fernanda Coelho1 arthur Maynart oliveira2 Wellingson silva paiva2 Fabio Rios Freire1 Vanessa T ome Calado1 Robson Luis amorim2 Iuri santana Neville2 almir Ferreira de andrade2 edson Bor-seng-shu3 Renato anghinah1 Manoel Jacobsen T eixeira2 1Neurorehabilitation Group,   Division of Neurology, 2Division of  Neurosurgery, 3Neurosonology and  Cerebral Hemodynamics Group,   University of são paulo Medical  school, são paulo, Brazil Correspondence: Iuri santana Neville   University of são paulo Medical school,  255 eneas aguiar street , Office 4080 ,   são paulo, 05403010 , Brazil   Tel +55 11 2661 7226   Fax +55 11 2661 5176   email iurineville@yahoo.com.b rAbstract:  Decompressive craniectomy is an established procedure to lower intracranial pressure  and can save patients’ lives.",Non-OADS,/arxiv_data1/oa_pdf/1a/d5/ndt-10-695.PMC4014378.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1a/d5/ndt-10-695.PMC4014378.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/d5/ndt-10-695.PMC4014378.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/74/0c/amep-5-103.PMC4014379.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 103–105Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  103SHORT REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6227 7An integrable, web-based solution for easy  assessment of video-recorded performances Y ousif Subhi1,2,3 T obias T odsen1,4 Lars Konge1,2 1Centre for Clinical Education,   Centre for HR, The Capital Region  of Denmark, Copenhagen, Denmark;   2University of Copenhagen,   Copenhagen, Denmark; 3Clinical  Eye Research Unit, Department  of Ophthalmology, Copenhagen  University Hospital Roskilde,   Roskilde,  Denmark; 4Department of  Internal Medicine, Queen Ingrid’s  Hospital, Nuuk, Greenland Correspondence: Yousif Subhi   Centre for Clinical Education,   Section  5404, Copenhagen University  Hospital Rigshospitalet,   Blegdamsvej  9, DK-2100 Copenhagen  East, Denmark   Tel +45 28 74 60 55  Email ysubhi@gmail.co mAbstract:  Assessment of clinical competencies by direct observation is problematic for two main  reasons: the identity of the examinee influences the assessment scores, and direct observation  demands experts at the exact location and the exact time.",Non-OADS,/arxiv_data1/oa_pdf/74/0c/amep-5-103.PMC4014379.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/74/0c/amep-5-103.PMC4014379.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/0c/amep-5-103.PMC4014379.pdf
Available from: http://www.vimeo.com /.,Non-OADS,/arxiv_data1/oa_pdf/74/0c/amep-5-103.PMC4014379.pdf
Available from: http://db-engines.com/en/ranking /.,OADS,/arxiv_data1/oa_pdf/74/0c/amep-5-103.PMC4014379.pdf
Available from: http://isea.cekukurser.dk/download.zip .,Non-OADS,/arxiv_data1/oa_pdf/74/0c/amep-5-103.PMC4014379.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/e3/cmar-6-217.PMC4014380.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 217–224Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  217Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S4015 1Future of bisphosphonates and denosumab for  men with advanced prostate cancer Maryam iranikhah Steve Stricker Maisha Kelly Freeman Samford University, Mc whorter  School of Pharmacy, Birmingham,    AL, USA Correspondence: Maryam iranikhah   Samford University, Mcwhorter School  of Pharmacy 800 Lakeshore Drive,  Birmingham, AL 35229, USA   Tel +1 205 726 2086   Fax +1 205 726 2669   email miranikh@samford.ed uAbstract : Prostate cancer is the most common cancer occurring in American men of all races.",Non-OADS,/arxiv_data1/oa_pdf/30/e3/cmar-6-217.PMC4014380.pdf
"Atlanta, GA,  USA: Department of Health and Human Services, Centers for Disease  Control and Prevention and National Cancer Institute; 2013 Available  from: http://www.cdc.gov/USC S. Accessed October 30, 2013.",Non-OADS,/arxiv_data1/oa_pdf/30/e3/cmar-6-217.PMC4014380.pdf
"Available from: http://seer.cancer.gove/statfacts/html/prost.htm l.  Accessed October 30, 2013.",Non-OADS,/arxiv_data1/oa_pdf/30/e3/cmar-6-217.PMC4014380.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/30/e3/cmar-6-217.PMC4014380.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/e3/cmar-6-217.PMC4014380.pdf
Available from: http://www.nccn.org/professionals/ physician gls/pdf/prostate.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/e3/cmar-6-217.PMC4014380.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/cb/opth-8-837.PMC4014381.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 837–842Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  837Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5667 0Journal name: Clinical Ophthalmology Journal Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Venkateswaran et al Running head recto: Recurrent nontuberculous mycobacterial endophthalmitis DOI: http://dx.doi.org/10.2147/OPTH.S56670 recurrent nontuberculous mycobacterial  endophthalmitis: a diagnostic conundrum Nandini Venkateswaran1 Gabrielle Yeaney2 Mina Chung3,4 Holly B Hindman3,4 1University of rochester school  of Medicine and Dentistry, University  of rochester, 2Department of  pathology and Laboratory Medicine,   3Flaum eye Institute, 4Center  for Visual science, University of  rochester school of Medicine  and Dentistry, rochester, NY, UsaObjective:  To report a case of recurrent nontuberculous mycobacterial endophthalmitis in  the context of neurotrophic keratopathy secondary to herpes zoster ophthalmicus that had an  atypical presentation and complex course, and highlights the challenges of causative organism  identification and therapeutic interventions in this condition.",Non-OADS,/arxiv_data1/oa_pdf/3c/cb/opth-8-837.PMC4014381.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3c/cb/opth-8-837.PMC4014381.pdf
"Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 842Venkateswaran et al given the rapidly rising resistance to antimicrobials within  RGNTM strains.18 Acknowledgments The authors wish to thank the Flaum Eye Institute’s Diagnos - tic Imaging Service for obtaining the clinical images, Adam  Weis for obtaining diagnostic images with fluorescence  microscopy, and Susan Raub for assisting us with PCR and  gene sequencing of our mycobacterial isolates.",Non-OADS,/arxiv_data1/oa_pdf/3c/cb/opth-8-837.PMC4014381.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/72/mder-7-091.PMC4014382.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 91–97Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  91ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S6183 9Validation of the integration of technology  that measures additional “vascular” indices into  an ambulatory blood pressure monitoring system Yulia V Kotovskaya1 Zhanna D Kobalava1 artemy V Orlov2 1Propedeutics Department, Peoples’  Friendship University   of Russia,  2competitive system  analysis Department (n o 65),  national Research nuclear   University MEPhi, Moscow, Russia correspondence: artemy V Orlov   competitive systems analysis  Department (no  65), national Research  nuclear University MEPhi, Kashirskoye  shosse  31, Moscow  115409, Russia   Tel +7 499 324 8766  Fax +7 499 324 2111  Email artemy.orlov@mail.r uBackground:  The objective of this study was to validate the novel integration of oscillometric  (Vasotens®) technology into a BPLab® ambulatory blood pressure (BP) monitoring system to  measure central BP , the aortic augmentation index, and pulse wave velocity (PWV) compared  with the recommended and widely accepted tonometric method.",Non-OADS,/arxiv_data1/oa_pdf/f5/72/mder-7-091.PMC4014382.pdf
"Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2014:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 97additional “vascular” indices integrated into an aBPM system  3. International Society for Chronobiology; American Association of  Medical Chronobiology and Chronotherapeutics; Spanish Society of  Applied Chronobiology, Chronotherapy, and Vascular Risk; Spanish  Society of Atherosclerosis; Romanian Society of Internal Medicine;  Hermida RC, Smolensky MH, Ayala DE, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/72/mder-7-091.PMC4014382.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/3d/cpaa-6-079.PMC4014383.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2014:6 79–86Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  79ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S6146 2Effects of irbesartan on serum uric acid levels   in patients with hypertension and diabetes Makiko Nakamura1 Nobuo Sasai2 Ichiro Hisatome3 Kimiyoshi Ichida1 1Department of Pathophysiology,   T okyo University of Pharmacy  and Life Sciences, T okyo, Japan;   2Sasai Clinic, Kanagawa, Japan;   3Division of Regenerative Medicine  and Therapeutics, Institute of  Regenerative Medicine and  Biofunction, Graduate School of  Medical Sciences, T ottori University,   T ottori, Japan Correspondence: Kimiyoshi Ichida   Tokyo University of Pharmacy and Life  Sciences, 1432-1 Horinouchi,   Hachiouji, Tokyo, Japan   Tel +81 42 676 5680   Fax +81 42 676 5680   Email ichida@toyaku.ac.j pBackground:  Hyperuricemia has been proposed to be a risk factor for cardiovascular disease  and chronic kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/2b/3d/cpaa-6-079.PMC4014383.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/2b/3d/cpaa-6-079.PMC4014383.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/3d/cpaa-6-079.PMC4014383.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/4c/copd-9-421.PMC4014384.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 421–430International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  421RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5101 2Corticosteroids in the treatment of acute  exacerbations of chronic obstructive   pulmonary disease J Andrew woods1 James S wheeler1 Christopher K Finch2 Nathan A Pinner3 1School of Pharmacy, wingate  University, wingate, NC, USA;   2Department of Pharmacy, Methodist  University Hospital, Memphis, TN,   USA;  3Harrison School of Pharmacy,   Auburn University, Auburn, AL, USA Correspondence: J Andrew woods   School of Pharmacy, Levine College   of Health Sciences, wingate University,   515 North Main Street, wingate,   NC 28174, USA   Tel +1 704 233 8646  Fax +1 704 233 8332  email a.woods@wingate.ed uBackground:  Chronic obstructive pulmonary disease (COPD) is a chronic and progressive  disease that affects an estimated  10% of the world’ s population over the age of  40 years.",Non-OADS,/arxiv_data1/oa_pdf/92/4c/copd-9-421.PMC4014384.pdf
Available from:  http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_ Feb20.pdf .,OADS,/arxiv_data1/oa_pdf/92/4c/copd-9-421.PMC4014384.pdf
Available from: http://guidance.nice.org.uk/cg101 .,Non-OADS,/arxiv_data1/oa_pdf/92/4c/copd-9-421.PMC4014384.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/92/4c/copd-9-421.PMC4014384.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/4c/copd-9-421.PMC4014384.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/47/ijn-9-2117.PMC4014385.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2117–2126International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2117OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5756 5Formulation and delivery of itraconazole   to the brain using a nanolipid carrier system Wei Meng lim1 Paruvathanahalli  siddalingam rajinikanth2 chitneni Mallikarjun1 Yew Beng Kang1 1school of Pharmacy, International  Medical University, Kuala lumpur,   Malaysia; 2school of Pharmacy, Taylor’s  University, selangor, Malaysia correspondence: Wei Meng lim   school of Pharmacy, International   Medical University, 126, Jalan Jalil   Perkasa 19, Bukit Jalil, 57000,   Kuala lumpur, Malaysia   Tel +60 3 2731 7486   Fax +60 3 8656 7229   email weimeng_lim@imu.edu.m yAbstract:  The objectives of this study were to develop and characterize itraconazole (ITZ)- loaded nanostructured lipid carriers (NLCs) and to study their potential for drug delivery into  the brain.",Non-OADS,/arxiv_data1/oa_pdf/c5/47/ijn-9-2117.PMC4014385.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c5/47/ijn-9-2117.PMC4014385.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/47/ijn-9-2117.PMC4014385.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/jaa-7-077.PMC4014386.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Asthma and Allergy 2014:7 77–83Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  77Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S3962 5New combination treatments in the management  of asthma: focus on fluticasone/vilanterol Laren D Tan1,2 Andrew L Chan1,2 Timothy e Albertson1–3 1Division of Pulmonary, Critical Care  and Sleep Medicine, Department of  internal Medicine, School of Medicine,  University of California, Davis,  Sacramento, CA, 2Department of  Medicine, veterans Administration  Northern California Health Care  System, Mather, CA, 3Department  of emergency Medicine, School of  Medicine, University of California,  Davis, Sacramento, CA, USA Correspondence: Te Albertson   Division of Pulmonary, Critical Care and  Sleep Medicine, Department of internal  Medicine, PSSB 3400, 4150 v Street,  Sacramento, CA 95817, USA   Tel +1 916 734 3564   Fax +1 916 734 7924   email tealbertson@ucdavis.ed uAbstract:  Despite the 2007 National Asthma Education and Prevention Program Expert Panel 3  guidelines for the treatment of uncontrolled asthma, many patients with poorly controlled asthma  still continue to tax the health care system.",Non-OADS,/arxiv_data1/oa_pdf/8d/9a/jaa-7-077.PMC4014386.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/8d/9a/jaa-7-077.PMC4014386.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/jaa-7-077.PMC4014386.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/b1/ijwh-6-429.PMC4014387.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 429–435International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  429RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4094 2Past, present, and future of hormonal therapy   in recurrent endometrial cancer Matthew J Carlson Kristina W Thiel Kimberly K Leslie Department of Obstetrics and  Gynecology, University of Iowa,    Iowa City, IA, USA Correspondence: Kimberly K Leslie   Department of Obstetrics and  Gynecology, University of Iowa, 200  Hawkins Drive, Iowa City, IA 52242, USA   Tel +1 319 356 1976   email kimberly-leslie@uiowa.ed uAbstract:  Endometrial cancer is a heterogeneous disease.",Non-OADS,/arxiv_data1/oa_pdf/c2/b1/ijwh-6-429.PMC4014387.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c2/b1/ijwh-6-429.PMC4014387.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/b1/ijwh-6-429.PMC4014387.pdf
"1-3 Functionally, the SAC negatively regulates the  ability of Cdc20 to activate anaphase-promoting complex or  *Correspondence to: Richard Bertrand; Email: richard.bertrand@umontreal.ca Submitted: 01/09/2014; Revised: 02/13/2014; Accepted: 02/19/2014; Published Online: 03/03/2014http://dx.doi.org/10.4161/cc.28293Phospho-Bcl-xL(Ser62) influences spindle  assembly and chromosome segregation   during mitosis Jianfang Wang1, Myriam Beauchemin1, and Richard Bertrand1,2,* 1Centre de recherche; Centre hospitalier de l’Université de Montréal (CRCHUM) and Institut du Cancer de Montréal; Montréal, Québec, Canada; 2Département de médecine;  Université de Montréal; Montréal, Québec, Canada Keywords:  Bcl-xL, mitosis, PLK1, MAPK14/SAPKp38 α, chromosome segregation, spindle-assembly checkpoint,   chromosome instability Abbreviations:  Ab, antibody; APC/C, anaphase-promoting complex/cyclosome; Bcl-xl, Bcl2-associated x protein (long isoform)  or Bcl2-like protein 1 (long isoform); Bub, budding uninhibited by benzimidazole protein; Cdc, cell division cycle protein; Cdk,  cyclin-dependent kinase; CENPA, centromere protein A; CHK1, checkpoint kinase 1; CLIP170, cytoplasmic linker protein 170;  DIC, differential interference contrast; FBS, fetal bovine serum; GFP, green fluorescence protein; GSK3, glycogen synthase kinase  3; HA tag, influenza hemagglutinin tag; HEC1, highly expressed in cancer protein 1; H2B, histone 2B; H3, histone 3; JNK,  Jun N-terminal kinase; Mad, mitotic arrest deficient protein; MAPK, mitogen-activated protein kinase; MAPKAPK2, mitogen- activated protein kinase-activated protein kinase 2; MPS1, monopolar spindle 1 kinase; PI, propidium iodide; PLK, polo kinase;  SAC, spindle-assembly checkpoint; SAPK, stress-activated protein kinase; siRNA, small interfering RNA; wt, wild-type Functional analysis of a series of phosphorylation mutants reveals that Bcl-xL(Ser62Ala) influences cell entry into  anaphase and mitotic exit in taxol-exposed cells compared with cells expressing wild-type Bcl-xL or a series of other  phosphorylation mutants, an effect that appears to be independent of its anti-apoptotic activity.",Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Nat Rev Mol Cell Biol  2007; 8:379-93;  PMID:17426725 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Nat Rev Mol Cell Biol 2009; 10:478-87; PMID:19546858 ; http://dx.doi.org/10.1038/ nrm2718 3.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Curr Biol 2012; 22:R966- 80; PMID:23174302 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Dev Cell 2010;  18:533-43;  PMID:20412769 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Cell Biol 2010; 189:247-59;  PMID:20404109 ; http://dx.doi.org/10.1083/ jcb.200909144 6.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Chromosome Res 2004; 12:599-616;  PMID:15289666 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Genes Dev  1998; 12:1871-83;  PMID:9637688 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Cell Biol 2001; 154:925-36;  PMID :11535616 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Dev Cell 2001; 1:227-37; PMID:11702782 ; http://dx.doi.org/10.1016/ S1534-5807(01)00019-3 12.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Mol Biol Cell 2002; 13:755-66; PMID:11907259 ; http://dx.doi.org/10.1091/ mbc.01-09-0437 13.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Nat Cell Biol 2003; 5:748-53; PMID:12855955 ;  http://dx.doi.org/10.1038/ncb1022 14.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Zhejiang Univ Sci B 2007; 8:377- 97; PMID:17565509 ; http://dx.doi.org/10.1631/ jzus.2007.B0377 15.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Adv Exp Med Biol 2010; 687:1-32;  PMID:20919635 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Biol Chem 2000; 275:29980- 5; PMID:10913135 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Oncogene  2005; 24:107-17;  PMID :15531923 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Oncogene 2009; 28:107-16;  PMID:18820703 ; http://dx.doi.org/10.1038/ onc.2008.368 21.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Mol Cell Biol 2010; 30:640- 56; PMID:19917720 ; http://dx.doi.org/10.1128/ MCB.00882-09 22.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
EMBO J  1997; 16:968-77;  PMID:9118958 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Oncogene 2007; 26:5851-65; PMID:17369848 ;  http://dx.doi.org/10.1038/sj.onc.1210396 25.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Cell Signal  2011; 23:2030-8;  PMID:21840391 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Cell Cycle 2012; 11:2159-69;  PMID:22617334 ; http://dx.doi.org/10.4161/ cc.20672 27.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Biol Chem 2008; 283:35517-25; PMID:18974096 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Cell  Death Differ 2013; 20:920-30;  PMID:23519076 ;  http://dx.doi.org/10.1038/cdd.2013.19 29.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Cell  1993; 74:597-608;  PMID:8358789 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Oncogene  2004 ; 23:3915-31;  PMID:15048082 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Trends Biochem Sci 2012; 37:534-42;  PMID:23141205 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Curr  Opin Cell Biol 2008; 20:650-60; PMID:19000759 ;  http://dx.doi.org/10.1016/j.ceb.2008.10.005 34.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Nat Rev Mol Cell Biol 2009; 10:265- 75; PMID:19305416 ; http://dx.doi.org/10.1038/ nrm2653 35.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Science 1998; 280:599-602; PMID:9554853 ; http://dx.doi.org/10.1126/ science.280.5363.599 36.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Biol Chem 2007; 282:22984- 92; PMID:17548358 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Cell Cycle 2005; 4:1385- 8; PMID:16138009 ; http://dx.doi.org/10.4161/ cc.4.10.2061 39.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Curr Biol 2006;  16:1194-200;  PMID:16782009 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Cancer Cell 2008; 14:111-22;  PMID:18656424 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Mol  Cancer Ther 2009; 8:1646-54; PMID:19509263 ;  http://dx.doi.org/10.1158/1535-7163.MCT-08-1084 42.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Cell Biol 2009; 186:675-84; PMID:19720871 ;  http://dx.doi.org/10.1083/jcb.200906150 43.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Nature 2007; 446:921-5;  PMID:17443186 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Nature 2007; 446:876-81; PMID:17443180 ; http://dx.doi.org/10.1038/ nature05694 45.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Dev Cell 2009; 16:105- 17; PMID:19154722 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Nat Cell Biol 2005; 7:137-47; PMID :15619620 ;  http://dx.doi.org/10.1038/ncb1215 50.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
EMBO J  2001; 20:2596-607;  PMID:11350949 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Oncogene 2006; 25:3196-205; PMID:16407825 ;  http://dx.doi.org/10.1038/sj.onc.120934452.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Mol Cell 2008; 29:488-98; PMID:18313386 ;  http://dx.doi.org/10.1016/j.molcel.2007.12.029 54.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Biol Chem 1997; 272:11671-3;  PMID :9115213 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Biol Chem 1998; 273:30777-84;  PMID:9804855 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
J Biol Chem 1998; 273:18984- 91; PMID:9668078 ; http://dx.doi.org/10.1074/ jbc.273.30.18984 58.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Leukemia 2001; 15:869-74;   PMID:11417471 ; http://dx.doi.org/10.1038/ sj.leu.2402134 62.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Oncogene 2004; 23:2016-27; PMID:15021889 ; http://dx.doi.org/10.1038/ sj.onc.1207374 63.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Nat Rev Cancer 2005; 5:773-85; PMID:16195750 ;  http://dx.doi.org/10.1038/nrc1714 64.,Non-OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Semin Cell Dev Biol 2011; 22:595-601; PMID:21392584 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Nat Cell Biol 2013; 15:96- 102; PMID :23242215 ; http://dx.doi.org/10.1038/ ncb2643 67.,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
Methods Enzymol 2012; 505:81- 103; PMID:22289449 ; http://dx.doi.org/10.1016/ B978-0-12-388448-0.00013-9,OADS,/arxiv_data1/oa_pdf/ae/87/cc-13-1313.PMC4014433.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/vhrm-10-253.PMC4014451.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 253–261Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  253ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/VHRM.S6136 3serum uric acid and target organ damage   in essential hypertension sandra n Ofori Osaretin J Odia Department of internal Medicine,   University of Port Harcourt Teaching  Hospital, Port Harcourt, Rivers state,   nigeria correspondence: sandra n Ofori   Department of internal Medicine,  University of Port Harcourt Teaching  Hospital, P.M.B 6173 Port Harcourt,  Rivers state, nigeria   Tel +234 080 96598508   email sandytom77@yahoo.co mBackground:  Hypertension is a major risk factor for cardiovascular mortality, as it acts through  its effects on target organs, such as the heart and kidneys.",Non-OADS,/arxiv_data1/oa_pdf/d1/f6/vhrm-10-253.PMC4014451.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/d1/f6/vhrm-10-253.PMC4014451.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/vhrm-10-253.PMC4014451.pdf
"Mobile Genetic Elements 2014; 4:e28907; http://dx.doi.org/10.4161/mge.28907 *Correspondence to: Gael Cristofari;   Email: Gael.Cristofari@unice.fr Commentary to: Monot C, Kuciak M, Viollet S, Mir AA, Gabus C, Darlix JL, Cristofari G. The specificity and flexibility of l1 reverse transcrip - tion priming at imperfect T-tracts.",Non-OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
PLoS Genet 2013; 9:e1003499; PMID:23675310; http://dx.doi.org/10.1371/journal.pgen.1003499,Non-OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
PLoS Genet  2011; 7:e1002384;  PMID:22144907 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Curr Opin  Genet Dev 2012; 22:191-203; PMID:22406018 ;  http://dx.doi.org/10.1016/j.gde.2012.02.006 3.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nature  1988; 332:164-6;  PMID:2831458 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Cell 2013; 153:101-11;  PMID:23540693 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Genome Res  2012; 22:2328-38;  PMID:22968929 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Science 2012; 337:967-71; PMID:22745252 ;  http://dx.doi.org/10.1126/science.1222077 8.,Non-OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Cell 2010; 141:1253- 61; PMID:20603005 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
PLoS Genet 2013; 9:e1003402; PMID:23555307 ;  http://dx.doi.org/10.1371/journal.pgen.1003402 11.,Non-OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Proc Natl Acad Sci U S A 2003;  100 :13815-20 ;  PMID :14615577 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nat Struct Mol Biol 2011; 18:1006- 14; PMID:21822284 ; http://dx.doi.org/10.1038/ nsmb.2097,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Mol Cell Biol 2001; 21:467- 75; PMID:11134335 ; http://dx.doi.org/10.1128/ MCB.21.2.467-475.2001 15.,Non-OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Science 1991; 254:1808-10; PMID:1722352 ; http://dx.doi.org/10.1126/ science.1722352 16.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Cell  1996; 87:905-16;  PMID:8945517 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nat Struct Mol Biol 2006; 13:655-60; PMID:16783376 ; http://dx.doi.org/10.1038/ nsmb1107 18.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
PLoS Genet 2010; 6:6; PMID:20949108 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Cell  1993; 72:595-605;  PMID:7679954 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
EMBO J 2002; 21:5899-910; PMID :12411507 ;  http://dx.doi.org/10.1093/emboj/cdf592 21.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Cell  1996; 87:917-27;  PMID:8945518 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Cell 2002 ; 110 :315-25;  PMID:12176319 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nat Genet 2002; 31:159- 65; PMID:12006980 ; http://dx.doi.org/10.1038/ ng89826.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nucleic Acids Res 2007; 35:3741- 51; PMID:17517773 ; http://dx.doi.org/10.1093/nar/ gkm317 27.,Non-OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nature 2007; 446:208-12; PMID:17344853 ; http://dx.doi.org/10.1038/ nature05560 28.,Non-OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
PLoS Genet 2013; 9:e1003499;  PMID:23675310 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Genome Biol  2002; 3:h0052;  PMID:12372140 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Gene 2007; 390:190- 8; PMID:17067767 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nucleic Acids Res  2007; 35:4914-26;  PMID:17626046 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Proc Natl Acad Sci U S A 2006; 103:17602- 7; PMID:17105809 ; http://dx.doi.org/10.1073/ pnas.060547610336.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Mol Cell Biol 2005;  25:6617-28;  PMID:16024797 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nat Struct Mol Biol 2013;  20:454-60;  PMID:23474713 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nucleic  Acids Res 2013; 41:7401-19; PMID:23749060 ;  http://dx.doi.org/10.1093/nar/gkt512 40.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Nucleus 2012; 3:16-21; PMID :22156744 ;  http://dx.doi.org/10.4161/nucl.18929 41.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Proc Natl Acad Sci U S A 2011; 108:20345-50; PMID:21940498 ; http://dx.doi.org/10.1073/ pnas.1100275108 42.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
Proc Natl Acad Sci U S A 1996; 93:10712- 7; PMID:8855245 ; http://dx.doi.org/10.1073/ pnas.93.20.10712 43.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
FEBS Lett 2010; 584:3703-8; PMID:20691183 ;  http://dx.doi.org/10.1016/j.febslet.2010.07.057 45.,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
J  Biol Chem 2008; 283:1197-208;  PMID:18025084 ;  http://dx.doi.org/10.1074/jbc.M706734200,OADS,/arxiv_data1/oa_pdf/f2/9c/mge-4-e28907.PMC4014453.pdf
"Biomatter 2014; 4:e28536; PMID: 24646905; http://dx.doi.org/10.4161/biom.28536The role of dialysis and freezing   on structural conformation, thermal properties  and morphology of silk fibroin hydrogels Marta Ribeiro1,2,*, Mariana A de Moraes3, Marisa M Beppu3, Fernando J Monteiro1,2, and Maria p Ferraz1,4 1Instituto de e ngenharia Biomédica; Universidade do p orto; p orto, p ortugal; 2Departamento de e ngenharia Metalúrgica e Materiais; Universidade do p orto; p orto, p ortugal;  3Faculdade de e ngenharia Química; Universidade e stadual de Campinas; Campinas, Brasil; 4Centro de e studos em Biomedicina; Universidade Fernando p essoa; p orto, p ortugal Keywords:  biomaterials; biopolymer; silk fibroin; gelation; scaffold Silk fibroin has been widely explored for many biomedical applications, due to its biocompatibility and  biodegradability.",Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials 2006; 27:5480-9;   PMID:16857254 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomacromolecules  2009 ;  10:1575 -83; PMID:19348419 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Chem Eng Res Des 2007 ; 85:1051 -64; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials  2003 ; 24:401- 16; PMID:12423595 ; http://dx.doi.org/10.1016/ S0142-9612(02)00353-8 5.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials  2006 ; 27:6064 -82;  PMID:16890988 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Eur J Biochem 1999 ;  259:120-6; PMID:9914483 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biotechnol Lett  2003 ;  25:1805 -9; PMID:14677702 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials   2002 ; 23:4131 -41; PMID :12182315 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Eur J Pharm Biopharm  2005 ; 60:373-81; PMID :15996578 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Tissue Eng  2006 ; 12:3383 -94; PMID:17518675 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials  2006 ; 27:6064 -82;  PMID:16890988 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials  2006 ; 27:3115 -24;  PMID:16458961 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomacromolecules  2004 ; 5:786-92;  PMID :15132662 ; http://dx.doi.org/10.1021/ bm0345460 15.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
J  Am Chem Soc 2002 ; 124:8794 -5; PMID:12137522 ;  http://dx.doi.org/10.1021/ja020244e 16.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Macromol  Mater Eng  2006 ; 291:458-62; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Polymers  2010 ;  2:719-27; http://dx.doi.org/10.3390/polym2040719 18.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Russ J Appl Chem 2006 ; 79:869-76; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Mat Sci Eng C-Mater  2011 ; 31:997-1001 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Int J Pharm 2010 ; 388:242-50;  PMID:20060449 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials  2008 ; 29:1054 -64; PMID:18031805 ;  http://dx.doi.org/10.1016/j.biomaterials.2007.11.00322.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
J Nanomater 2013 ;2013 ;  http://dx.doi.org/10.1155/2013/832710 23.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Prog Polym Sci 2010 ;  35:1093 -115; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Macromol Biosci  2008 ; 8:807-18; PMID:18702171 ;  http://dx.doi.org/10.1002/mabi.200800113 25.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials   2002 ; 23:4765 -73; PMID:12361615 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
J Mater Sci 2001 ; 36:2523 -7; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Adv Mater  2007 ; 19:1529 -33;  http://dx.doi.org/10.1002/adma.200700154 28.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials  2005 ;  26:2775 -85; PMID :15585282 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Int J Biol Macromol 2005 ; 36:66-70;  PMID:15916801 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Polym Int  2005 ; 54:1076 -81; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Macromolecules  2005 ; 38:5640 -6; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomacromolecules  2011 ; 12:1686 - 96; PMID:21425769 ; http://dx.doi.org/10.1021/ bm200062a,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Macromolecules  2006 ;  39:6161-70; http://dx.doi.org/10.1021/ma0610109 34.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Acta Biomater  2010 ; 6:1380 -7; PMID:19874919 ;  http://dx.doi.org/10.1016/j.actbio.2009.10.041 35.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Particul  Sci Technol  2013 ; 31:379-84; http://dx.doi.org/10.1 080/02726351.2013.766289 36.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
J Appl Polym Sci 2001 ; 80:1848 - 53; http://dx.doi.org/10.1002/app.1281 37.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
J Appl Polym  Sci 2009 ; 114:617-23; http://dx.doi.org/10.1002/ app.30627 39.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Adv  Drug Deliv Rev 2007 ; 59:207-33; PMID:17482309 ;  http://dx.doi.org/10.1016/j.addr.2007.03.012 40.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
J Phys Chem B 2006 ; 110:21630 - 8; PMID:17064118 ; http://dx.doi.org/10.1021/ jp056350v41.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
J Appl Polym  Sci 1996 ; 60:1619 -27; http://dx.doi.org/10.1002/ (SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-# 42.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Int J Biol Macromol  1999 ; 24:251-63; PMID:10342772 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Chem Pharm Bull (Tokyo) 2006 ; 54: 156- 62; PMID:16462057 ; http://dx.doi.org/10.1248/ cpb.54.156 44.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomacromolecules   2004 ; 5:718-26; PMID :15132652 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Colloids Surf B Biointerfaces   2014 ; 113:352-60; PMID:24121078 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Int J Biol Macromol 2010 ; 46:199-205;  PMID:19941890 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Mater Sci Eng C Mater Biol Appl  2013 ; 33:4777 -85; PMID:24094187 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
J Chem Technol Biotechnol  2011 ; 86:172-84; http://dx.doi.org/10.1002/ jctb.2495 49.,Non-OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials  2005 ; 26:3961 - 71; PMID:15626443 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
J Biomater Sci  Polym Ed  2004 ; 15:1341 -53; PMID:15648567 ;  http://dx.doi.org/10.1163/1568562042368103 51.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
Biomaterials  2002 ; 23:2827 -34; PMID:12069321 ;  http://dx.doi.org/10.1016/S0142-9612(01)00399-4 53.,OADS,/arxiv_data1/oa_pdf/84/38/biom-4-e28536.PMC4014454.pdf
"Biomatter 2014; 4:e27979; PMID: 24509417; http://dx.doi.org/10.4161/biom.27979Grafting of a model protein on lactide   and caprolactone based biodegradable films   for biomedical applications Aitor Larrañaga1,2, Andrée-Anne Guay-Bégin1,2, pascale Chevallier2,3, Gad Sabbatier2,3, Jorge Fernández1, Gaétan Laroche2,3,  and Jose-Ramon Sarasua1,* 1Department of Mining-Metallurgy e ngineering and Materials Science; po LYMA t; University of the Basque Country (U pV/eHU); School of e ngineering; Bilbao, Spain;  2Laboratoire d’Ingénierie de Surface (LIS); Centre de recherche du CHU de Québec; Hôpital Saint-François d’Assise; Québec, QC Canada; 3Département de génie des mines, de  la métallurgie et des matériaux; Centre de Recherche sur les Matériaux Avancés (C eRMA); Université Laval; Québec, QC Canada Keywords:  poly(lactide/ ε-caprolactone), terpolymer, surface modification, albumin, grafting, hydrolytic degradation thermoplastic biodegradable polymers displaying elastomeric behavior and mechanical consistency are greatly  appreciated for the regeneration of soft tissues and for various medical devices.",Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Biomaterials 2012; 33:5683-95; PMID:22594970 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Biomater Sci Polym Ed 2010; 21:1173-90; PMID:20507714 ; http://dx.doi.org/10.1163/09205 0609X12471222313524 3.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J R Soc Interface 2011; 8:671- 7; PMID:21106575 ; http://dx.doi.org/10.1098/ rsif.2010.0520 4.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Mech Behav  Biomed Mater 2012; 9:100-12; PMID:22498288 ;  http://dx.doi.org/10.1016/j.jmbbm.2012.01.003 5.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Mech Behav Biomed Mater 2012; 12:29-38;  PMID:22659093 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Polym Degrad Stabil 2013; 98:481-9; http://dx.doi.org/10.1016/j.polymdegradstab.2012.12.0147.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Appl Polym Sci 1996; 59:1299-304; http://dx.doi.org/10.1002/ (SICI)1097-4628(19960222)59:8<1299::AID- APP13>3.0.CO;2-1 8.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Biomed Mater Res A 2013; In  press;  PMID:24243562 ; http://dx.doi.org/10.1002/ jbma.35036 .,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Biomaterials 2004; 25:5499-55;  PMID :15142731 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Biomaterials 1995; 16:25-31;  PMID:7718688 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Macromol Biosci 2007; 7:738- 45; PMID:17457945 ; http://dx.doi.org/10.1002/ mabi.200600267 12.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Biomaterials  2005; 26:7402-9;  PMID:16005960 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Biomaterials 2006; 27:68- 78; PMID:16005962 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Biomacromolecules 2008; 9:901-5;  PMID:18247564 ;  http://dx.doi.org/10.1021/bm701267u 15.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Biomacromolecules  2009; 10:2351-78;  PMID:19655722 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Plasma Process  Polym 2011; 8:171-90; http://dx.doi.org/10.1002/ppap.201000153 17.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Biomaterials 2002; 23:2411-28;  PMID:12013189 ; http://dx.doi.org/10.1016/ S0142-9612(01)00377-5 18.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Acta Biomater 2012 ; 8:2969 -77; PMID:22522130 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Biomater Sci Polym Ed 2007;  18:369-82;  PMID:17540114 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Radiat Phys Chem  2008; 77:280-7; http://dx.doi.org/10.1016/j.radphyschem.2007.05.013,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Biomed Mater Res A 2005; 75:138- 45; PMID:16044403 ; http://dx.doi.org/10.1002/ jbm.a.30397 22.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Polym Environ 2001; 9:63-84; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Prog Polym Sci 2002; 27:1123-63; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Appl Polym Sci 2003; 89:86-103; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Jpn J Appl  Phys 2007; 46:4238-45; http://dx.doi.org/10.1143/ JJAP.46.4238 28.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Plasma Chem Plasma  Process 2012; 32:17-33; http://dx.doi.org/10.1007/ s11090-011-9330-3 29.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Plasmas  Polym 1996; 1:91-112; http://dx.doi.org/10.1007/BF02532821 30.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Colloids Surf B Biointerfaces 2013;  102:45-52;  PMID:23000676 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Phys  D Appl Phys 2006; 39:3461-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Langmuir 2009; 25:9432-40; PMID:19572502 ;  http://dx.doi.org/10.1021/la900652y 33.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Appl Polym Sci 2012; 125:239-47;  http://dx.doi.org/10.1002/app.36827 34.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
React Funct Polym 2009; 69:287-92; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Biomed Mater Res A 2005; 75:767- 77; PMID:16121386 ; http://dx.doi.org/10.1002/ jbm.a.30487 36.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Polym  Sci A Polym Chem 2007; 45:2755-64; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Polym Degrad Stabil  2013; 98:751-8; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Mol Struct  2001; 596:69-75; http://dx.doi.org/10.1016/ S0022-2860(01)00688-339.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Circulation 2008; 118:2563- 70; PMID:19029464 ; http://dx.doi.org/10.1161/ CIRCULATIONAHA.108.795732 40.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Arterioscler Thromb Vasc Biol 2007; 27:1500-10; PMID:17510464 ; http://dx.doi.org/10.1161/ ATVBAHA.107.144220 41.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Am Coll Cardiol 2006;  47:2108-11;  PMID:16697331 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
Polymer (Guildf) 2013; 54:2621- 31; http://dx.doi.org/10.1016/j.polymer.2013.03.009 43.,OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
J Phys Chem B 2001; 105:12490-7; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/07/biom-4-e27979.PMC4014455.pdf
"Artificial DNA: PNA & XNA 2014; 5:e27896; PMID: 24488125; http://dx.doi.org/10.4161/adna.27896Universal strategies for the DNA-encoding   of libraries of small molecules using the chemical  ligation of oligonucleotide tags alexander Litovchick, Matthew a c lark, and a nthony D Keefe* X-chem Pharmaceuticals; Waltham, M a Usa Keywords:  chemical ligation, click chemistry, combinatorial chemistry, drug discovery, modified nucleotide, photochemistry,  polymerase, template-dependent polymerization, unimolecular information recording and retrieval, in vitro selection The affinity-mediated selection of large libraries of DN a-encoded small molecules is increasingly being used to  initiate drug discovery programs.",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Proc Natl Acad Sci U S A 1992; 89:5381- 3; PMID:1608946 ; http://dx.doi.org/10.1073/ pnas.89.12.5381 2.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
J Am Chem Soc 2001; 123:6961-3; PMID:11448217 ; http://dx.doi.org/10.1021/ ja015873n 4.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Angew Chem Int Ed Engl 2002; 41:1796-800;  PMID:19750721 ; http://dx.doi.org/10.1002/1521- 3773(20020517)41:10<1796::AID-ANIE1796>3.0.CO;2-Z 5.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Science  2004; 305:1601-5;  PMID :15319493 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
PLoS Biol  2004; 2:E173;  PMID:15221027 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
PLoS Biol 2004; 2:E174;  PMID:15221028 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
PLoS Biol 2004; 2:E175; PMID:15221029 ;  http://dx.doi.org/10.1371/journal.pbio.0020175 9.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Nat  Biotechnol 2004; 22:568-74; PMID:15097996 ;  http://dx.doi.org/10.1038/nbt961 10.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Nat Chem Biol  2009; 5:647-54;  PMID:19648931 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
J Am Chem Soc 2009; 131:1322-7; PMID:19123795 ;  http://dx.doi.org/10.1021/ja808558a 12.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
J Med Chem  2012; 55:7061-79;  PMID:22891645 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Bioorg Med Chem Lett  2012; 22:1989-94;  PMID:22310227 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
J Med Chem 2013; 56:3666- 79; PMID:23570514 ; http://dx.doi.org/10.1021/ jm400204k,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Prostaglandins  Other Lipid Mediat 2013; 104-105:25-31;  PMID:23434473 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Bioconjug Chem 2008; 19:778- 85; PMID:18254582 ; http://dx.doi.org/10.1021/ bc7004347 17.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
J Am Chem Soc 2010; 132:11779-91;  PMID:20681606 ; http://dx.doi.org/10.1021/ ja104903x 18.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Chem Biol 2009; 16:1075-86; PMID:19875081 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
ChemMedChem 2010; 5:584-90; PMID:20229565 ;  http://dx.doi.org/10.1002/cmdc.200900520 21.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Chemistry  2012; 18:7729-37;  PMID:22588840 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Bioorg Med Chem Lett  2008; 18:5926-31;  PMID:18674904 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Biochemistry 1966; 5:2722-8; PMID:5968580 ;  http://dx.doi.org/10.1021/bi00872a032 27.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Nucleic Acids Res 1991; 19:4247-51; PMID:1870979 ; http://dx.doi.org/10.1093/ nar/19.15.4247 28.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Nucleic Acids Res 1998; 26:3159-64;  PMID:9628913 ; http://dx.doi.org/10.1093/ nar/26.13.3159 29.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Proc Natl Acad Sci U S A 2011;  108:11338-43;  PMID:21709264 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Proc Natl Acad Sci U S  A 1968; 60:1356-62; PMID:4299945 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
J Am Chem  Soc 1982; 104:6764-9; http://dx.doi.org/10.1021/ ja00388a046 33.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Cold Spring Harb Symp Quant  Biol 1966; 31:77-84; PMID:5237214 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Proc Natl Acad Sci U S A 2001; 98:8319-25; PMID:11459970 ; http://dx.doi.org/10.1073/ pnas.111008398 35.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
J Biol Chem 1999; 274:27481-90; PMID:10488082 ;  http://dx.doi.org/10.1074/jbc.274.39.27481 36.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Nucleic Acids Res 2000; 28:E83;  PMID:10982894 ; http://dx.doi.org/10.1093/ nar/28.18.e83 38.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Adv Drug Deliv Rev 2001; 46:3-26;  PMID:11259830 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Chem Commun (Camb) 2011; 47:6257-9;  PMID:21547301 ; http://dx.doi.org/10.1039/ c1cc10743g 40.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Org Lett 2006; 8:3639- 42; PMID:16898780 ; http://dx.doi.org/10.1021/ ol0610946 41.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
J Am Chem Soc 2007; 129:6859-64; PMID:17488075 ; http://dx.doi.org/10.1021/ ja070273v 42.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Nature 1994; 370:389-91;  PMID:8047147 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/e9/adna-5-e27896.PMC4014522.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e2/9f/srep04793.PMC4014620.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4793 | DOI: 10.1038/srep04793 6",Non-OADS,/arxiv_data1/oa_pdf/e2/9f/srep04793.PMC4014620.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d1/0e/srep04859.PMC4014621.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4859 | DOI: 10.1038/srep04859 10",Non-OADS,/arxiv_data1/oa_pdf/d1/0e/srep04859.PMC4014621.pdf
Geographical distances database (last accessed on 16 june 2013 ) URL: http://www.cepii.fr.,Non-OADS,/arxiv_data1/oa_pdf/53/96/srep04860.PMC4014622.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/96/srep04860.PMC4014622.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4860 | DOI: 10.1038/srep04860 10",Non-OADS,/arxiv_data1/oa_pdf/53/96/srep04860.PMC4014622.pdf
"Available from: http://seer.cancer.gov/ csr/1975_2009_pops09/.based on November 2011 SEER data  submission, posted to the SEER website 2012.",OADS,/arxiv_data1/oa_pdf/d6/ab/SAJC-3-101.PMC4014639.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/c5/f0/SAJC-3-107.PMC4014640.pdf
Start a QR‑code reading software (see  list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR‑code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/13/a6/SAJC-3-112.PMC4014641.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/13/a6/SAJC-3-112.PMC4014641.pdf
Available  at http://www.moh.gov.my/images/gallery/stats/heal_fact/ health_fact_2012_page_by_page.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/9b/SAJC-3-116.PMC4014642.pdf
Available from: http://www.aanos.org/epidemiologyboneca.html.,Non-OADS,/arxiv_data1/oa_pdf/3d/9b/SAJC-3-116.PMC4014642.pdf
Available from: http://www.seriandc.sarawak.gov.my/more.,Non-OADS,/arxiv_data1/oa_pdf/3d/9b/SAJC-3-116.PMC4014642.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/18/1b/SAJC-3-122.PMC4014643.pdf
Available from: http://www.icmr.nic.in/ncrp/ report_pop_2001-04/05_Delhi%20Pages%20154-1 73.pdf [Last  accessed on 2014 Feb 2].,Non-OADS,/arxiv_data1/oa_pdf/75/7a/SAJC-3-128.PMC4014644.pdf
Available from: http://www.icmr.nic.in/ncrp/1999-00/PBCR%20 Report%201999_00.pdf [Last accessed on 2014 Feb 2].,Non-OADS,/arxiv_data1/oa_pdf/75/7a/SAJC-3-128.PMC4014644.pdf
Available from: http://globocan.iarc.fr/ factsheet.asp [Last accessed on 2012 Sep 26].,Non-OADS,/arxiv_data1/oa_pdf/eb/08/SAJC-3-138.PMC4014646.pdf
Available from:  http://www.cancer.org/Cancer/LungCancer- Non-SmallCell/ DetailedGuide/index [Last accessed on 2012 Mar 22].,Non-OADS,/arxiv_data1/oa_pdf/eb/08/SAJC-3-138.PMC4014646.pdf
Available from: http://www.nccn.org/professionals/physician_ gls/pdf/nscl.pdf [Last accessed on 2013 Mar 12].,Non-OADS,/arxiv_data1/oa_pdf/eb/08/SAJC-3-138.PMC4014646.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Preliminary study on safe thresholds for temporary internal  carotid artery occlusion in aneurysm surgery based on  motor‑evoked potential monitoring Jun Tanabe, Tatsuya Ishikawa, Junta Moroi, Akifumi Suzuki Department of Surgical Neurology, Research Institute for Brain and Blood Vessels‑AKITA, 6‑10 Senshu‑Kubota‑Machi, Akita, Japan E‑mail: *Jun Tanabe ‑ j.tanabe@akita‑noken.jp; Tatsuya Ishikawa ‑ teddyish@akita‑noken.jp; Junta Moroi ‑ moroi@akita‑noken.jp;   Akifumi Suzuki ‑ akifumi@akita‑noken.jp   *Corresponding author Received: 18 November 13   Accepted: 23 February 14   Published: 11 April 14 Abstract Background:  The study aims were to clarify safe duration for temporary vessel  occlusion of the internal carotid artery (ICA) during aneurysm surgery as exactly  as possible.",Non-OADS,/arxiv_data1/oa_pdf/29/a8/SNI-5-47.PMC4014813.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/47/130560 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130560  Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/29/a8/SNI-5-47.PMC4014813.pdf
"Surgical Neurology International 2014, 5:47  http://www.surgicalneurologyint.com/content/5/1/47the risk of procedure‑related rupture.",Non-OADS,/arxiv_data1/oa_pdf/29/a8/SNI-5-47.PMC4014813.pdf
"Surgical Neurology International 2014, 5:47  http://www.surgicalneurologyint.com/content/5/1/47RESULTS Among 45 patients who underwent temporary vessel  occlusion of the ICA, 38 (84.4%) received proximal flow  control only (proximal‑control group).",Non-OADS,/arxiv_data1/oa_pdf/29/a8/SNI-5-47.PMC4014813.pdf
"Surgical Neurology International 2014, 5:47  http://www.surgicalneurologyint.com/content/5/1/47factors such as the functionally maintained area, the area  of salvageable functional failure (ischemic penumbra),  and the area of permanent functional loss (ischemic  core).",Non-OADS,/arxiv_data1/oa_pdf/29/a8/SNI-5-47.PMC4014813.pdf
"Surgical Neurology International 2014, 5:47  http://www.surgicalneurologyint.com/content/5/1/47available in the neurosurgical field.",Non-OADS,/arxiv_data1/oa_pdf/29/a8/SNI-5-47.PMC4014813.pdf
"Surgical Neurology International 2014, 5:47  http://www.surgicalneurologyint.com/content/5/1/47single‑centre design, and a larger patient population and  further studies are needed to achieve more definitive  values.",Non-OADS,/arxiv_data1/oa_pdf/29/a8/SNI-5-47.PMC4014813.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Evaluation of an intraoperative ultrasound training model based  on a cadaveric sheep brain Jan Vavruska, Ralf Buhl1, Athanasios K. Petridis, Homajoun Maslehaty, Martin Scholz2 Department of Neurosurgery, Wedau Kliniken, Duisburg, 1Department of Neurosurgery, Städtisches Klinikum, Solingen, North Rhine-Westphalia,   2Neurosurgical Department, Universitätsklinikum Knappschaft, IGSN, Ruhr-Universität Bochum, Bochum, North Rhine-Westphalia, Germany E mail: *Jan Vavruska - janvavruska@gmx.de; Ralf Buhl - buhl@klinikumsolingen.de; Athanasios K. Petridis - opticdisc@aol.com;   Homajoun Maslehaty - h.maslehaty@gmx.de; Martin Scholz - Martin.Scholz kdu@Sana.de   *Corresponding author Received: 23 October 13  Accepted: 16 February 14  Published: 09 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130314  Quick Response Code: Abstract Background:  The present study evaluates the effectiveness of an ultrasound (US)  practice course based on a sheep brain cadaver.",Non-OADS,/arxiv_data1/oa_pdf/d6/d3/SNI-5-46.PMC4014814.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/46/130314 Copyright: © 2014 Buhl R. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d6/d3/SNI-5-46.PMC4014814.pdf
"Surgical Neurology International 2014, 5:46  http://www.surgicalneurologyint.com/content/5/1/4660% consider their theoretical and practical skills as  “basic‑poor”.",Non-OADS,/arxiv_data1/oa_pdf/d6/d3/SNI-5-46.PMC4014814.pdf
"Surgical Neurology International 2014, 5:46  http://www.surgicalneurologyint.com/content/5/1/46an artificial echogenic tumor made out of graphite and glue  with a diameter of approximately 0.5 cm into the second  specimen (specimen B).",Non-OADS,/arxiv_data1/oa_pdf/d6/d3/SNI-5-46.PMC4014814.pdf
"Surgical Neurology International 2014, 5:46  http://www.surgicalneurologyint.com/content/5/1/46Of the nine participants, six (66%) were able to show  the anatomical landmarks in the second session with an  already remarkably decreased mean time of 154 s (SD  73.9).",Non-OADS,/arxiv_data1/oa_pdf/d6/d3/SNI-5-46.PMC4014814.pdf
"Surgical Neurology International 2014, 5:46  http://www.surgicalneurologyint.com/content/5/1/46for neurosurgical training like the various virtual reality  models,[1] the artificial model by Mori,[13] and the human  cadaver model by Olabe[14] are available but not useful  for US training.",Non-OADS,/arxiv_data1/oa_pdf/d6/d3/SNI-5-46.PMC4014814.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comReview Article An overview of the current surgical options for pineal region  tumors Waleed A. Azab, Khurram Nasim, Waleed Salaheddin Department of Neurosurgery, Ibn Sina Hospital, Kuwait City, Kuwait E‑mail: *Waleed A. Azab‑waleedazab@hotmail.com; Khurram Nasim‑neurosurgeon88@gmail.com; Waleed Salaheddin‑waleedsalah1977@gmail.com   *Corresponding author: Received: 31 January 14  Accepted: 16 February 14  Published: 25 March 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.129430  Quick Response Code: Abstract Background:  The list of pineal region tumors comprises an extensive array  of pathological entities originating within one of the most complex areas of the  intracranial cavity.",Non-OADS,/arxiv_data1/oa_pdf/2e/b2/SNI-5-39.PMC4014815.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/39/129430 Copyright: © 2014 Azab  WA.,Non-OADS,/arxiv_data1/oa_pdf/2e/b2/SNI-5-39.PMC4014815.pdf
"Surgical Neurology International 2014, 5:39  http://www.surgicalneurologyint.com/content/5/1/39In this article we present an overview of the contemporary  surgical interventions for management of pineal region  tumors.",Non-OADS,/arxiv_data1/oa_pdf/2e/b2/SNI-5-39.PMC4014815.pdf
"Surgical Neurology International 2014, 5:39  http://www.surgicalneurologyint.com/content/5/1/39and in cases with low‑lying torcula Herophili [Figure 2].",Non-OADS,/arxiv_data1/oa_pdf/2e/b2/SNI-5-39.PMC4014815.pdf
"Surgical Neurology International 2014, 5:39  http://www.surgicalneurologyint.com/content/5/1/39described by Ellenbogen and Moores in 1997,[15] and  has become the most favorable initial diagnostic and  therapeutic methodology in many patients with tumors  of the pineal region since they commonly present with  noncommunicating hydrocephalus [Figures 4‑6].",Non-OADS,/arxiv_data1/oa_pdf/2e/b2/SNI-5-39.PMC4014815.pdf
"Surgical Neurology International 2014, 5:39  http://www.surgicalneurologyint.com/content/5/1/39as they permit the passage of larger ‑diameter biopsy   forceps and consequently larger sample sizes.",Non-OADS,/arxiv_data1/oa_pdf/2e/b2/SNI-5-39.PMC4014815.pdf
"Surgical Neurology International 2014, 5:39  http://www.surgicalneurologyint.com/content/5/1/39It should, however, be emphasized that pineal region  tumors in general and germ cell tumors in particular  commonly display heterogeneity and mixed cell  populations within the same tumor.",Non-OADS,/arxiv_data1/oa_pdf/2e/b2/SNI-5-39.PMC4014815.pdf
"Surgical Neurology International 2014, 5:39  http://www.surgicalneurologyint.com/content/5/1/39REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/2e/b2/SNI-5-39.PMC4014815.pdf
"Surgical Neurology International 2014, 5:39  http://www.surgicalneurologyint.com/content/5/1/3949.",Non-OADS,/arxiv_data1/oa_pdf/2e/b2/SNI-5-39.PMC4014815.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Cranio cervical tuberculous hypertrophic pachymeningitis Satya Bhusan Senapati, Sudhansu Sekhar Mishra, Srikanta Das, Deepak Kumar Parida,   Mani Charan Satapathy Department of Neurosurgery, SCB Medical College and Hospital, Cuttack, Odisha, India E‑mail: *Satya Bhusan Senapati ‑ satya.bhusan.senapati@gmail.com; Sudhansu Sekhar Mishra ‑ drsmishra@gmail.com; Srikanta Das ‑ drsrikantdas@gmail.com;  Deepak Kumar Parida ‑ deepak7077@gmail.com; Mani Charan Satapathy ‑ drmcsatapathy@gmail.com   *Corresponding author Received: 26 November 13  Accepted: 07 March 14  Published: 16 April 14 Abstract Background:  Hypertrophic pachymeningitis is a unique clinical entity characterized  by fibrosis and thickening of dura mater resulting in neurological dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/56/99/SNI-5-52.PMC4014816.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/52/130907 Copyright: © 2014 Senapati SB.,Non-OADS,/arxiv_data1/oa_pdf/56/99/SNI-5-52.PMC4014816.pdf
"Surgical Neurology International 2014, 5:52  http://www.surgicalneurologyint.com/content/5/1/52this report, we describe the clinical features, radiological  findings, and therapeutic options of this unique clinical  entity.",Non-OADS,/arxiv_data1/oa_pdf/56/99/SNI-5-52.PMC4014816.pdf
"Surgical Neurology International 2014, 5:52  http://www.surgicalneurologyint.com/content/5/1/52third stage, patients eventually suffer from spinal cord  compression.",Non-OADS,/arxiv_data1/oa_pdf/56/99/SNI-5-52.PMC4014816.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Durotomy repair in minimally invasive transforaminal lumbar  interbody fusion by nonpenetrating clips Yen‑Po Cheng, Ping‑ Yi Lin1, Abel Po‑Hao Huang2, Chun‑ Yuan Cheng, Chien‑Min Chen,   Dueng‑ Yuan Hueng3 Division of Neurosurgery, Department of Surgery, 1Transplant Medicine and Surgery Research Centre, Changhua Christian Hospital, Changhua, 2Department of  Neurosurgery, Department of Surgery, National Taiwan University Hospital, and National Taiwan University College of Medicine, 3Department of Neurological  Surgery, Tri‑Service General Hospital, National Defense Medical Center, Taipei, Taiwan E‑mail: Yen‑Po Cheng ‑ 134309@cch.org.tw; Ping‑Yi Lin ‑ 69221@cch.org.tw; Abel Po‑Hao Huang ‑ how .how0622@gmail.com; Chun‑Yuan Cheng ‑ 83998@ cch.org.tw; *Chien‑Min Chen ‑ 96015@cch.org.tw; *Dueng ‑ Yuan Hueng‑hondy2195@yahoo.com.tw   *Corresponding author  Received: 02 January 14   Accepted: 14 February 14   Published: 20 March 14 Abstract Background:  Closure of the dura defect may be easy to perform in open lumbar  surgery but could be difficult in minimally invasive transforaminal lumbar interbody  fusions (MIS‑TLIF) since MIS‑TLIF was done through a small tube, which limited  the use of standard dural repair instruments.",Non-OADS,/arxiv_data1/oa_pdf/9a/5f/SNI-5-36.PMC4014817.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/36/129161 Copyright:  © 2014 Cheng Y.,Non-OADS,/arxiv_data1/oa_pdf/9a/5f/SNI-5-36.PMC4014817.pdf
"Surgical Neurology International 2014, 5:36  http://www.surgicalneurologyint.com/content/5/1/36spinal stenosis.",Non-OADS,/arxiv_data1/oa_pdf/9a/5f/SNI-5-36.PMC4014817.pdf
"Surgical Neurology International 2014, 5:36  http://www.surgicalneurologyint.com/content/5/1/36durotomy to heal.",Non-OADS,/arxiv_data1/oa_pdf/9a/5f/SNI-5-36.PMC4014817.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor RE: The risks of epidural and transforaminal steroid injections in the  spine: Commentary and a comprehensive review of the literature Laxmaiah Manchikanti, Alan D. Kaye1, Joshua A. Hirsch2 Medical Director, Pain Management Center of Paducah, Paducah, Clinical Professor, Anesthesiology and Perioperative Medicine, University of Louisville, Louisville,  KY , Paducah, Kentucky, 1Department of Anesthesia, LSU Health Science Center, New Orleans, LA 2Vice Chief of Interventional Care, Chief of Minimally Invasive  Spine Surgery, Service Line Chief of Interventional Radiology, Director of Endovascular Neurosurgery and Neuroendovascular Program, Massachusetts General  Hospital, Associate Professor, Harvard Medical School, Boston, MA, USA E‑mail: *Laxmaiah Manchikanti ‑ drlm@thepainmd.com; Alan David Kaye ‑ alankaye44@hotmail.com; Joshua Hirsch ‑ HIrsch@snisonline.org   *Corresponding author Received: 14 January 14  Accepted: 24 February 14  Published: 25 March 14 Dear Editor, We read with interest the comprehensive literature review  and commentary by Dr. Epstein of the risks of epidural  and transforaminal steroid injections in the spine.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/38/129429 Copyright: © 2014 Manchikanti L. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38Overall this manuscript would be appropriate for  describing the infectious complications based on  contaminated steroid injection.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38results of a randomized, double‑blind, active‑control trial.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38demonstrated “efficacy for up to 6 months of pain relief,  though long‑term benefits are less reliable.”[19] Dr. Epstein  also did not exclude Dr. Landa’s acknowledgement that  “.these injections can also result in severe complications.”  Landa et al .’s words were included to present Landa’s  balanced views, and his statements/conclusions were not  Dr. Epstein’s “erroneous interpretations.” Query It would appear that her focus may have been on the  contaminated epidural steroid injections resulting in  meningitis.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38Table 1: Sections and summaries News of Infections Attributed to Epidural/Transforaminal  Steroid Injections The Failure to Adequately Regulate Specialty Pharmacies New England Compounding CenterThe Center for Disease Control (October 29, 2012) reported 25 deaths due to  meningitis, 337 patients sickened in 18 states, and an additional 14,000 patients  probably exposed to contaminated steroids.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38Table 1: Continued Relative Efficacy of Caudal Epidural Injections with Local  Anesthetic With or Without SteroidsIn a 2‑year randomized, double‑blind, controlled trial of fluoroscopic caudal epidural  injections (with or without steroids), Manchikanti et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38Table 1: Continued Clinical Example of Irreversible Paraplegia Secondary to  Adhesive ArachnoiditisIn Rodriguez Luna et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38A 30% or greater reduction in radicular pain utilizing the  Visual Analog Scale (VAS) was considered a “success”.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38Cervical Epidural Steroid Injections, No Long‑standing  Benefit of Epidural Steroids/Local Anesthetic vs. Sterile .",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38any significant radiographic findings.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/38will substantiate the summaries I have provided in this  review article.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology International 2014, 5:38  http://www.surgicalneurologyint.com/content/5/1/3815.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/SNI-5-38.PMC4014818.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Use of Dyna CT in evaluation and treatment of pseudoaneurysm  secondary to craniofacial tumor resection: Case report and  diagnostic implications Akil P .",Non-OADS,/arxiv_data1/oa_pdf/65/76/SNI-5-48.PMC4014819.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/48/130561 Copyright: © 2014 Patel AP .,Non-OADS,/arxiv_data1/oa_pdf/65/76/SNI-5-48.PMC4014819.pdf
"Surgical Neurology International 2014, 5:48  http://www.surgicalneurologyint.com/content/5/1/48success.",Non-OADS,/arxiv_data1/oa_pdf/65/76/SNI-5-48.PMC4014819.pdf
"Surgical Neurology International 2014, 5:48  http://www.surgicalneurologyint.com/content/5/1/482.",Non-OADS,/arxiv_data1/oa_pdf/65/76/SNI-5-48.PMC4014819.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Acute posttraumatic pediatric cerebral venous thrombosis: Case  report and review of literature Al-Wala Awad, Ratan Bhardwaj1 University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA, 1Department of Pediatric Neurosurgery, Barrow Neurological Institute at Phoenix  Children’s Hospital, Phoenix, AZ 85004, USA E-mail: *Al-Wala Awad - wala.awad@arizona.edu; Ratan Bhardwaj - ratan.bhardwaj@gmail.com   *Corresponding author Received: 02 January 14  Accepted: 17 February 14  Published: 16 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130908  Quick Response Code: Abstract Background:  Pediatric cerebral venous thrombosis (CVT) is a common sequelae  of infection, coagulopathies, and dehydration in the pediatric population.",Non-OADS,/arxiv_data1/oa_pdf/a7/27/SNI-5-53.PMC4014820.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/53/130908 Copyright: © 2014 Awad AThis is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited",Non-OADS,/arxiv_data1/oa_pdf/a7/27/SNI-5-53.PMC4014820.pdf
"Surgical Neurology International 2014, 5:53  http://www.surgicalneurologyint.com/content/5/1/53venous thrombosis”, and “sigmoid sinus thrombosis after  closed head injury in children”.",Non-OADS,/arxiv_data1/oa_pdf/a7/27/SNI-5-53.PMC4014820.pdf
"Surgical Neurology International 2014, 5:53  http://www.surgicalneurologyint.com/content/5/1/53a Glasgow coma scale (GCS) of 14.",Non-OADS,/arxiv_data1/oa_pdf/a7/27/SNI-5-53.PMC4014820.pdf
"Surgical Neurology International 2014, 5:53  http://www.surgicalneurologyint.com/content/5/1/53coagulopathies, and infection all of which were  negative.",Non-OADS,/arxiv_data1/oa_pdf/a7/27/SNI-5-53.PMC4014820.pdf
"Surgical Neurology International 2014, 5:53  http://www.surgicalneurologyint.com/content/5/1/53REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/a7/27/SNI-5-53.PMC4014820.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Giant Intradiploic Angiolipoma of the skull.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/SNI-5-50.PMC4014821.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/50/130773 Copyright: © 2014 Amirjamshidi A.,Non-OADS,/arxiv_data1/oa_pdf/5e/c5/SNI-5-50.PMC4014821.pdf
"Surgical Neurology International 2014, 5:50  http://www.surgicalneurologyint.com/content/5/1/50which the magnetic resonance imaging  (MRI) and full  histopathological characteristics were not described.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/SNI-5-50.PMC4014821.pdf
"Surgical Neurology International 2014, 5:50  http://www.surgicalneurologyint.com/content/5/1/50and less than 10  cases reported in the calvarium.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/SNI-5-50.PMC4014821.pdf
"Surgical Neurology International 2014, 5:50  http://www.surgicalneurologyint.com/content/5/1/50 Figure  5:  FLAIR sequence of MR images in coronal view showing  mixed hypo- and hyper-intensities compatible with mixed lipoid and  hemosiderin/clot filled compartments in the vicinity of the tumor  Figure  6:  a and b, demonstrating the lesional flap involving the thickened bone measuring 20 × 13 × 6 cm regarding the greatest diameter  of the lesion.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/SNI-5-50.PMC4014821.pdf
"Surgical Neurology International 2014, 5:50  http://www.surgicalneurologyint.com/content/5/1/50embolization of the lesion as suggested for some cases  of bone hemangiomas.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/SNI-5-50.PMC4014821.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Surgical management of large scalp infantile hemangiomas Imad S. Khan, Erin N. Kiehna1, Komal F .",Non-OADS,/arxiv_data1/oa_pdf/6d/f7/SNI-5-41.PMC4014822.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/41/129560 Copyright: © 2014 Khan IS.,Non-OADS,/arxiv_data1/oa_pdf/6d/f7/SNI-5-41.PMC4014822.pdf
"Surgical Neurology International 2014, 5:41  http://www.surgicalneurologyint.com/content/5/1/41advocated early surgical consideration.",Non-OADS,/arxiv_data1/oa_pdf/6d/f7/SNI-5-41.PMC4014822.pdf
"Surgical Neurology International 2014, 5:41  http://www.surgicalneurologyint.com/content/5/1/41out with elevated supraperiosteal flaps from both the left  and right advancing toward the midline and closed using  #4‑0 Vicryl interrupted sutures.",Non-OADS,/arxiv_data1/oa_pdf/6d/f7/SNI-5-41.PMC4014822.pdf
"Surgical Neurology International 2014, 5:41  http://www.surgicalneurologyint.com/content/5/1/41doing well with no visual problems and is achieving  milestones [Figure 4].",Non-OADS,/arxiv_data1/oa_pdf/6d/f7/SNI-5-41.PMC4014822.pdf
"Surgical Neurology International 2014, 5:41  http://www.surgicalneurologyint.com/content/5/1/41be required to close the wound (as seen in patient 2).",Non-OADS,/arxiv_data1/oa_pdf/6d/f7/SNI-5-41.PMC4014822.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Delayed rebleeding of a spontaneously thrombosed aneurysm  after subarachnoid hemorrhage Muhammad Omar Chohan,  Franklin D. Westhout, Christopher L. Taylor Department of Neurosurgery, University of New Mexico, Albuquerque, New Mexico, USA E‑mail: *Muhammad Omar Chohan ‑ mchohan@salud.unm.edu; Franklin D. Westhout ‑ westhout@yahoo.com;   Christopher L. Taylor ‑ctaylor@salud.unmedu   *Corresponding author Received: 07 November 13  Accepted: 14 February 14  Published: 28 March 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.129615  Quick Response Code: Abstract Background: This report provides a rare documentation of spontaneous thrombosis  of a ruptured aneurysm followed by delayed recanalization and subsequent  rerupture.",Non-OADS,/arxiv_data1/oa_pdf/d3/b5/SNI-5-42.PMC4014823.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/42/129615 Copyright: © 2014 Chohan MO.,Non-OADS,/arxiv_data1/oa_pdf/d3/b5/SNI-5-42.PMC4014823.pdf
"Surgical Neurology International 2014, 5:42  http://www.surgicalneurologyint.com/content/5/1/42First intervention Catheter angiography on postbleed day (PBD) #1 showed  irregularity at the basilar apex with no filling of the dome  of the basilar aneurysm, consistent with spontaneous  thrombosis [Figure 2a‑d].",Non-OADS,/arxiv_data1/oa_pdf/d3/b5/SNI-5-42.PMC4014823.pdf
"Surgical Neurology International 2014, 5:42  http://www.surgicalneurologyint.com/content/5/1/42factor‑1a (HIF‑1a) is upregulated in the aneurysm wall  and has been shown to promote pathological smooth  muscle remodeling and neo‑vascularization, likely  contributing to aneurysm progression and rupture.",Non-OADS,/arxiv_data1/oa_pdf/d3/b5/SNI-5-42.PMC4014823.pdf
BMJ Case Rep 2013;2013: http://www.ncbi.nlm.nih.gov/ pubmed/23576642.,Non-OADS,/arxiv_data1/oa_pdf/d3/b5/SNI-5-42.PMC4014823.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor Trigeminocardiac reflex: Some thought to the definition Pooyan Sadr‑Eshkevari, Bernhard J. Schaller1, Behnam Bohluli2 Professional Program for International Dentists, University of California, Los Angeles, USA, 1Research, University of Southampton,UK, 2Craniomaxillofacial  Research Center, Azad University; T ehran, Iran E‑mail: *Pooyan Sadr‑Eshkevari ‑ psadr@ucla.edu; Bernhard J. Schaller ‑ bernhardjschaller@gmail.com; Behnam Bohluli ‑ bbohluli@yahoo.com   *Corresponding author Received: 15 Januray 2014  Accepted: 18 February 14  Published: 29 March 14 Dear Editor, We read with great interest one of the rare prospective  studies related to the Trigeminocardiac Reflex (TCR)  by Etezadi et al .",Non-OADS,/arxiv_data1/oa_pdf/4b/e2/SNI-5-43.PMC4014824.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/43/129617,Non-OADS,/arxiv_data1/oa_pdf/4b/e2/SNI-5-43.PMC4014824.pdf
"Surgical Neurology International 2014, 5:43  http://www.surgicalneurologyint.com/content/5/1/43be expected and its rate is much higher that what is  described throughout the literature.",Non-OADS,/arxiv_data1/oa_pdf/4b/e2/SNI-5-43.PMC4014824.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Endoscopic endonasal skull base approach for parasellar lesions:  Initial experiences, results, efficacy, and complications Shigetoshi Yano, Takuichiro Hide, Naoki Shinojima, Yu Hasegawa1, Takayuki Kawano,  Jun‑ichi Kuratsu Departments of Neurosurgery, and 1Pharmacology and Molecular Therapeutics, Faculty of Life Sciences Research, Kumamoto University Graduate School,  Kumamoto, Japan E‑mail: *Shigetoshi Yano ‑ yanos@kumamoto‑u.ac.jp; Takuichiro Hide ‑ thide@fc.kuh.kumamoto‑u.ac.jp; Naoki Shinojima ‑ nshinojima@hotmail.com;  Yu Hasegawa ‑ fpmhasse@yahoo.co.jp; Takayuki Kawano ‑ tkawano‑nsu@umin.ac.jp; Jun‑ichi Kuratsu ‑ jkuratsu@kumamoto‑u.ac.jp   *Corresponding author Received: 15 August 13  Accepted: 11 November 13  Published: 16 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130901  Quick Response Code: Abstract Background:  Endoscopic surgery is suitable for the transsphenoidal approach; it  is minimally invasive and provides a well‑lit operative field.",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/51/130901 Copyright: © 2014 Yano S. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Surgical Neurology International 2014, 5:51  http://www.surgicalneurologyint.com/content/5/1/51approach for frontal base meningiomas[2,4,23,28] or  craniopharyngiomas,[4,5] the lateral approach for  intracavernous tumors,[6] and the clival approach for  chordoma[16,18] carried out under endoscopy have been  reported.",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Surgical Neurology International 2014, 5:51  http://www.surgicalneurologyint.com/content/5/1/51structures under clear endoscopic visualization (Anterior  extended approach; Figure 1b].",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Surgical Neurology International 2014, 5:51  http://www.surgicalneurologyint.com/content/5/1/51and basilar artery.",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Surgical Neurology International 2014, 5:51  http://www.surgicalneurologyint.com/content/5/1/5112 cases; of these 8 cases of clival lesions showed complete  recovery postoperatively, and 3 cases of cavernous lesion  and 1 case of atypical meningioma extending into the  superior orbital fissure showed no improvement after  surgery.",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Surgical Neurology International 2014, 5:51  http://www.surgicalneurologyint.com/content/5/1/51Three of the seven cases of CSF leakage developed  meningitis.",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Surgical Neurology International 2014, 5:51  http://www.surgicalneurologyint.com/content/5/1/51Intratumoral hematoma in the remnant tumor under the  optic nerve was observed in a recurrent pituitary adenoma  1 week after removal, and incomplete recovery of a visual  deficit was noted.",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Surgical Neurology International 2014, 5:51  http://www.surgicalneurologyint.com/content/5/1/51were noted (excluding hormonal deficit).",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Surgical Neurology International 2014, 5:51  http://www.surgicalneurologyint.com/content/5/1/51CONCLUSION This study summarizes our initial experiences using  the endoscopic skull base approach for midline lesions.",Non-OADS,/arxiv_data1/oa_pdf/40/4f/SNI-5-51.PMC4014825.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Os odontoideum in identical twins: Comparative gene   expression analysis David Straus, Shunbin Xu1, Vincent C. Traynelis Departments of Neurological Surgery, and 1Pharmacology, Ophthalmology and Neurological Sciences, Rush University Medical Center, Chicago, IL, USA E‑mail: David Straus ‑ David_Straus@rush.edu; Shunbin Xu ‑ Shunbin_Xu@rush.edu; *Vincent C. Traynelis ‑ Vincent_Traynelis@rush.edu   *Corresponding author Received: 04 December 13  Accepted: 06 February 14  Published: 20 March 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.129259  Quick Response Code: Abstract Background: Os odontoideum is a well identified anomaly of the craniovertebral  junction.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/37/129259 Copyright: © 2014 Straus D. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37INTRODUCTION Os odontoideum is a well‑defined anatomic anomaly  consisting of a smooth ossicle of bone separated from  a shortened odontoid process.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37pain and myelopathy.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37array cards was performed using the Taqman Gene  Expression Master mix (Applied Biosystem) according  to manufacturer’s protocol on a 7900HTReal‑time  PCR system at the miRNA and Gene Expression Core,  Rush University Medical Center.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37Table 1: Top 30 gene expression differences between Twins and non‑os Twin os ( n=2) vs non‑os ( n=4) Gene R/Q BH Location NCBI Gene summary[28] CACNG6 565.44 P<0.05 19q13.4 Voltage‑dependent calcium channels are composed of five subunits.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37Table 1: Continued Twin os ( n=2) vs non‑os ( n=4) Gene R/Q BH Location NCBI Gene summary[28] IGF2 101.36 P<0.05 11p15.5 This gene encodes a member of the insulin family of polypeptide growth factors, which are  involved in development and growth.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37Table 1: Continued Twin os ( n=2) vs non‑os ( n=4) Gene R/Q BH Location NCBI Gene summary[28]  facilitate complex assembly and transcription initiation.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37Table 1: Continued Twin os ( n=2) vs non‑os ( n=4) Gene R/Q BH Location NCBI Gene summary[28] PRKCZ 71.11 P<0.05 1p36.33‑p36.2 Protein kinase C (PKC) zeta is a member of the PKC family of serine/threonine kinases, which are  involved in a variety of cellular processes such as proliferation, differentiation and secretion.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37Table 2: Complete results of os vs. non‑os relative gene  expression Twin os ( n=2) vs non‑os ( n=4) Gene R/Q BH (56%) CACNG6‑Hs00230428_m1 565.442076 P<0.05 PHEX‑Hs01011692_m1 446.7033746 P<0.005 CACNA2D3‑Hs01045030_m1 124.9153678 P<0.005 IL2‑Hs00174114_m1 116.2778264 P<0.0005 FAS‑Hs00531110_m1 113.2674924 P<0.05 TUFT1‑Hs00360629_m1 108.8061243 P<0.005 KIT‑Hs00174029_m1 107.2826289 P<0.0005 TGFBR2‑Hs00559661_m1 102.401766 P<0.05 IGF2‑Hs00171254_m1 101.3615162 P<0.05 PLCG2‑Hs00182192_m1 99.78758191 P<0.005 CACNA1H‑Hs01103523_m1 97.34123004 P<0.05 TGFBI‑Hs00165908_m1 91.5777402 P<0.05 MMP8‑Hs00233972_m1 90.29371725 P<0.0001 CACNA2D2‑Hs01021049_m1 86.02436482 P<0.05 SMAD7‑Hs00178696_m1 83.99117987 P<0.05 TBP‑Hs99999910_m1 77.38842737 P<0.005 UBC‑Hs00824723_m1 77.01042068 P<0.05 NFKB1‑Hs00765730_m1 76.42075734 P<0.05 PLCB2‑Hs00190117_m1 74.9898958 P<0.0005 GATA2‑Hs00231119_m1 72.83520954 P<0.005 SIRT6‑Hs00213036_m1 72.36975003 P<0.005 TBP‑Hs00427621_m1 71.90909955 P<0.005 PRKCZ‑Hs00177051_m1 71.10906373 P<0.05 CREB3‑Hs00197255_m1 69.57215719 P<0.005 CAMK4‑Hs00174318_m1 67.7555896 P<0.0001 CASP4‑Hs01031947_m1 67.27551 P<0.0005 YWHAZ‑Hs00237047_m1 67.1263045 P<0.005 POLR2C‑Hs00160308_m1 66.63915512 P<0.05 RUNX2‑Hs00231692_m1 65.995599 P<0.005 E2F3‑Hs00605457_m1 65.10544495 P<0.0001 SMAD5‑Hs00195437_m1 61.96846685 P<0.05 ELF4‑Hs01086125_m1 61.74899285 P<0.005 GNAI3‑Hs00197803_m1 61.3856538 P<0.05 PSMA3‑Hs00541059_m1 59.90719904 P<0.005 RELA‑Hs00153294_m1 58.51434644 P<0.005 CSNK1D‑Hs01017895_m1 57.87562737 P<0.005 GNAI2‑Hs01064686_m1 57.49499065 P<0.005 TGFBR1‑Hs00610319_m1 57.37234408 P<0.005 GNG2‑Hs00828232_m1 56.75024144 P<0.005 POLR2B‑Hs00265358_m1 54.65071194 P<0.05 PIK3CD‑Hs00192399_m1 54.15796684 P<0.005 GNAQ‑Hs00387073_m1 53.36054444 P<0.005 SIRT5‑Hs00202043_m1 52.99381137 P<0.005 E2F5‑Hs00231092_m1 52.51367852 P<0.005 GADD45B‑Hs00169587_m1 52.407263 P<0.05 CASP7‑Hs00169152_m1 51.68136143 P<0.005 MRPL19‑Hs00608519_m1 50.97490762 P<0.0005 TCF4‑Hs00162613_m1 50.25789151 P<0.005 (Contd ...)Table 2: Continued Twin os ( n=2) vs non‑os ( n=4) Gene R/Q BH (56%) NFKB2‑Hs00174517_m1 48.7725478 P<0.005 VEGFA‑Hs00900054_m1 48.4581505 P<0.05 CREBBP‑Hs00231733_m1 47.78444394 P<0.005 CASP8‑Hs01018151_m1 46.28991997 P<0.05 FGFR1‑Hs00241111_m1 46.06621367 P<0.0005 PRKAR1A‑Hs00267597_m1 45.75140814 P<0.05 MAPK9‑Hs00177102_m1 45.27242174 P<0.005 IPO8‑Hs00183533_m1 44.70904295 P<0.005 IGF1R‑Hs00609566_m1 44.33924933 P<0.05 REL‑Hs00968436_m1 44.31068845 P<0.0005 PLCG1‑Hs00234046_m1 44.1343681 P<0.0005 SOS1‑Hs00362308_m1 43.58778631 P<0.05 MAPK13‑Hs00234085_m1 43.51318621 P<0.005 STAT1‑Hs01014002_m1 43.15939505 P<0.05 TFIP11‑Hs00201749_m1 43.00329653 P<0.005 AKT1‑Hs00178289_m1 42.35735581 P<0.005 HDAC3‑Hs00187320_m1 41.3957745 P<0.05 CASP3‑Hs00234387_m1 41.39331585 P<0.005 JMJD4‑Hs01061169_m1 41.29007126 P<0.0005 GSK3B‑Hs00275656_m1 40.34632151 P<0.05 GTF2B‑Hs00155321_m1 40.19048896 P<0.005 HDAC4‑Hs00195814_m1 40.10003337 P<0.05 PSMB2‑Hs01002946_m1 40.03032093 P<0.005 CBFB‑Hs00242387_m1 40.01894293 P<0.05 CASP9‑Hs00154260_m1 39.6212818 P<0.005 GAPDH‑Hs99999905_m1 39.45539253 P<0.005 VEGFB‑Hs00173634_m1 38.55567983 P<0.005 GATA3‑Hs00231122_m1 38.41059059 P<0.005 MAPK14‑Hs00176247_m1 38.05872744 P<0.05 PSMC2‑Hs00739800_m1 38.0290858 P<0.005 MAPK3‑Hs00385075_m1 37.51114806 P<0.005 CACNB4‑Hs00167878_m1 37.16357932 P<0.005 INPP5D‑Hs00183290_m1 37.14258136 P<0.005 GRB2‑Hs00157817_m1 36.9891534 P<0.05 PSMB5‑Hs00605652_m1 36.97894053 P<0.05 RB1‑Hs01078066_m1 36.90756433 P<0.0005 ABL1;BCR‑Hs00245445_m1 36.81411873 P<0.05 VDR‑Hs01045840_m1 36.32582263 P<0.005 RAF1‑Hs00234119_m1 36.14930246 P<0.005 SIRT1‑Hs01009006_m1 35.85850486 P<0.005 HDAC8‑Hs00218503_m1 35.85287274 P<0.005 PRKCD‑Hs01090047_m1 35.35934633 P<0.005 PLCB1‑Hs00248563_m1 35.28520599 P<0.05 COL19A1‑Hs00156940_m1 35.24923961 P<0.005 PSMC3‑Hs00267682_m1 34.76949247 P<0.05 PSMC4‑Hs00197826_m1 34.75465601 P<0.05 PRKAR1B‑Hs00406762_m1 34.54533798 P<0.05 DDR1‑Hs00233612_m1 34.38126556 P<0.005 ITPR1‑Hs00181881_m1 34.34596481 P<0.005 (Contd ...)",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37Table 2: Continued Twin os ( n=2) vs non‑os ( n=4) Gene R/Q BH (56%) GADD45G‑Hs00198672_m1 34.26597171 P<0.05 TAB1‑Hs00196143_m1 34.16783805 P<0.0005 PIK3CA‑Hs00180679_m1 33.87132397 P<0.005 ATR‑Hs00354807_m1 33.82496736 P<0.05 EP300‑Hs00230938_m1 33.80868932 P<0.005 ACVR2B‑Hs00609603_m1 33.4621255 P<0.05 CASP2‑Hs00234982_m1 32.85577281 P<0.05 PTEN‑Hs01920652_s1 32.81195837 P<0.005 PRKACB‑Hs00176944_m1 32.81096995 P<0.005 PRKCE‑Hs00178455_m1 32.62503402 P<0.0005 CDK4‑Hs00175935_m1 32.55518355 P<0.005 DVL2‑Hs00182901_m1 32.43859181 P<0.005 CAMK2D‑Hs00241833_m1 32.35887661 P<0.05 TAB2‑Hs00248373_m1 32.35869844 P<0.05 MAPK1‑Hs01046830_m1 32.26353183 P<0.05 PRKDC‑Hs00179161_m1 32.20590998 P<0.005 TFRC‑Hs99999911_m1 32.0255323 P<0.005 BCL2‑Hs99999018_m1 31.98634237 P<0.0005 SMAD4‑Hs00929647_m1 31.75346606 P<0.005 EFNB1‑Hs00270004_m1 31.69950049 P<0.005 PIAS1‑Hs00184008_m1 31.59519581 P<0.005 MAP2K4‑Hs00387426_m1 31.10665912 P<0.05 ELK1‑Hs00428286_g1 31.01493418 P<0.005 PRKCB‑Hs00176998_m1 30.86544478 P<0.005 E2F6‑Hs00242501_m1 30.83945104 P<0.005 CACNB1‑Hs00609501_m1 30.59402173 P<0.05 ATM‑Hs01112307_m1 30.48818951 P<0.005 SIRT2‑Hs00247263_m1 30.43753762 P<0.005 PSMC5‑Hs00267687_m1 30.12796121 P<0.0005 HDAC10‑Hs00368899_m1 29.7331829 P<0.05 MDM2‑Hs99999008_m1 29.45532391 P<0.005 MAP3K7‑Hs00177373_m1 29.38079948 P<0.005 SMAD3‑Hs00232222_m1 29.23583914 P<0.005 CREB1‑Hs00231713_m1 28.88115729 P<0.05 PUM1‑Hs00206469_m1 28.77393578 P<0.005 HDAC5‑Hs00608366_m1 28.73987704 P<0.005 CASP1‑Hs00354836_m1 28.63819756 P<0.05 ATF2‑Hs00153179_m1 28.54531252 P<0.005 CREB3L4‑Hs00370116_m1 28.4467662 P<0.005 CASP10‑Hs01017902_m1 28.41388429 P<0.05 TP53‑Hs01034249_m1 28.16113504 P<0.005 PRKAR2A‑Hs00177760_m1 27.53676717 P<0.05 EIF2B1‑Hs00426752_m1 27.46093807 P<0.05 HPRT1‑Hs99999909_m1 27.17679034 P<0.05 HIPK2‑Hs00179759_m1 27.05025347 P<0.005 LTBP3‑Hs00221445_m1 26.83850085 P<0.005 HDAC2‑Hs00231032_m1 26.78680935 P<0.05 PSMA2‑Hs00855061_sH 26.63525188 P<0.05 BAX‑Hs00180269_m1 26.15599313 P<0.005 (Contd ...)Table 2: Continued Twin os ( n=2) vs non‑os ( n=4) Gene R/Q BH (56%) CDK2‑Hs01548894_m1 26.13292739 P<0.005 SATB1‑Hs00161515_m1 26.03928831 P<0.005 PSMA6‑Hs00853240_sH 26.02093338 P<0.005 SMAD4‑Hs00232068_m1 25.83323033 P<0.005 CALM1‑Hs00237233_m1 25.77014659 P<0.005 GNB1‑Hs00181845_m1 24.69083394 P<0.005 BMPR2‑Hs00176148_m1 24.62245822 P<0.005 ABL1‑Hs01104728_m1 24.61795195 P<0.005 PSMD4‑Hs00356654_m1 24.57953187 P<0.005 TNFRSF10B‑Hs00366278_ m124.12849866 P<0.05 PPIA‑Hs99999904_m1 23.92599791 P<0.05 AKT2‑Hs01086102_m1 23.92056217 P<0.005 AKT3‑Hs00178533_m1 23.90283245 P<0.005 PIK3R1‑Hs00381459_m1 23.84109847 P<0.005 SIRT3‑Hs00202030_m1 23.54284675 P<0.005 HDAC9‑Hs00206843_m1 23.23657342 P<0.05 TGFB1‑Hs00998133_m1 23.21367265 P<0.005 SMAD2‑Hs00183425_m1 22.83644723 P<0.005 CHEK1‑Hs00967506_m1 22.83572474 P<0.05 HDAC7‑Hs00248789_m1 22.62838313 P<0.005 ATF1‑Hs00270896_m1 22.09395959 P<0.005 GUSB‑Hs99999908_m1 21.8421666 P<0.05 RELB‑Hs00232399_m1 21.80654839 P<0.05 BRCA1‑Hs01556193_m1 21.74461398 P<0.005 POLR2A‑Hs00172187_m1 21.44807146 P<0.005 RPS17‑Hs00734303_g1 21.0322051 P<0.05 CALM3‑Hs00270914_m1 20.18818718 P<0.005 HOXA1‑Hs00939046_m1 19.94715129 P<0.05 MAP2K6‑Hs00992389_m1 19.93605922 P<0.05 JUN‑Hs99999141_s1 19.67108465 P<0.005 CREM‑Hs01582003_g1 19.59083741 P<0.005 SMAD6‑Hs00178579_m1 18.90720269 P<0.05 TGFB1‑Hs99999918_m1 18.78369714 P<0.005 PRKACG‑Hs01033925_s1 18.11711499 P<0.05 CCNE1‑Hs01026536_m1 17.88807742 P<0.05 PRKCA‑Hs00176973_m1 17.55625604 P<0.05 COL1A1‑Hs00164004_m1 17.36127983 P<0.005 MSX2‑Hs00751239_s1 16.76995145 P<0.005 PES1‑Hs00362795_g1 16.74832062 P<0.05 BMPR1A‑Hs01034913_g1 16.64656557 P<0.005 RPL30‑Hs00265497_m1 15.71607734 P<0.05 E2F4‑Hs00608098_m1 15.29984765 P<0.005 CDKN1A‑Hs00355782_m1 15.15061788 P<0.05 HDAC1‑Hs02621185_s1 15.11899763 P<0.005 FGF2‑Hs00266645_m1 14.90047621 P<0.005 CASC3‑Hs00201226_m1 14.54674123 P<0.005 BAI1‑Hs00181777_m1 14.0180953 P<0.05 BMPR1A‑Hs00831730_s1 13.98018185 P<0.005 (Contd ...)",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37Table 2: Continued Twin os ( n=2) vs non‑os ( n=4) Gene R/Q BH (56%) EIF4E‑Hs00908915_g1 13.9589797 P<0.05 BMP6‑Hs00233470_m1 13.35696978 P<0.005 IHH‑Hs00745531_s1 13.26092052 P<0.05 ACVR1‑Hs00153836_m1 13.00447825 P<0.005 CHEK2‑Hs00200485_m1 12.92288988 P<0.005 CACNB3‑Hs00167873_m1 12.67721395 P<0.05 HDAC6‑Hs00195869_m1 12.52217699 P<0.005 COL4A4‑Hs00164150_m1 11.96933439 P<0.005 GNB2‑Hs00929275_g1 11.79646015 P<0.05 ADCY3‑Hs00269618_m1 11.54764087 P<0.05 KAT2B‑Hs00187332_m1 10.6524953 P<0.05 OAZ1‑Hs00427923_m1 10.36895925 P<0.05 GNAS‑Hs00255603_m1 9.843423704 P<0.05 PDGFA‑Hs00234994_m1 9.287349766 P<0.05 PIK3R2‑Hs00178181_m1 8.060432114 P<0.05 TNNT1‑Hs00162848_m1 8.050441173 P<0.05 E2F1‑Hs00153451_m1 7.929855963 P<0.05 ATF4‑Hs00909568_g1 7.697303147 P<0.05 PRKAR2B‑Hs00176966_m1 6.308900397 P<0.05 BH: Benjamini‑Hochberg correction, RQ: Relative quantification valuebinds both basic and acidic fibroblast growth factor and  mediates cell differentiation and mitogenesis.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37This study identified a litany of significant differences  in gene expression (213/380 genes in total) between  the T wins with the non‑os group.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37Table 4: Top 10 RQ values in os vs non‑os with uncorrected P<0.1 Os (n=4) vs non‑os ( n=4) Gene R/Q BH Location NCBI Gene summary[28] MMP8 95.31 P=ns 11q22.3 Proteins of the matrix metalloproteinase family are involved in the breakdown of extracellular matrix in  normal physiological processes, such as embryonic development, reproduction, and tissue remodeling,  as well as in disease processes, such as arthritis and metastasis.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37in the T wins.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology International 2014, 5:37  http://www.surgicalneurologyint.com/content/5/1/37opsismodysplasia.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
Available from: http://www.ncbi.nlm.nih.gov/gene.,OADS,/arxiv_data1/oa_pdf/f0/fb/SNI-5-37.PMC4014826.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Is surgical spinal decompression for supratentorial GBM  symptomatic drop down metastasis warranted?",Non-OADS,/arxiv_data1/oa_pdf/79/27/SNI-5-40.PMC4014827.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/40/129558 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.129558  Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/79/27/SNI-5-40.PMC4014827.pdf
"Surgical Neurology International 2014, 5:40  http://www.surgicalneurologyint.com/content/5/1/40report and compare outcomes in patients who received  surgical decompression with those who did not.",Non-OADS,/arxiv_data1/oa_pdf/79/27/SNI-5-40.PMC4014827.pdf
"Surgical Neurology International 2014, 5:40  http://www.surgicalneurologyint.com/content/5/1/40supportive care and antibiotics and discharged from the  hospital once in stable condition.",Non-OADS,/arxiv_data1/oa_pdf/79/27/SNI-5-40.PMC4014827.pdf
"Surgical Neurology International 2014, 5:40  http://www.surgicalneurologyint.com/content/5/1/40However, it seems reasonable to use steroids in acute  settings till appropriate guidelines become available.",Non-OADS,/arxiv_data1/oa_pdf/79/27/SNI-5-40.PMC4014827.pdf
"Surgical Neurology International 2014, 5:40  http://www.surgicalneurologyint.com/content/5/1/40CONCLUSION No evidence‑based guidelines have yet been developed  due to the rare incidence of spinal metastasis from a  GBM and no treatment regimen has yet demonstrated  survival benefit.",Non-OADS,/arxiv_data1/oa_pdf/79/27/SNI-5-40.PMC4014827.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report A rare giant scalp dermatofibrosarcoma protuberans Muhammad Z. Arifin1,2, Farid Yudoyono1, Rully H. Dahlan1, Bethy S. Hernowo3,   Agung B. Sutiono1,2, Ahmad Faried1,2 1Department of Neurosurgery, 2Oncology Working Group, Health Research Unit, 3Department of Anatomical Pathology, Faculty of Medicine, Universitas  Padjadjaran-Dr.  Hasan Sadikin General Hospital, Bandung, Indonesia E-mail: Muhammad Z. Arifin - ipung_mza@yahoo.co.id; *Farid Yudoyono - faridense@gmail.com; Rully H. Dahlan - rullyneurosurgeon@gmail.com;   Bethy S. Hernowo - bethy_hernowo@yahoo.com; Agung B. Sutiono - agungbudis@gmail.com; Ahmad Faried - faried.fkup@gmail.com   *Corresponding author Received: 09 December 13  Accepted: 17 February 14  Published: 01 April 14 Abstract Background: Giant dermatofibrosarcoma protuberans (DFSP) of the scalp is a  rare case, which is an intermediate grade soft tissue neoplasm originating from  the dermal layer of the skin, which usually occurs in adults.",Non-OADS,/arxiv_data1/oa_pdf/e4/f3/SNI-5-45.PMC4014828.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/45/129909 Copyright: © 2014 Arifin MZ.,Non-OADS,/arxiv_data1/oa_pdf/e4/f3/SNI-5-45.PMC4014828.pdf
"Surgical Neurology International 2014, 5:45  http://www.surgicalneurologyint.com/content/5/1/45frontal region [Figure 1a‑d] since 2.5 years before  admission.",Non-OADS,/arxiv_data1/oa_pdf/e4/f3/SNI-5-45.PMC4014828.pdf
